compound_name,cas_number,smiles,Pathway,target,Information
(-)-epicatechin,490-46-0,,TGF-β / Smad Signaling,PKC,
(-)-epicatechin gallate,1257-08-5,,TGF-β / Smad Signaling,PKC,
(-)-Huperzine A,102518-79-6,C/C=C1[C@@]2(N)C3=C(NC(C=C3)=O)C[C@]/1([H])C=C(C)C2,Neuroscience,Alzheimer,NMDA receptor antagonist/AChE inhibitor
(-)-Lobeline hydrochloride,134-63-4,O[C@H](C1=CC=CC=C1)C[C@H]2N(C)[C@H](CC(C3=CC=CC=C3)=O)CCC2.Cl,Neuroscience,Nicotinic Receptor,nicotinic receptor partial agonist
(-)-Tetramisole,16595-80-5,C1CSC2=NC(CN21)C3=CC=CC=C3.Cl,Immunology/Inflammation,Parasite,Inhibitor of alkaline phosphatase
"(+,-)-Octopamine HCl",770-05-8,C1=CC(=CC=C1C(CN)O)O.Cl,Neuroscience,Dopamine Receptor,adrenoceptor agonist
(+)-Catechin hydrate,225937-10-0,,Natural Products,Others,
(+)-Ketoconazole,142128-59-4,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,Metabolism,P450,Potent inhibitor of cytochrome P450c17
(+/-)-Sulfinpyrazone,57-96-5,O=C(N1C2=CC=CC=C2)C(C(N1C3=CC=CC=C3)=O)CCS(C4=CC=CC=C4)=O,Neuroscience,COX,platelet COX inhibitor
(±)-Baclofen,1134-47-0,C10H12ClNO2,Neuroscience,GABA Receptor,
"(2S,3S)-2-Amino-3-methylpentanoic acid",73-32-5,,Others,Others,
(6-)ε-​Aminocaproic acid,60-32-2,C(CCC(=O)O)CCN,Others,Others,antifibrinolytic agent
"(R,S)-Atenolol",29122-68-7,NC(CC1=CC=C(OCC(O)CNC(C)C)C=C1)=O,GPCR/G protein,Adrenergic Receptor,β1-adrenergic receptor antagonist
"(R)-(+)-1,2-Dithiolane-3-pentanoic acid",1200-22-2,,Others,Others,
(R)-baclofen,69308-37-8,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,Membrane Transporter/Ion Channel,GABA Receptor,GABA receptor agonist
(R)-Crizotinib,877399-52-5,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,Tyrosine Kinase,c-MET,"C-MET/ALK inhibitor,potent and ATP-competitve"
(RS)-(&#177;)-Sulpiride,15676-16-1,O=C(C(C=C1S(=O)(N)=O)=C(C=C1)OC)NC[C@@H]2N(CC)CCC2,Neuroscience,Dopamine Receptor,D2-like dopamine receptor antagonist
(S)-10-Hydroxycamptothecin,19685-09-7,,DNA Damage/DNA Repair,Topoisomerase,
(S)-Flurbiprofen,51543-39-6,FC1=CC([C@@H](C(O)=O)C)=CC=C1C2=CC=CC=C2,Neuroscience,COX,inhibitors of COX-1 and COX-2
(S)-Ketoprofen,22161-81-5,O=C(C1=CC=CC([C@H](C)C(O)=O)=C1)C2=CC=CC=C2,Neuroscience,COX,COX-1 and COX-2 inhibitor
(S)-Naproxen,22204-53-1,C[C@H](C(O)=O)C1=CC=C2C=C(OC)C=CC2=C1,Neuroscience,COX,non-selective COX inhibitor
&alpha;-Estradiol,57-91-0,O[C@H]1[C@]2(C)[C@@H](CC1)[C@H](CCC3=C4C=CC(O)=C3)[C@@H]4CC2,Endocrinology and Hormones,Estrogen/progestogen Receptor,Endogenous estrogen receptor ligand
1-Hexadecanol,36653-82-4,CCCCCCCCCCCCCCCCO,Others,Others,Fatty alcohol
"1,4-Benzoquinone",106-51-4,,Others,Others,
10-DAB (10-Deacetylbaccatin),32981-86-5,O[C@](C(C)(C)C1=C(C)[C@H]2O)(C2)[C@H]([C@@H]([C@@](C([C@H]1O)=O)(C)[C@@H]3O)[C@]4([C@@H](C3)OC4)OC(C)=O)OC(C5=CC=CC=C5)=O,Cell Cycle/Checkpoint,Microtubule/Tubulin,Precursor of antitumor compound Palitaxel and Docetaxel
10-Hydroxycamptothecin,64439-81-2,,Natural Products,Topoisomerase,
17-AAG (KOS953),75747-14-7,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC,Proteases,HSP,Hsp90 inhibitor
17-Hydroxyprogesterone,68-96-2,CC([C@@]1(O)CC[C@@]2([H])[C@]([C@]3([H])CC[C@@]21C)([H])CCC4=CC(CC[C@@]43C)=O)=O,Endocrinology and Hormones,Estrogen/progestogen Receptor,endogenous progestogen as well as chemical intermediate in the biosynthesis of other steroid hormones
2-Deoxy-D-glucose,154-17-6,,Others,Hexokinase,
2-Deoxyuridine,951-78-0,OC[C@](O1)([H])[C@](O)([H])C[C@]1([H])N2C=CC(O)=NC2=O,Others,kinase,"Rutin metabolite, antioxidant"
2-Methoxyestradiol (2-MeOE2),362-07-2,CC12CCC3C(C1CCC2O)CCC4=CC(=C(C=C34)OC)O,Apoptosis,Apoptosis Inducers,"Apoptotic, antiproliferative and antiangiogenic agent"
2-Naphthol,135-19-3,,Others,Others,
2-Thiouracil,141-90-2,C1=CNC(=S)NC1=O,Others,Others,antihyperthyroid agent
2'-Deoxyguanosine,961-07-9,,Others,Others,2'-Deoxyguanosine
3-Hydroxy-2-methyl-4H-pyran-4-one,118-71-8,,Others,Others,
3-n-Butylphathlide,6066-49-5,,Natural Products,Others,
"3,4-Dihydroxybenzoic acid",99-50-3,,Natural Products,Others,
4-Aminobenzoic acid,150-13-0,,Others,Others,
4-Aminobutyric acid,56-12-2,C(CC(=O)O)CN,Others,APIs,
4-Aminophenol,123-30-8,,Others,Others,
4-Aminopyridine,504-24-5,,Membrane Transporter/Ion Channel,Potassium Channel,potassium channel-blocking agent
4-Aminosalicylic acid,65-49-6,,Microbiology & Virology,Anti-infection,
4-Hydroxybenzoic acid,99-96-7,,Others,Others,
4-Methylbenzylidene camphor,36861-47-9,,Endocrinology and Hormones,Estrogen/progestogen Receptor,
4-Methylumbelliferone (4-MU),90-33-5,,Others,Others,
4-Nitrophenol,100-02-7,,Others,Others,
5-Aminolevulinic acid HCl,5451-9-2,NCC(CCC(O)=O)=O.Cl,Others,Others,photosensitizing agent， antineoplastic agent
5-Azacytidine,320-67-2,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,Chromatin/Epigenetics,DNA Methyltransferase,DNA methyltransferase inhibitor.
5-hydroxy-L-Tryptophan,4350-09-8,OC1=CC=C2C(C(C[C@H](N)C(O)=O)=CN2)=C1,Others,Others,
5-hydroxymethyl-2-furaldehyde,67-47-0,C1=C(OC(=C1)C=O)CO,Natural Products,Others,
5-Methoxypsoralen,484-20-8,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3,Natural Products,DNA/RNA Synthesis,
5-Methoxytryptamine,608-07-1,COC1=CC(C(CCN)=CN2)=C2C=C1,Neuroscience,5-HT Receptor,"Full agonist at the 5-HT1, 5-HT2, 5-HT4, 5-HT6, and 5-HT7 receptors but has no affinity for the 5-HT3 receptor"
"6,7-Dihydroxycoumarin",305-01-1,,Natural Products,Lipoxygenase,
8-Methoxypsoralen,298-81-7,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,Natural Products,P450 (e.g. CYP17),CYP inhibitor
Abacavir,136470-78-5,C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,Inhibitor of HIV reverse transcriptase
Abacavir sulfate,188062-50-2,C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.OS(=O)(=O)O,Others,Others,Reverse transcriptase inhibitor
Abiraterone,154229-19-3,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,Metabolism,P450,Potent CYP17 inhibitor
Abiraterone acetate,154229-18-2,CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C,Metabolism,P450,Cytochrome p450 17a1 inhibitor
Abscisic Acid (Dormin),21293-29-8,,Others,Others,
ABT-199,1257044-40-8,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,Apoptosis,Bcl-2 Family,"Bcl-2 inhibitor,potent and selective"
ABT-263 (Navitoclax),923564-51-6,CC(CC1)(C)CC(CN2CCN(C3=CC=C(C(NS(C4=CC=C(N[C@@H](CSC5=CC=CC=C5)CCN6CCOCC6)C(S(C(F)(F)F)(=O)=O)=C4)(=O)=O)=O)C=C3)CC2)=C1C7=CC=C(Cl)C=C7,Apoptosis,Bcl-2 Family,"Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w"
ABT-888 (Veliparib),912444-00-9,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,Chromatin/Epigenetics,PARP,Potent PARP inhibitor
Acamprosate calcium,77337-73-6,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2],Membrane Transporter/Ion Channel,GABA Receptor,GABA receptor agonist and modulator of glutamatergic systems
Acarbose,56180-94-0,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,Others,Others,Alpha-glucosidase inhibitor
Acebutolol HCl,34381-68-5,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C.Cl,GPCR/G protein,Adrenergic Receptor,β-adrenergic receptors antagonist
Acemetacin,53164-05-9,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O,Neuroscience,COX,COX inhibitor
Acetaminophen,103-90-2,C/C(O)=N/C1=CC=C(O)C=C1,Neuroscience,COX,COX inhibitor
Acetanilide,103-84-4,CC(=O)NC1=CC=CC=C1,Others,Others,aniline derivative
Acetazolamide,59-66-5,C/C(O)=N/C1=NN=C(S(N)(=O)=O)S1,Metabolism,Carbonic Anhydrase,carbonic anhydrase (CA) inhibitor
Acetohydroxamic Acid,546-88-3,,Microbiology & Virology,Anti-infection,"Irreversible inhibitor of urease, derivative of hydroxyurea"
Acetylcholine Chloride,60-31-1,CC(=O)OCC[N+](C)(C)C.[Cl-],Neuroscience,AChR,Major transmitter at many nervous sites
Acetylcysteine,616-91-1,CC(=O)NC(CS)C(=O)O,Neuroscience,AChR,Antioxidant;mucolytic agent
Acipimox,51037-30-0,CC1=CN=C(C=[N+]1[O-])C(=O)O,Others,Others,Antilipolytic agent
Acitretin,55079-83-9,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,Others,RAR/RXR,Metabolite of etretinate
Aclidinium Bromide,320345-99-1,C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5.[Br-],Neuroscience,Muscarinic Receptor,LAMAs antagonist
ACP-196,1420477-60-6,O=C(NC1=NC=CC=C1)C2=CC=C(C3=C4C(N)=NC=CN4C([C@H]5N(C(C#CC)=O)CCC5)=N3)C=C2,Angiogenesis,BTK,irreversible BTK inhibitor
Actinomycin D,50-76-0,C62H86N12O16,Apoptosis,Apoptosis Inducers,
Acyclovir,59277-89-3,C1=NC2=C(N1COCCO)NC(=NC2=O)N,DNA Damage/DNA Repair,DNA Synthesis,Antiviral agent
Adapalene,106685-40-9,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,Others,Others,RARβ and RARγ agonist
Adapalene sodium salt,911110-93-5,COC1=C(C23C[C@@]4([H])C[C@](C2)([H])C[C@](C3)([H])C4)C=C(C5=CC=C6C=C(C([O-])=O)C=CC6=C5)C=C1.[Na+],Others,Others,Retinoic acid receptor agonist
Adefovir Dipivoxil,142340-99-6,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C,Microbiology & Virology,CMV,Reverse transcriptase inhibitor
Ademetionine,29908-03-0,C[S+](C[C@](O1)([H])[C@](O)([H])[C@](O)([H])[C@]1([H])N2C=NC(C2=NC=N3)=C3N)CC[C@@](N)([H])C([O-])=O,Others,Others,"S-adenosylmethionine, PDE4B inhibitor"
Adenine,73-24-5,C1=NC2=C(N1)C(=NC=N2)N,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,High affinity adenine receptor agonist
Adenine HCl,2922-28-3,C1=NC2=C(N1)C(=NC=N2)N.Cl,DNA Damage/DNA Repair,DNA Synthesis,Adenine receptor agonist
Adenine sulfate,321-30-2,2(C5H5N5).H2SO4,DNA Damage/DNA Repair,DNA Synthesis,
Adenosine,58-61-7,C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,nucleoside
Adenosine 5-triphosphate,34369-07-8,NC1=C(N=CN2[C@@]3([H])[C@@](O)([H])[C@@](O)([H])[C@@](O3)([H])COP(O)(OP(O)(OP(O)(O)=O)=O)=O)C2=NC=N1,Others,Others,Purinergic P2 receptor agonist
Adenosine-5'-diphosphate,58-64-0,O[C@H]1[C@H](N2C=NC3=C2N=CN=C3N)O[C@H](COP(OP(O)(O)=O)(O)=O)[C@H]1O,Metabolism,Others,"central component of energy storage, metabolism, and signal transduction in vivo;agonist of purinergic receptors"
Adiphenine HCl,50-42-0,CCN(CC)CCOC(=O)C(C1=CC=CC=C1)C2=CC=CC=C2.Cl,Neuroscience,AChR,nicotinic receptor inhibitor
Adrenalone HCl,62-13-5,CNCC(=O)C1=CC(=C(C=C1)O)O.Cl,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist
Afatinib (BIBW2992),439081-18-2,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,JAK/STAT Signaling,EGFR,Irreversible EGFR/HER2 inhibitor
Afatinib dimaleate,850140-73-7,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,Tyrosine Kinase,HER2,EGFR inhibitor
Afuresertib,1047644-62-1,CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl,PI3K/Akt/mTOR Signaling,PKB,pan-AKT inhibitor
AG-120,1448347-49-6,C28H22ClF3N6O3,Metabolism,Dehydrogenase,
AG-221 (Enasidenib),1446502-11-9,CC(O)(C)CNC1=NC(C2=NC(C(F)(F)F)=CC=C2)=NC(NC3=CC(C(F)(F)F)=NC=C3)=N1,Metabolism,Dehydrogenase,mutant isocitrate dehydrogenase 2 (IDH2) inhibitor
Agomelatine,138112-76-2,CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC,Neuroscience,5-HT Receptor,MT1/MT2 / 5-HT2C agonist
AHU-377 hemicalcium salt,1369773-39-6,C24H28Ca0.5NO5,Metabolism,Neprilysin,
AHU-377(Sacubitril),149709-62-6,C24H29NO5,GPCR/G protein,Angiotensin Receptor,
Alarelin Acetate,79561-22-1,C60H86N16O16,Endocrinology and Hormones,GnRH,
Albendazole,54965-21-8,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,Microbiology & Virology,Antibiotic,treatment of a variety of parasitic worm infestations
Albendazole Oxide,54029-12-8,CCCS(=O)C1=CC2=C(C=C1)N=C(N2)NC(=O)OC,Cell Cycle/Checkpoint,Microtubule Associated,Microtubule associated inhibitor
Alcaftadine,147084-10-4,CN1CC/C(CC1)=C2C3=CC=CC=C3CCN4C(C=O)=CN=C/24,Neuroscience,Histamine Receptor,H1 histamine receptor antagonist
Alendronate,121268-17-5,[O-]P(O[H])(C(O[H])(C([H])([H])C([H])([H])C([H])([H])N([H])[H])P(O[H])(O[H])=O)=O.[H]O[H].[H]O[H].[H]O[H].[Na+],Others,Farnesyl Diphosphate Synthase,Bone resorption inhibitor
Alendronate sodium,129318-43-0,C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.[Na+],Others,Others,Osteoclast-mediated bone resorption inhibitor
Alfacalcidol,41294-56-8,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,Vitamin D Related,VD/VDR,Bone resorption inhibitor
Alfuzosin HCl,81403-68-1,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl,GPCR/G protein,Adrenergic Receptor,"α1 adrenoceptor antagonist,functionally uro-selective"
Alibendol,26750-81-2,COC1=C(C(=CC(=C1)CC=C)C(=O)NCCO)O,Others,Others,"antispasmodic,choleretic,cholekinetic"
Aliskiren,173334-57-1,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,Others,Renin,Direct renin inhibitor
Aliskiren Hemifumarate,173334-58-2,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.C(=CC(=O)O)C(=O)O,Others,Renin,renin inhibitor
Allantoin,97-59-6,C1(C(=O)NC(=O)N1)NC(=O)N,Natural Products,Others,
Allopregnanolone,516-54-1,O[C@H]1C[C@H]2[C@@](CC1)(C)[C@@H]3[C@@H](CC2)[C@H]4[C@]([C@@H](C(C)=O)CC4)(C)CC3,Membrane Transporter/Ion Channel,GABA Receptor,GABAA receptor positive allosteric modulator
Allopurinol,315-30-0,C1=C2C(=NC=NC2=O)NN1,Others,XAO,Xanthine oxidase inhibitor
Allylthiourea,109-57-9,C=CCNC(=S)N,Others,Others,Selective inhibitor of ammonia oxidation
Almotriptan Malate,181183-52-8,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3.C(C(C(=O)O)O)C(=O)O,Neuroscience,5-HT Receptor,5-HT1B/1D-receptor agonist
Alogliptin (SYR-322),850649-61-5,CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N,Proteases,DPP-4,"DPP-4 inhibitor,potent and highly selective"
Alogliptin Benzoate,850649-62-6,CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N.C1=CC=C(C=C1)C(=O)O,Proteases,DPP-4,"DPP-4 inhibitor,selective and potent,antidiabetic drug"
Alosetron Hydrochloride,122852-69-1,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl,Neuroscience,5-HT Receptor,"5-HT3 receptor antagonist,potent and highly selective"
alpha-tocopherol,59-02-9,CC(CCC[C@@](CCC[C@@](CCC[C@@]1(CCC2=C(C(O)=C(C(C)=C2O1)C)C)C)([H])C)([H])C)C,Neuroscience,"COX,VEGFR",
Alprostadil,745-65-3,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,GPCR/G protein,Prostaglandin Receptor,vasodilator
Altrenogest,850-52-2,CC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(CC=C)O,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progestogen receptor agonist
Altretamine,645-05-6,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,DNA Damage/DNA Repair,DNA Alkylating,Antineoplastic agent
Alvelestat,848141-11-7,CC(N1C2=CC=CC(C(F)(F)F)=C2)=C(C3=CC=NN3C)C=C(C1=O)C(NCC4=NC=C(S(C)(=O)=O)C=C4)=O,Proteases,Elastase,NE inhibitor
Alverine Citrate,5560-59-8,CCN(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,GPCR/G protein,OX Receptor,Drug used for functional gastrointestinal disorders
Alvimopan,156053-89-3,C[C@@]1([H])CN(C[C@](/C(O)=N/CC(O)=O)([H])CC2=CC=CC=C2)CC[C@]1(C3=CC(O)=CC=C3)C,Endocrinology and Hormones,Opioid Receptor,Mu-opioid receptors antagonist
Amantadine,768-94-5,,Microbiology & Virology,Anti-infection,
Amantadine HCl,665-66-7,C1C2CC3CC1CC(C2)(C3)N.Cl,Neuroscience,Dopamine Receptor,Dopamine receptor agonist
Ambrisentan,177036-94-1,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,Neuroscience,Dopamine Receptor,ETA-receptor antagonist
Ambroxol HCl,23828-92-4,C1CC(CCC1NCC2=CC(=CC(=C2N)Br)Br)O.Cl,Membrane Transporter/Ion Channel,Sodium Channel,TTX-resistant Na+ currents inhibitor
Amfenac Sodium Monohydrate,61618-27-7,C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)[O-])N.O.[Na+],Neuroscience,COX,COX inhibitor
Amidopyrine,58-15-1,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C,,,analgesic，antipyretic
Amifostine,20537-88-6,NCCCNCCSP(O)(O)=O,Others,Others,cytoprotective adjuvant
Amikacin,37517-28-5,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N,Microbiology & Virology,Antibiotic,aminoglycoside antibiotic
Amikacin disulfate,39831-55-5,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N.OS(=O)(=O)O.OS(=O)(=O)O,Microbiology & Virology,Anti-infection,Semisynthetic aminoglycoside antibiotic
Amiloride HCl,2016-88-8,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.Cl,Membrane Transporter/Ion Channel,"Sodium Channel, Calcium Channel","epithelial sodium channel (ENaC) inhibitor, selective"
Amiloride HCl dihydrate,17440-83-4,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.O.O.Cl,Membrane Transporter/Ion Channel,Sodium Channel,potent epithelial sodium channel (ENaC) blocker
Aminoglutethimide,125-84-8,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,Endocrinology and Hormones,Aromatase,Aromatase inhibitor
Aminoguanidine hydrochloride,1937-19-5,N/C(N)=N\N.Cl,Others,iNOS,iNOS inhibitor
Aminophylline,317-34-0,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,Metabolism,PDE,Pan-PDE inhibitor
Aminothiazole,96-50-4,C1=CSC(=N1)N,Microbiology & Virology,Anti-infection,Thyroid inhibitor
Amiodarone HCl,19774-82-4,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I.Cl,Membrane Transporter/Ion Channel,Potassium Channel,Anti-arrhythmic drug
Amisulpride,71675-85-9,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,Neuroscience,Dopamine Receptor,Dopamine D2/D3 receptor antagonist
Amitriptyline HCl,549-18-8,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl,Neuroscience,5-HT Receptor,Serotonin /norepinephrine receptor/5-HT4/5-HT2 inhibitor
Amlexanox,68302-57-8,CC(C1=CC=C2C(C(C3=C(O2)N=C(N)C(C(O)=O)=C3)=O)=C1)C,Immunology/Inflammation,,
Amlodipine,88150-42-9,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker
Amlodipine Besylate,111470-99-6,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O,Membrane Transporter/Ion Channel,Calcium Channel,Block of L-type calcium channel
Amodiaquine dihydrochloride dihydrate,6398-98-7,CCN(CC1=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=CC=C1O)CC.Cl.Cl.O.O,Metabolism,Transferase,histamine N-methyl transferase inhibitor
Amonafide,69408-81-7,CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N,DNA Damage/DNA Repair,Topoisomerase,"DNA intercalator,Topo II inhibitor"
Amorolfine HCl,78613-38-4,CCC(C)(C)C1=CC=C(C=C1)CC(C)CN2CC(OC(C2)C)C.Cl,Microbiology & Virology,Antibiotic,antifungal reagent
Amoxapine,14028-44-5,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,Neuroscience,GlyT,GLYT2a transport activity inhibitor
Amoxicillin,26787-78-0,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,Microbiology & Virology,Anti-infection,"Moderate-spectrum, bacteriolytic, β-lactam antibiotic"
Amoxicillin trihydrate,61336-70-7,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.O.O.O,Microbiology & Virology,Anti-infection,Broad spectrum antibiotic
Amphotericin B,1397-89-3,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,Microbiology & Virology,Antibiotic,amphipathic polyene antibiotic
Ampicillin,69-52-3,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C.[Na+],Microbiology & Virology,Antibiotic,β-lactam antibiotic
Ampicillin Trihydrate,7177-48-2,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C.O.O.O,Microbiology & Virology,Anti-infection,β-lactam antibiotic
Amprenavir (agenerase),161814-49-9,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,Proteases,HIV Protease,HIV-1 protease inhibitor
Amprolium HCl,137-88-2,CCCC1=NC=C(C(=N1)N)C[N+]2=CC=CC=C2C.Cl.[Cl-],Metabolism,Vitamin,Thiamin antagonist/coccidiostat
Amsacrine,51264-14-3,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase 2 inhibitor
Amsacrine hydrochloride,54301-15-4,C21H20ClN3O3S,DNA Damage/DNA Repair,Topoisomerase,
"Amuvatinib (MP-470, HPK 56)",850879-09-3,C1CN(CCN1C2=NC=NC3=C2OC4=CC=CC=C43)C(=S)NCC5=CC6=C(C=C5)OCO6,Tyrosine Kinase,c-RET,Tyrosine kinase inhibitor
Amygdalin,29883-15-6,,Natural Products,Others,
AN-2690,174671-46-6,B1(C2=C(CO1)C=C(C=C2)F)O,Microbiology & Virology,Antibiotic,Antifungal agent
AN-2728,906673-24-3,N#CC1=CC=C(OC2=CC=C3C(COB3O)=C2)C=C1,Metabolism,PDE,"PDE4 inhibitor,anti-inflammatory compound"
Anagrelide HCl,58579-51-4,C1C2=C(C=CC(=C2Cl)Cl)NC3=NC(=O)CN31.Cl,Metabolism,PDE,Thrombocytopenic agent
Anastrozole,120511-73-1,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,Endocrinology and Hormones,Aromatase,Aromatase inhibitor
Andrographolide,5508-58-7,,Immunology/Inflammation,IκB/IKK,
Androsterone,53-41-8,O=C1CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@@]21C,Endocrinology and Hormones,Androgen Receptor,
Angiotensin II,4474-91-3,C50H71N13O12,Cardiovascular,Angiotensin Receptor,
Anidulafungin,166663-25-8,O[C@H]1[C@H](C)CN(C([C@H]([C@H](C)O)NC([C@H]([C@@H]([C@@H](C(C=C2)=CC=C2O)O)O)NC([C@H](C3)N(C([C@H]([C@H](C)O)NC4=O)=O)C[C@@H]3O)=O)=O)=O)[C@@H]1C(N[C@H]([C@@H](C[C@@H]4NC(C5=CC=C(C6=CC=C(C(C=C7)=CC=C7OCCCCC)C=C6)C=C5)=O)O)O)=O,Microbiology & Virology,Antibiotic,Antifungal drug
Aniracetam,72432-10-1,COC1=CC=C(C=C1)C(=O)N2CCCC2=O,Membrane Transporter/Ion Channel,AMPAR,Nootropic drug for senile dementia
Anisodamine,55869-99-3,O=C([C@H](CO)C1=CC=CC=C1)O[C@@H]2C[C@@H](N3C)[C@@H](O)C[C@@H]3C2,GPCR/G protein,Adrenergic Receptor,weak antagonist of α1-adrenoceptors
Anisole Methoxybenzene,100-66-3,,Others,Others,"Flavouring agent; precursor to perfumes, insect pheromones, and pharmaceuticals"
Antazoline HCl,2508-72-7,C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3.Cl,Neuroscience,Histamine Receptor,Histamine receptor inhibitor
Antipyrine,60-80-0,CC1=CC(=O)N(N1C)C2=CC=CC=C2,Others,Others,analgesic and antipyretic agent
Apatinib,811803-05-1,CS(=O)(=O)O.C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4,Tyrosine Kinase,VEGFR,"VEGFR2 inhibitor, orally bioavailable, selective"
Apigenin,520-36-5,,Natural Products,P450 (e.g. CYP17),
Apixaban,503612-47-3,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,Proteases,Thrombin,Factor Xa inhibitor
Apramycin Sulfate,65710-07-8,CNC1C(C2C(CC(C(O2)OC3C(CC(C(C3O)O)N)N)N)OC1OC4C(C(C(C(O4)CO)N)O)O)O.OS(=O)(=O)O,Microbiology & Virology,Anti-infection,Aminoglycoside antibiotic
Apremilast (CC-10004),608141-41-9,CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,Metabolism,PDE,PDE4 inhibitor
Aprepitant,170729-80-3,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F,Neuroscience,Substance P/NK1 Receptor,Substance P (SP) inhibitor
Aprotinin,9087-70-1,CC(O)=O.CC.CC.CCccC.[R].[P].[2H].[L].[E].[P].[P].[Y].[3H].[G].[KH].[R].[R].[Y].F.[Y].[*].[L].F.[V].[Y].[G].[G].[R].[KH].[R].N.N.F.[KH].S.[*].[2H].[R].[G].[G].[*].[KH].[*].[3H].C.[*].F.[P].[*].I.I.N.[Q].[3H].[M],Proteases,Serine Protease,Inhibitor of bovine pancreatic trypsin
Arbidol HCl,131707-23-8,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3.Cl,Microbiology & Virology,Influenza A virus,Antiviral chemical agent
Arbutin,497-76-7,C1=CC(=CC=C1O)OC2C(C(C(C(O2)CO)O)O)O,Natural Products,Tyrosinase,
Arecoline hydrobromide,300-08-3,CN1CCC=C(C1)C(=O)OC.Br,Neuroscience,AChR,muscarinic acetylcholine receptor agonist
Argatroban,74863-84-6,O=C([C@H](CCC/N=C(N)/N)NS(=O)(C1=C2NC[C@H](C)CC2=CC=C1)=O)N3[C@@H](C(O)=O)C[C@H](C)CC3,Proteases,Thrombin,Thrombin mediated fibrinogen cleavage inhibitor
Aripiprazole,129722-12-9,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,Neuroscience,Dopamine Receptor,5-HT receptor partial agonist
Aristolochic Acid A,313-67-7,,Natural Products,,
ARN-509,956104-40-8,C21H15F4N5O2S,Endocrinology and Hormones,Androgen Receptor,
Arsonic acid,97-44-9,CC(=O)NC1=C(C=CC(=C1)[As](=O)(O)O)O,Others,Others,An organoarsenic compound
Artemether,71963-77-4,[H][C@@]1(C([H])([H])C2([H])[H])[C@]3([C@@]([C@@]4([H])C([H])([H])[H])([H])C([H])([H])C([H])([H])[C@@]1([H])C([H])([H])[H])OOC2(C([H])([H])[H])O[C@@]3([H])O[C@]4([H])OC([H])([H])[H],Natural Products,Anti-infection,
Artemether (SM-224),71963-77-4,,Ubiquitination/Proteasome,Proteasome,
Artemisinine,63968-64-9,O=C1O[C@]2([H])OC3(C([H])([H])[H])OO[C@]42[C@](C([H])([H])C3([H])[H])([H])[C@@](C([H])([H])[H])([H])C([H])([H])C([H])([H])[C@@]4([H])[C@@]1([H])C([H])([H])[H],Natural Products,Anti-infection,
Artesunate,88495-63-0,O=C(CCC(O)=O)O[C@H]1O[C@@H]2O[C@@]3(C)OO[C@]42[C@@H](CC3)[C@H](C)CC[C@H]4[C@H]1C,Others,Others,derivative of the natural product artemisinin
Articaine HCl,23964-57-0,CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC.Cl,Others,Others,dental local anesthetic
Ascomycin(FK 520),104987-12-4,C43H69NO12,Microbiology & Virology,Antibiotic,
Asenapine,85650-56-2,[H][C@@]1(C(C=C(Cl)C=C2)=C2OC3=C4C=CC=C3)[C@]4([H])CN(C)C1.OC(/C=C/C(O)=O)=O,Neuroscience,5-HT Receptor,Inhibits adrenergic receptor/5-HT receptor
Asiaticoside,16830-15-2,,Natural Products,ROS,
Aspartame,22839-47-0,COC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)N,Others,Others,non-saccharide sweetener
Aspirin (Acetylsalicylic acid),50-78-2,CC(=O)OC1=CC=CC=C1C(=O)O,Neuroscience,COX,Cyclooxygenase (COX) inhibitor
Asunaprevir (BMS-650032),630420-16-5,CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C,Proteases,HCV Protease,NS3 protease inhibitor
AT13387,912999-49-6,CC(C)C1=C(C=C(C(=C1)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C)O)O,Proteases,HSP,Hsp90 inhibitor
Atazanavir,198904-31-3,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,Proteases,HIV Protease,"HIV protease inhibitor,highly potent"
Atazanavir sulfate (BMS-232632-05),229975-97-7,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O,Proteases,HIV Protease,Protease inhibitor
Atipamezole hydrochloride,104075-48-1,CCC1(C2=CN=CN2)CC3=CC=CC=C3C1.Cl,GPCR/G protein,Adrenergic Receptor,α2-adrenergic receptor antagonist
Atomoxetine HCl,82248-59-7,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2.Cl,Neuroscience,5-HT Receptor,Noradrenalin re-uptake inhibitor
Atorvastatin Calcium,134523-03-8,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2],Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor
Atovaquone,95233-18-4,ClC1=C([H])C([H])=C(C([H])=C1[H])C2([H])C([H])([H])C([H])([H])C(C(C3=O)=C(C4=C([H])C([H])=C([H])C([H])=C4C3=O)O[H])([H])C([H])([H])C2([H])[H],Microbiology & Virology,Anti-infection,unique naphthoquinone with broad-spectrum antiprotozoal activity
ATP disodium salt,987-65-5,C10H14N5Na2O13P3,Others,Others,
Atracurium Besylate,64228-81-5,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],Neuroscience,AChR,Neuromuscular blocking agent
Atropine,5908-99-6,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.O.OS(=O)(=O)O,Neuroscience,AChR,MAChRs antagonist
Atropine,51-55-8,,Neuroscience,mAChR,"Non-selective, competitive antagonist of the muscarinic acetylcholine receptor"
Aucubin,479-98-1,,Natural Products,,
Auranofin,34031-32-8,[S-][C@@H]1O[C@H](COC(C)=O)[C@@H]([C@@H]([C@H]1OC(C)=O)OC(C)=O)OC(C)=O.CCP(CC)CC.[Au+],Others,Reductases,thioredoxin reductase (TrxR) inhibitor
Avanafil,330784-47-9,O=C(C1=CN=C(N2[C@H](CO)CCC2)N=C1NCC3=CC=C(OC)C(Cl)=C3)NCC4=NC=CC=N4,Metabolism,PDE,PDE5 inhibitor
Avibactam sodium,1192491-61-4,O=S(ON1[C@@]2(CC[C@H]([N@](C1=O)C2)C(N)=O)[H])([O-])=O.[Na+],Microbiology & Virology,Anti-infection,β-lactamase inhibitor
Avobenzone,70356-09-1,CC(C)(C)C1=CC=C(C=C1)C(=O)CC(=O)C2=CC=C(C=C2)OC,Others,Others,"topical, broad range UV protector"
Axitinib (AG 013736),319460-85-0,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,Tyrosine Kinase,VEGFR,VEGFR1/ c-Kit inhibitor
AXL1717,477-47-4,,Tyrosine Kinase,IGF1R,
Azacyclonol,115-46-8,C1CNCCC1C(C2=CC=CC=C2)(C3=CC=CC=C3)O,Neuroscience,5-HT Receptor,tranquilizer，antipsychotic
Azaguanine-8,134-58-7,C12=NNNC1=NC(=NC2=O)N,Others,Others,Purine analogs
Azaperone,1649-18-9,C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=N3,Neuroscience,Dopamine Receptor,Dopamine antagonist
Azathioprine,446-86-6,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],DNA Damage/DNA Repair,DNA Synthesis,purine synthesis and GTP-binding protein Rac1 activation inhibitor
AZD-9291,1421373-65-0,CN1C=C(C2=NC(NC3=C(OC)C=C(N(CCN(C)C)C)C(NC(C=C)=O)=C3)=NC=C2)C4=C1C=CC=C4,JAK/STAT Signaling,EGFR,Mutated forms EGFR inhibitor
AZD6244 (Selumetinib),606143-52-6,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,MAPK Signaling,MEK1/2,MEK inhibitor
AZD7545,252017-04-2,C19H18ClF3N2O5S,Others,PDHK,
Azelaic Acid,123-99-9,O=C(O)CCCCCCCC(O)=O,Microbiology & Virology,Anti-infection,
Azelastine HCl,79307-93-0,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl.Cl,Neuroscience,Histamine Receptor,"Potent, second-generation, selective, histamine receptor antagonist"
Azelnidipine,123524-52-7,CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C,Membrane Transporter/Ion Channel,Calcium Channel,L-type calcium channel blocker;antihypertensive
Azilsartan,147403-03-0,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NC(=O)ON5)C(=O)O,GPCR/G protein,Angiotensin Receptor,Potent angiotensin II type 1 (AT1) receptor inverse agonist
Azilsartan Medoxomil,863031-21-4,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NC(=O)ON5)C(=O)OCC6=C(OC(=O)O6)C,GPCR/G protein,Angiotensin Receptor,Angiotensin II receptor type 1 antagonist
Azithromycin,83905-01-5,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,Microbiology & Virology,Antibiotic,Antibiotic by inhibiting protein synthesis
Azithromycin Dihydrate,117772-70-0,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O.O.O,Microbiology & Virology,Anti-infection,Macrolide antibiotic
Azlocillin sodium salt,37091-65-9,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)[O-])C.[Na+],Microbiology & Virology,Anti-infection,semisynthetic penicillin and β-lactam antibiotic
Aztreonam,78110-38-0,CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,Microbiology & Virology,Antibiotic,"Monobactam antibiotic,selectively active against Gram-negative aerobic bacteria"
Bacitracin,1405-87-4,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,Microbiology & Virology,Anti-infection,Peptide antibiotic
Bacitracin Zinc,1405-89-6,C66H101N17O16SZn,Microbiology & Virology,Antibiotic,
BAF312 (Siponimod),1230487-00-9,CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)O,GPCR/G protein,S1P receptor,"S1P agonist,potent and selective"
Baicalein,491-67-8,,Natural Products,P450 (e.g. CYP17),
Baicalin,21967-41-9,,Natural Products,GABA Receptor,
Balsalazide,80573-04-2,OC1=C(C(O)=O)C=C(/N=N/C2=CC=C(C(NCCC(O)=O)=O)C=C2)C=C1,Ubiquitination/Proteasome,Interleukin Related; STAT,anti-inflammatory drug
Bambuterol (hydrochloride),81732-46-9,C18H30ClN3O5,GPCR/G protein,Adrenergic Receptor,"Prodrug for terbutaline, long-acting β-adrenoceptor agonist"
Barasertib (AZD1152-HQPA),722544-51-6,CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCO,Chromatin/Epigenetics,Aurora Kinase,"Aurora Kinase B inhibitor, Potent and selective"
Bardoxolone methyl,218600-53-4,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)OC)C,Chromatin/Epigenetics,JAK,"IKK inhibitor, potent antioxidant inflammation modulator"
"Baricitinib (LY3009104, INCB028050)",1187594-09-7,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,Chromatin/Epigenetics,JAK,"JAK1/JAK2 inhibitor,selective orally bioavailable"
Baricitinib phosphate,1187595-84-1,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OP(=O)(O)O,Chromatin/Epigenetics,JAK,JAK1/JAK2 inhibitor
Batimastat (BB-94),130370-60-4,CNC([C@@H](NC([C@@H]([C@H](CSC1=CC=CS1)C(NO)=O)CC(C)C)=O)CC2=CC=CC=C2)=O,Proteases,MMP,MMP inhibitor
Bazedoxifene acetate,198481-33-3,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O.CC(=O)O,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor modulator
Beclomethasone dipropionate,5534-09-8,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC,GPCR/G protein,Glucocorticoid Receptor,Corticosteroid used for asthma and rhinitis
Bedaquiline,843663-66-1,CN(C)CC[C@@]([C@H](C1=CC=CC=C1)C2=CC3=CC(Br)=CC=C3N=C2)(O)C4=CC=CC5=C4C=CC=C5,Microbiology & Virology,Antibiotic,anti-tuberculosis drug
Bedaquiline fumarate,845533-86-0,CN(CC[C@@]([C@](C1=CC2=CC(Br)=CC=C2N=C1OC)([H])C3=CC=CC=C3)(O)C4=CC=CC5=CC=CC=C54)C.O=C(O)/C([H])=C([H])/C(O)=O,Microbiology & Virology,Antibiotic,anti-tuberculosis drug
Belinostat (PXD101),414864-00-9,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,DNA Damage/DNA Repair,HDAC,Hydroxamate-type HDAC inhibitor
Bemegride,64-65-3,CCC1(CC(=O)NC(=O)C1)C,Neuroscience,GABA Receptor,GABA receptor antagonist
Benazepril HCl,86541-74-4,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O.Cl,Others,Others,angiotensin-converting enzyme (ACE) inhibitor
Bendamustine HCl,3543-75-7,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl,Apoptosis,Apoptosis Inducers,Cytostatic agent for non-Hodgkin lymphomas
Benidipine HCl,91599-74-5,CC1=C(C(C(=C(N1)C)C(=O)OC2CCCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC.Cl,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker
Benserazide HCl,14919-77-8,C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O.Cl,Metabolism,Decarboxylase,Decarboxylase inhibitor
Benzbromarone,3562-84-3,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,Metabolism,P450,TMEM16A/B calcium-activated chloride channel (CaCC) blocker
Benzethonium Chloride,121-54-0,CC(C)(C)CC(C)(C)C1=CC=C(C=C1)OCCOCC[N+](C)(C)CC2=CC=CC=C2.[Cl-],Neuroscience,AChR,Potent inhibitor of nAChRs
Benzocaine,1994-9-7,CCOC(=O)C1=CC=C(C=C1)N,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor
Benzoic Acid,65-85-0,C1=CC=C(C=C1)C(=O)O,Others,Others,Organic aromatic monocarboxylic acid
Benztropine mesylate,132-17-2,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O,Neuroscience,Histamine Receptor,Dopamine transporter (DAT) inhibitor
Benzydamine HCl,132-69-4,CN(C)CCCOC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3.Cl,Immunology/Inflammation,PGE synthase,Topical nonsteroidal anti-inflammatory drug (NSAID)
Benzyl alcohol,100-51-6,,Others,Others,
Benzyl benzoate,120-51-4,,Others,Others,
Bephenium Hydroxynaphthoate,3818-50-6,C[N+](C)(CCOC1=CC=CC=C1)CC2=CC=CC=C2.C1=CC=C2C=C(C(=CC2=C1)C(=O)O)[O-],Others,Others,Anthelmintic agent
Bepotastine Besilate,190786-44-8,C1CN(CCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O.C1=CC=C(C=C1)S(=O)(=O)O,Neuroscience,Histamine Receptor,"Non-sedating, selective antagonist of histamine 1 (H1) receptor"
Berbamine hydrochloride,6078-17-7,C37H42Cl2N2O6,Natural Products,Bcr-Abl,
Berberine,2086-83-1,,Natural Products,Others,
Berberine hydrochloride,633-65-8,C20H18ClNO4,Natural Products,Anti-infection,
Berberine Sulfate,633-66-9,,Natural Products,Anti-infection,
Bergenin,477-90-7,,Natural Products,Others,
Besifloxacin HCl,405165-61-9,C1CCN(CC(C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F.Cl,Microbiology & Virology,Antibiotic,fourth-generation fluoroquinolone antibiotic
Bestatin,58970-76-6,CC(C)CC(C(=O)O)NC(=O)C(C(CC1=CC=CC=C1)N)O,Proteases,Aminopeptidase,Aminopeptidase inhibitor
beta-Alanine,107-95-9,,Others,Others,
Betacarotene,7235-40-7,,Others,Others,
Betahistine 2HCl,5579-84-0,CNCCC1=CC=CC=N1.Cl.Cl,Neuroscience,Histamine Receptor,Histamine H3 receptor inhibitor
Betaine,107-43-7,C[N+](C)(C)CC(=O)[O-],Natural Products,Others,PCR Reagent
Betaine hydrochloride,590-46-5,C[N+](C)(C)CC(=O)O.[Cl-],Natural Products,Others,
Betamethasone,378-44-9,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist
Betamethasone Dipropionate,5593-20-4,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC,Others,Others,Glucocorticoid receptor agonist
Betamethasone Valerate,2152-44-5,CCCCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CO,Others,Others,anti-inflammatory corticosteroid
Betamipron,3440-28-6,C1=CC=C(C=C1)C(=O)NCCC(=O)O,Microbiology & Virology,Anti-infection,Parenteral carbapenem antibiotic
Betaxolol,63659-18-7,CC(NCC(O)COC1=CC=C(CCOCC2CC2)C=C1)C,GPCR/G protein,Adrenergic Receptor,βadrenergic receptor blocker
Betaxolol HCl,63659-19-8,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl,GPCR/G protein,Adrenergic Receptor,β1 adrenergic receptor blocker
Bethanechol chloride,590-63-6,CC(C[N+](C)(C)C)OC(=O)N.[Cl-],Neuroscience,AChR,Muscarinic receptor agonist
Betrixaban,330942-05-7,C23H22ClN5O3,Metabolism,Factor Xa,
Bexarotene,153559-49-0,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,Others,Retinoid X Receptors,Retinoid Receptor agonist
Bezafibrate,41859-67-0,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,Metabolism,PPAR,Lipid-lowering agent
BHT,128-37-0,CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1,Others,Others,
BI6727 (Volasertib),755038-65-4,CCC1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C,Cell Cycle/Checkpoint,PLK,"Plk inhibitor,highly potent"
Biapenem,120410-24-4,CC1C2C(C(=O)N2C(=C1SC3CN4C=NC=[N+]4C3)C(=O)[O-])C(C)O,Microbiology & Virology,Antibiotic,Highly broad spectrum antibiotic agent
BIBR-1048,211915-06-9,CCCCCCOC(=O)N=C(C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)N,Proteases,Thrombin,Thrombin inhibitor
Bicalutamide,90357-06-5,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonist
Bifonazole,60628-96-8,C1=CC=C(C=C1)C2=CC=C(C=C2)C(C3=CC=CC=C3)N4C=CN=C4,Microbiology & Virology,Anti-infection,imidazole antifungal drug
Bimatoprost,155206-00-1,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,GPCR/G protein,Prostaglandin Receptor,prostaglandin analog
Bindarit,130641-38-2,CC(C)(C(=O)O)OCC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3,Immunology/Inflammation,CCR,"CCL2, CCL7 and CCL8 inhibitor"
Biotin,58-85-5,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,Labels and tags,Biotinylation Reagents,Lysine probe coupled to mass spectrometry detection
Biperiden HCl,1235-82-1,C21H30ClNO,Neuroscience,Muscarinic Receptor,
BIRB 796 (Doramapimod),285983-48-4,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5,MAPK Signaling,p38,"P38 MAPK inhibitor,cell permeable and highly selective"
Birinapant (TL32711),1260251-31-7,CCC(C(=O)N1CC(CC1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)CC6CC(CN6C(=O)C(CC)NC(=O)C(C)NC)O)O)NC(=O)C(C)NC,Apoptosis,IAP,Potent XIAP/cIAP1 antagonist
Bisacodyl,603-50-9,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3,Others,Others,stimulant laxative drug
Bisoprolol fumarate,104344-23-2,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O.C(=CC(=O)O)C(=O)O,GPCR/G protein,Adrenergic Receptor,Selective α-adrenergic blocker
Bisphenol A,80-05-7,,Others,Others,
Bivalirudin Trifluoroacetate,128270-60-0,CC[C@]([C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/C/N=C(O)/[C@](/N=C(O)/C/N=C(O)/C/N=C(O)/C/N=C(O)/C/N=C(O)/[C@]1([H])CCCN1C([C@](/N=C(O)/[C@]2([H])CCCN2C([C@@](N)([H])CC3=CC=CC=C3)=O)([H])CCCNC(N)=N)=O)([H])CC(O)=N)([H])CC(O)=O)([H,Proteases,Thrombin,Reversible thrombin inhibitor
Bleomycin Sulfate,9041-93-4,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.OS(=O)(=O)[O-],DNA Damage/DNA Repair,DNA Synthesis,"Chemotherapy agent, induces DNA strand break"
Blonanserin,132810-10-7,C23H30FN3,Neuroscience,5-HT Receptor,
BMN 673,1207456-01-6,C19H14F2N6O,DNA Damage/DNA Repair,PARP,
BMS-708163 (Avagacestat),1146699-66-2,C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl,Proteases,Gamma Secretase,γ-secretase inhibitor
Boceprevir,394730-60-0,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,Proteases,HCV Protease,"HCV protease inhibitor,potent and selective"
Bortezomib (PS-341),179324-69-7,C19H25BN4O4,Ubiquitination/Proteasome,Proteasome,
Bosentan,147536-97-8,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,GPCR/G protein,Endothelin Receptor,Endothelin receptor antagonist
Bosentan Hydrate,157212-55-0,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC.O,GPCR/G protein,Endothelin Receptor,endothelin receptor antagonist
Bosutinib (SKI-606),380843-75-4,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,TGF-β / Smad Signaling,Bcr-Abl,Potent Abl/Src kinases
Brexpiprazole,913611-97-9,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,Neuroscience,Dopamine Receptor,"5-HT2A, α1B-, and α2C-adrenergic receptors antagonist"
Brimonidine Tartrate,70359-46-5,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.C(C(C(=O)O)O)(C(=O)O)O,GPCR/G protein,Adrenergic Receptor,Highly selective α-adrenergic receptor agonist
Brinzolamide,138890-62-7,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC,Metabolism,Carbonic Anhydrase,CA II inhibitor
Brivaracetam,357336-20-0,C33H41N3O10S2,16mg/mL in ethanol;20mg/mL in DMSO;14mg/mL in dimethyl formamide,,High-affinity ligand for synaptic vesicle glycoprotein 2A (SV2A)
Bromfenac Sodium,91714-93-1,C1=CC(=C(C(=C1)CC(=O)[O-])N)C(=O)C2=CC=C(C=C2)Br.[Na+],Neuroscience,COX,COX inhibitor
Bromhexine HCl,611-75-6,CN(CC1=CC(=CC(=C1N)Br)Br)C2CCCCC2.Cl,Others,Others,bronchial mucolytic agent
Bromocriptine mesylate,22260-51-1,BrC(NC1=CC=CC2=C31)=C3C[C@H](C2=C4)N(C)C[C@@H]4C(N[C@]5(C(C)C)O[C@@]6(N(C5=O)[C@@H](CC(C)C)C(N7[C@H]6CCC7)=O)O)=O.OS(=O)(C)=O,Neuroscience,Dopamine Receptor,D2-like dopamine receptor agonist
Brompheniramine hydrogen maleate,980-71-2,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,Neuroscience,Histamine Receptor,Histamine H1 receptors antagonist
Broxyquinoline,521-74-4,C1=CC2=C(C(=C(C=C2Br)Br)O)N=C1,Microbiology & Virology,Anti-infection,Antiprotozoal agent
Brucine,357-57-3,COC1=C(C=C2C(=C1)C34CCN5C3CC6C7C4N2C(=O)CC7OCC=C6C5)OC,Natural Products,Others,
Budesonide,51333-22-3,O=C(C([H])([H])O[H])[C@@]12OC(C([H])([H])C([H])([H])C([H])([H])[H])([H])O[C@]1([H])C([H])([H])[C@]([C@@](C([H])([H])C3([H])[H])([H])[C@@]4([H])[C@@](C([H])([H])[H])(C([H])=C5[H])C3=C([H])C5=O)([H])[C@]2(C([H])([H])[H])C([H])([H])[C@]4([H])O[H],GPCR/G protein,Glucocorticoid Receptor,Anti-inflammatory corticosteroid
Bufexamac,2438-72-4,CCCCOC1=CC=C(C=C1)CC(=O)NO,Neuroscience,COX,COX inhibitor
Buflomedil HCl,35543-24-9,COC1=CC(=C(C(=C1)OC)C(=O)CCCN2CCCC2)OC.Cl,GPCR/G protein,Adrenergic Receptor,vasodilator
Bumetanide,28395-03-1,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,Membrane Transporter/Ion Channel,NKCC,NKCC cotransporter inhibitor
Bupivacaine HCl,18010-40-7,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl,Membrane Transporter/Ion Channel,Sodium Channel,Anaesthetic drug
Bupropion hydrochloride,31677-93-7,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl,Neuroscience,"AChR,Dopamine Receptor",Dopamine/norepinephrine inhibitor
Buspirone HCl,33386-08-2,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4.Cl,Neuroscience,5-HT Receptor,Classic 5-HT1A partial agonist
Busulfan,55-98-1,CS(=O)(=O)OCCCCOS(=O)(=O)C,DNA Damage/DNA Repair,DNA Alkylating,DNA alkylating agent
Butane diacid,110-15-6,,Natural Products,Others,
Butenafine HCl,101827-46-7,CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32.Cl,Microbiology & Virology,Antibiotic,synthetic benzylamine antifungal
Butoconazole nitrate,64872-77-1,C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl.[N+](=O)(O)[O-],Microbiology & Virology,Anti-infection,Antifungal agent
Butylparaben,94-26-8,,Microbiology & Virology,Anti-infection,
BYL-719,1217486-61-7,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,PI3K/Akt/mTOR Signaling,PI3K,Selective PI3Kα inhibitor
Cabazitaxel,183133-96-2,CO[C@H]1C[C@]2([H])[C@](CO2)(OC(C)=O)[C@]3([H])[C@]1(C)C([C@H](OC)C4=C(C)[C@@H](OC([C@H](O)[C@H](C5=CC=CC=C5)NC(OC(C)(C)C)=O)=O)C[C@]([C@H]3OC(C6=CC=CC=C6)=O)(O)C4(C)C)=O,Cell Cycle/Checkpoint,Microtubule/Tubulin,Microtubule associated inhibitor
"Cabozantinib (XL184, BMS-907351)",849217-68-1,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,Tyrosine Kinase,c-MET,VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor
Cabozantinib malate (XL184),1140909-48-3,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F.C(C(C(=O)O)O)C(=O)O,Tyrosine Kinase,c-MET,MET andVEGF receptor2 inhibitor
Caffeic acid,331-39-5,C1=CC(=C(C=C1C=CC(=O)O)O)O,Natural Products,Others,
"CAL-101 (Idelalisib, GS-1101)",870281-82-6,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,PI3K/Akt/mTOR Signaling,PI3K,PI3K inhibitor
Calcifediol,19356-17-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,Vitamin D Related,VD/VDR,Major circulating form of vitamin D3
Calcipotriol,112965-21-6,CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,Vitamin D Related,VD/VDR,"Vitamin D3 analog,regulates cell differentiation and proliferation"
Calcitriol,32222-06-3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,Vitamin D Related,VD/VDR,Active metabolite of vitamin D3
Calcium D-Panthotenate,137-08-6,CC(CO)([C@](O)([H])/C([O-])=N/CCC([O-])=O)C.CC(CO)([C@](O)([H])/C(O)=N/CCC(O)=O)C.[Ca+2],Metabolism,Vitamin,"water-soluble vitamin, precursor in the biosynthesis of coenzyme A"
Calcium Gluceptate,17140-60-2,C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.[Ca+2],Others,Others,Calcium supplement
Camostat Mesilate,59721-29-8,CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N.CS(=O)(=O)O,Membrane Transporter/Ion Channel,Sodium Channel,Trypsin-like protease inhibitor
Camptothecin,7689-03-4,C20H16N2O4,DNA Damage/DNA Repair,Topoisomerase,
Canagliflozin,842133-18-0,CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,Metabolism,SGLT,"SGLT2 inhibitor,potent and selective"
Candesartan,139481-59-7,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,Endocrinology and Hormones,RAAS,Angiotensin II receptor 1 (AT1) antagonist
Candesartan Cilexetil,145040-37-5,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OC(C)OC(=O)OC6CCCCC6,Endocrinology and Hormones,RAAS,Prodrug of the angiotensin II receptor 1 (AT1) antagonist candesartan
Canrenone,976-71-6,O=C1O[C@]2(CC1)[C@]3(C)[C@@H](CC2)[C@H](C=C4)[C@@H]([C@](CC5)(C)C4=CC5=O)CC3,Others,Mineralocorticoid Receptor,Mineralocorticoid receptor antagonist
Capecitabine,154361-50-9,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,DNA Damage/DNA Repair,DNA Synthesis,"DNA, RNA and protein synthesis inhibitor"
Capreomycin Sulfate,1405-37-4,O=C([C@]([H])(C)NC([C@](N)([H])CNC1=O)=O)N[C@@]([H])(CNC(CC(CCCN)N)=O)C(NC(C(N[C@@]1([H])[C@@H]2CCNC(N)=N2)=O)=CNC(N)=O)=O.[xH2SO4],Microbiology & Virology,Anti-infection,Cyclic peptide antibiotic
Capsaicin,404-86-4,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,Apoptosis,Apoptosis Inducers,TRPV1 receptor agonist
Captopril,62571-86-2,C9H15NO3S,Endocrinology and Hormones,RAAS,
Carbadox,6804-7-5,COC(=O)N=NC=C1C=[N+](C2=CC=CC=C2N1O)[O-],Others,Others,antibiotic
Carbamazepine,298-46-4,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,Membrane Transporter/Ion Channel,Sodium Channel,Inhibitor of neuronal voltage-gated Na+ channels
Carbamoylcholine chloride,51-83-2,O=C(N)OCC[N+](C)(C)C.[Cl-],Neuroscience,Nicotinic Receptor,Cholinergic receptor agonist
Carbazochrome sodium sulfonate (AC-17),51460-26-5,CN1C(CC2=CC(=NNC(=O)N)C(=O)C=C21)S(=O)(=O)[O-].[Na+],Others,Others,antihemorrhagic agent
"Carbenicillin, Disodium Salt",4800-94-6,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)[O-])C(=O)[O-])C.[Na+].[Na+],Microbiology & Virology,Antibiotic,"Inhibits the cell-wall synthesis,antibiotic"
Carbenoxolone disodium,7421-40-1,CC1(C2CCC3(C(C2(CCC1OC(=O)CCC(=O)[O-])C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)[O-])C)C)C)C.[Na+].[Na+],Neuroscience,Gap Junction,11β-HSD inhibitor
Carbetocin,37025-55-1,,Others,Others,oxytocin receptor agonist
Carbidopa,28860-95-9,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,Metabolism,Decarboxylase,Decarboxylase inhibitor
Carbimazole,22232-54-8,CCOC(=O)N1C=CN(C1=S)C,Others,Others,imidazole antithyroid agent
Carboplatin,41575-94-4,C1CC(C1)(C(=O)[O-])C(=O)[O-].N.N.[Pt+2],DNA Damage/DNA Repair,DNA Synthesis,Antitumor agent that forms platinum-DNA adducts.
Carfilzomib (PR-171),868540-17-4,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,Ubiquitination/Proteasome,Proteasome,"Proteasome inhibitor,epoxomicin analog"
Cariprazine,839712-12-8,CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl,Neuroscience,Dopamine Receptor,"D2/D3 partial agonist,antipsychotic drug"
Carmofur,61422-45-5,CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F,DNA Damage/DNA Repair,DNA Synthesis,"Cytostatic derivative of fluorouracilm,antineoplatic agent"
Carmustine,154-93-8,ClCC/N=C(O)/N(N=O)CCCl,DNA Damage/DNA Repair,DNA Alkylating,cell-cycle phase nonspecific alkylating antineoplastic agent
Carprofen,53716-49-7,CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O,Neuroscience,COX,COX inhibitor
Carteolol HCl,51781-21-6,CC(C)(NCC(O)COC1=CC=CC2=C1CCC(O)=N2)C.Cl,GPCR/G protein,Adrenergic Receptor,Non-selective beta-adrenoceptor antagonist
Carvacrol,499-75-2,,Others,Others,
Carvedilol,72956-09-3,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,GPCR/G protein,Adrenergic Receptor,Potent β-adrenoceptor and α1-adrenoceptor antagonist
Casanthranol,8024-48-4,C21H22O10,Others,Others,
Caspofungin,162808-62-0,O=C([C@@H]1C[C@@H](O)CN1C([C@@H](NC(C2CC(CCCCCCCCC(C)CC(CC)C)=O)=O)[C@@H](C)O)=O)N[C@@H]([C@H](O)[C@@H](O)C3=CC=C(O)C=C3)C(N[C@@H]([C@H](O)CCN)C(N4CC[C@H](O)[C@H]4C(N[C@@H](NCCN)[C@H](O)C2)=O)=O)=O,Microbiology & Virology,Anti-infection,lipopeptide antifungal drug
Caspofungin Acetate,179463-17-3,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O.CC(=O)O.CC(=O)O,Others,"β(1,3)-D-Glucan Synthase",lipopeptide antifungal drug
Catharanthine,2468-21-5,O=C([C@@]1(C(N([H])C2=C([H])C([H])=C([H])C([H])=C32)=C3C([H])([H])C4([H])[H])[C@](C(C([H])([H])C([H])([H])[H])=C5[H])([H])N4C([H])([H])[C@@]5([H])C1([H])[H])OC([H])([H])[H],Natural Products,AChR,
CB-5083,1542705-92-9,,Ubiquitination/Proteasome,p97,
Cediranib (AZD217),288383-20-0,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,Tyrosine Kinase,VEGFR,"VEGFR inhibitor receptor,highly potent"
Cefaclor,53994-73-3,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,Microbiology & Virology,Antibiotic,Cephalosporin antibiotic inhibiting cell wall synthesis.
Cefadroxil (hydrate),66592-87-8,OC1=CC=C([C@@H](N)C(N[C@@H]2C(N3[C@]2([H])SCC(C)=C3C(O)=O)=O)=O)C=C1.O,Microbiology & Virology,Antibiotic,broad-spectrum antibiotic
Cefazolin (sodium salt),27164-46-1,O=C(CN1N=NN=C1)N[C@H](C2=O)[C@]3([H])N2C(C([O-])=O)=C(CSC4=NN=C(C)S4)CS3.[Na+],Microbiology & Virology,Antibiotic,"broad-spectrum, first-generation cephalosporin antibiotic"
Cefdinir,91832-40-5,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O,Microbiology & Virology,Antibiotic,Third generation cephalosporin antibiotic
Cefditoren Pivoxil,117467-28-4,C25H28N6O7S3,Microbiology & Virology,Antibiotic,
Cefepime Dihydrochloride Monohydrate,123171-59-5,NC1=NC(/C(C(N[C@H]2[C@]3([H])C(C(C([O-])=O)=C(C[N+]4(C)CCCC4)CS3)C2=O)=O)=N/OC)=CS1.Cl.Cl.O,Microbiology & Virology,Antibiotic,broad-spectrum cephalosporin
Cefixime,79350-37-1,[H][C@@]1([C@@H]2NC(/C(C3=CSC(N)=N3)=N\OCC(O)=O)=O)N(C(C(O)=O)=C(C=C)CS1)C2=O,Microbiology & Virology,Antibiotic,third generation cephalosporin antibiotic
Cefonicid (sodium salt),61270-78-8,O=C(N[C@H]1[C@](SCC(CSC2=NN=NN2CS([O-])(=O)=O)=C3C([O-])=O)([H])N3C1=O)[C@H](O)C4=CC=CC=C4.[Na+].[Na+],Microbiology & Virology,Antibiotic,second-generation cephalosporin antibiotic
Cefoperazone,62893-19-0,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,Microbiology & Virology,Antibiotic,Third-generation cephalosporin antibiotic
Cefoselis Sulfate,122841-12-7,CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)CN4C=CC(=N)N4CCO)C(=O)O.OS(=O)(=O)O,Microbiology & Virology,Antibiotic,beta-lactam antibiotic
Cefotaxime (sodium salt),64485-93-4,[H][C@@]1([C@@H]2NC(/C(C3=CSC(N)=N3)=N\OC)=O)N(C(C([O-])=O)=C(COC(C)=O)CS1)C2=O.[Na+],Microbiology & Virology,Antibiotic,cephalosporin antibiotic
Cefoxitin (sodium salt),33564-30-6,O=C1[C@](NC(CC2=CC=CS2)=O)(OC)[C@]3([H])N1C(C([O-])=O)=C(COC(N)=O)CS3.[Na+],Microbiology & Virology,Antibiotic,second generation cephalosporin antibiotic
Cefpodoxime Proxetil,87239-81-4,CC(C)OC(OC(C)OC(C1=C(COC)CS[C@]([H])([C@@H]2NC(/C(C3=CSC(N)=N3)=N\OC)=O)N1C2=O)=O)=O,Microbiology & Virology,Anti-infection,cephalosporin antibiotic
Cefprozil,92665-29-7,OC1=CC=C([C@@H](N)C(N[C@@H]2C(N3[C@@]2([H])SCC(/C=C/C)=C3C(O)=O)=O)=O)C=C1,Microbiology & Virology,Bacterial,antibiotic
Cefprozil hydrate,121123-17-9,C18H19N3O5S.H2O,Microbiology & Virology,Bacterial,
Cefsulodin (sodium salt),52152-93-9,O=C(N[C@@H]1C(N2[C@]1([H])SCC(C[N+]3=CC=C(C(N)=O)C=C3)=C2C([O-])=O)=O)[C@H](S([O-])(=O)=O)C4=CC=CC=C4.[Na+],Microbiology & Virology,Antibiotic,β-lactam antibiotic
Ceftazidime,72558-82-8,CC(C([O-])=O)(O/N=C(\C(O)=N\[C@]([C@]1([H])N2C(C(O)=O)=C(CS1)C[N+]3=CC=CC=C3)([H])C2=O)C(N4)=CSC4=N)C,Microbiology & Virology,Antibiotic,third-generation cephalosporin
Ceftazidime,78439-06-2,C22H32N6O12S2,Others,Others,Broad-spectrum β-lactam antibiotic used for parenteral administration
Ceftiofur HCl,103980-44-5,CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)CSC(=O)C4=CC=CO4)C(=O)O.Cl,Microbiology & Virology,Anti-infection,cephalosporin antibiotic
Ceftriaxone Sodium Trihydrate,104376-79-6,O=C1N(C(C([O-])=O)=C2CSC(N(C)N=C3[O-])=NC3=O)[C@H](SC2)[C@@H]1NC(/C(C4=CSC(N)=N4)=N\OC)=O.[Na+].[Na+].[3.5H2O],Microbiology & Virology,Anti-infection,Third-generation cephalosporin antibiotic
Celecoxib,169590-42-5,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Neuroscience,COX,Selective cyclooxygenase-2 (COX-2) inhibitor
Cellobiose,528-50-7,,Others,Others,
CEP-18770,847499-27-8,B(C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)(O)O,Ubiquitination/Proteasome,Proteasome,Proteasome inhibitor
Cephalexin,15686-71-2,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,Microbiology & Virology,Antibiotic,Antibiotic
Cepharanthine,481-49-2,CN1CCC2=CC3=C(C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3,Natural Products,TNF-α,antiperoxidant potency
Cesium chloride,7647-17-8,,Apoptosis,Other Apoptosis,
Cetirizine,83881-51-0,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,Neuroscience,Histamine Receptor,Antihistamine
Cetirizine DiHCl,83881-52-1,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl,Neuroscience,Histamine Receptor,H1 receptor inverse agonist
Cetrimonium Bromide (CTAB),57-09-0,CCCCCCCCCCCCCCCC[N+](C)(C)C.[Br-],Microbiology & Virology,Anti-infection,Component of the broad-spectrum antiseptic cetrimide
Cetrorelix,120287-85-6,,GPCR/G Protein,GNRH Receptor,gonadotropin-releasing hormone (GnRH) antagonist
Cetylpyridinium Chloride,123-03-5,CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1.[Cl-],Microbiology & Virology,Anti-infection,Cationic quaternary ammonium compound used as oropharyngeal antiseptic.
CH5424802,1256580-46-7,CCC1=C(C=C2C(=C1)C(=O)C3=C(C2(C)C)NC4=C3C=CC(=C4)C#N)N5CCC(CC5)N6CCOCC6,Tyrosine Kinase,ALK,"ALK inhibitor,potent and ATP-competitive"
Chenodeoxycholic Acid,474-25-9,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,Others,FXR,nuclear receptors(FXR) activator
Chitosamine hydrochloride,66-84-2,C(C(C(C(C(C=O)N)O)O)O)O.Cl,Natural Products,Others,
Chlorambucil,305-03-3,ClCCN(CCCl)C(C=C1)=CC=C1CCCC(O)=O,Others,Others,nitrogen mustard alkylating agent
Chloramphenicol,56-75-7,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],Microbiology & Virology,Antibiotic,Inhibits translation(blocking peptidyl transferase)
Chlorcyclizine (hydrochloride),14362-31-3,C18H21ClN2 • HCl,Neuroscience,Histamine Receptor,
Chlorhexidine digluconate,18472-51-0,ClC1=CC=C(NC(NC(NCCCCCCNC(NC(NC2=CC=C(Cl)C=C2)=N)=N)=N)=N)C=C1.OC[C@](O)([H])[C@](O)([H])[C@@](O)([H])[C@](O)([H])C(O)=O.OC[C@](O)([H])[C@](O)([H])[C@@](O)([H])[C@](O)([H])C(O)=O,Microbiology & Virology,Antibiotic,antiseptic
Chlorhexidine HCl,3697-42-5,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl.Cl.Cl,Microbiology & Virology,Anti-infection,Antiseptic
Chlormezanone,80-77-3,CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl,Others,Others,Anxiolytic and skeletal muscle relaxant
Chlorocresol,59-50-7,CC1=C(C=CC(=C1)O)Cl,Membrane Transporter/Ion Channel,Calcium Channel,Activator of ryanodine receptor
Chlorogenic acid,327-97-9,C1C(C(C(CC1(C(=O)O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)O)O,Natural Products,Others,
Chloroquine diphosphate,50-63-5,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O,Ubiquitination/Proteasome,Autophagy,"Antimalarial drug,TLR7 TLR9 inhibitor"
Chlorothiazide,58-94-6,ClC1=C(C=C2S(=O)(NC=NC2=C1)=O)S(=O)(N)=O,Others,Others,Carbonic anhydrase inhibitor
Chlorotrianisene,569-57-3,COC1=CC=C(/C(C2=CC=C(OC)C=C2)=C(Cl)/C3=CC=C(OC)C=C3)C=C1,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen agonist
Chloroxine,773-76-2,C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1,Microbiology & Virology,Anti-infection,synthetic antibacterial compound
Chlorpheniramine Maleate,113-92-8,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist
Chlorpromazine HCl,69-09-0,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl,Neuroscience,Dopamine Receptor,dopamine receptor antagonist
Chlorpropamide,94-20-2,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,Others,Others,Oral antihyperglycemic agent
Chlorprothixene,113-59-7,CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist
Chlorprothixene (hydrochloride),6469-93-8,C18H18ClNS • HCl,Neuroscience,Dopamine Receptor,
Chlorquinaldol,72-80-0,CC1=NC2=C(C=C1)C(=CC(=C2O)Cl)Cl,Microbiology & Virology,Anti-infection,Antifungal and antibacterial
Chlortalidone,77-36-1,C14H11ClN2O4S,Others,Others,Diuretic drug used to treat hypertension
Chlortetracycline HCl,64-72-2,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O.Cl,Microbiology & Virology,Anti-infection,Tetracycline antibiotic
Chlorzoxazone,95-25-0,C1=CC2=C(C=C1Cl)NC(=O)O2,Metabolism,P450,Muscle-relaxing drug
Cholic acid,81-25-4,CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C,Natural Products,Others,
Choline Chloride,67-48-1,C[N+](C)(C)CCO.[Cl-],Neuroscience,AChR,Quaternary ammonium salt
Choline Fenofibrate,856676-23-8,CC(C([O-])=O)(OC1=CC=C(C(C2=CC=C(Cl)C=C2)=O)C=C1)C.C[N+](C)(CCO)C,Immunology/Inflammation,IκB/IKK,Choline salt of fenofibric acid
Chondroitin sulfate,9007-28-7,,Natural Products,Others,
Chromocarb,4940-39-0,C1=CC=C2C(=C1)C(=O)C=C(O2)C(=O)O,Others,Others,Vasoprotectant
Ciclesonide,126544-47-6,CC(C(OCC([C@@]12[C@@](O[C@@](O2)([H])C3CCCCC3)([H])C[C@@]4([H])[C@]([C@]5([H])[C@](O)([H])C[C@@]41C)([H])CCC6=CC(C=C[C@@]65C)=O)=O)=O)C,GPCR/G protein,Glucocorticoid Receptor,glucocorticoid
Ciclopirox,29342-05-0,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,Membrane Transporter/Ion Channel,"ATPase,Anti-infection",broad-spectrum antifungal agent
Ciclopirox ethanolamine,41621-49-2,CC1=CC(=O)N(C(=C1)C2CCCCC2)O.C(CO)N,Membrane Transporter/Ion Channel,ATPase,"iron chelator, broad-spectrum antifungal agent"
Cidofovir,113852-37-2,C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O,Microbiology & Virology,CMV,Anti-CMV drug;inhibitor of viral DNA syntheis
Cilastatin,82009-34-5,C16H26N2O5S,Others,Others,Renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor
Cilengitide,188968-51-6,CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N,Angiogenesis,Integrin,Integrin inhibitor for αvβ3 and αvβ5
Cilnidipine,132203-70-4,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC,Membrane Transporter/Ion Channel,Calcium Channel,Blocker of Dual L- and N-type calcium channel
Cilomilast,153259-65-5,COC1=C(C=C(C=C1)C2(CCC(CC2)C(=O)O)C#N)OC3CCCC3,Metabolism,PDE,Potent PDE4 inhibitor
Cilostazol,73963-72-1,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,Metabolism,PDE,PDE3 inhibitor
Cimetidine,51481-61-9,CC1=C(N=CN1)CSCCNC(=NC)NC#N,Neuroscience,Histamine Receptor,H2 receptor antagonist
Cinacalcet,226256-56-0,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,GPCR/G protein,Calcimimetic Agent,"Calcimimetic agent,orally active"
Cinacalcet HCl,364782-34-3,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F.Cl,GPCR/G protein,Calcimimetic Agent,Calcium-sensing receptor (CaR) agonist
Cinchonidine,485-71-2,O[C@H](C1=CC=NC2=CC=CC=C12)[C@H]3[N@@]4C[C@@H](C=C)[C@@H](CC4)C3,Others,Others,alkaloid
Cinchophen,132-60-5,C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)C(=O)O,Others,Others,Analgesic drug
Cinepazide maleate,26328-04-1,COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCN(CC2)CC(=O)N3CCCC3.C(=CC(=O)O)C(=O)O,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel inhibitor
Cinnamic acid,140-10-3,C1=CC=C(C=C1)C=CC(=O)O,Natural Products,Others,Unsaturated carboxylic acid
Cinnarizine,298-57-7,C1(/C=C/CN2CCN(C(C3=CC=CC=C3)C4=CC=CC=C4)CC2)=CC=CC=C1,Neuroscience,Histamine Receptor,antihistamine and calcium channel blocker
Ciprofibrate,52214-84-3,CC(C(O)=O)(OC1=CC=C(C2CC2(Cl)Cl)C=C1)C,Metabolism,PPAR,PPARα agonist
Ciprofloxacin (hydrochloride),93107-08-5,C17H18FN3O3 • HCl,Microbiology & Virology,Antibiotic,
cis-aconitate,585-84-2,O=C(O)/C([H])=C(C(O)=O)/CC(O)=O,Others,Others,
cis-Anethol,104-46-1,CC=CC1=CC=C(C=C1)OC,Natural Products,Others,
Cisapride,81098-60-4,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,Neuroscience,5-HT Receptor,5-HT4 receptor agonist
Cisatracurium Besylate,96946-42-8,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],GPCR/G protein,Adrenergic Receptor,Neuromuscular-blocking drug
Cisplatin,15663-27-1,N.N.Cl[Pt+2]Cl,Apoptosis,Caspase,"Inhibits DNA synthesis,chemotherapy drug"
Citalopram hydrobromide,59729-32-7,FC1=CC=C(C=C1)[C@@]2(CCCN(C)C)OCC3=CC(C#N)=CC=C23.Br,Neuroscience,5-HT Receptor,5-HT uptake inhibitor
Citicoline (sodium salt),33818-15-4,O=P([O-])(OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)N2C(N=C(C=C2)N)=O)OP(OCC[N+](C)(C)C)([O-])=O.[Na+],Others,Others,
Citric acid,77-92-9,OC(CC(O)=O)(C(O)=O)CC(O)=O,Others,Reagents,Commonly used laboratory reagent
Cladribine,4291-63-8,C1C(C(OC1N2C=NC3=C2N=C(N=C3N)Cl)CO)O,DNA Damage/DNA Repair,DNA Synthesis,Apoptosis inducer in CLL cells
Clarithromycin,81103-11-9,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,Metabolism,CYP3A/CYP450,"CYP3A inhibitor, potent"
Clemastine Fumarate,14976-57-9,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C.C(=CC(=O)O)C(=O)O,Neuroscience,Histamine Receptor,Selective histamine H1 receptor antagonist
Clemizole hydrochloride,1163-36-6,C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl.Cl,Neuroscience,HCV; HCV Protease; Histamine Receptor,H1 histamine receptor antagonist
Clenbuterol (hydrochloride),21898-19-1,ClC1=CC(C(O)CNC(C)(C)C)=CC(Cl)=C1N.Cl,GPCR/G protein,Adrenergic Receptor,sympathomimetic β2-adrenoceptor agonist used as a bronchodilator in the treatment of pulmonary diseases
Clevidipine Butyrate,167221-71-8,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Membrane Transporter/Ion Channel,Calcium Channel,Dihydropyridine calcium channel blocker
Climbazole,38083-17-9,CC(C)(C)C(=O)C(N1C=CN=C1)OC2=CC=C(C=C2)Cl,Microbiology & Virology,Anti-infection,Broad-spectrum imidazole antifungal agent
Clindamycin,18323-44-9,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,Others,Others,Antibiotic
Clindamycin HCl,21462-39-5,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl.Cl,Microbiology & Virology,Anti-infection,Lincosamide antibiotic
Clindamycin Phosphate,24729-96-2,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl,Microbiology & Virology,Anti-infection,Lincosamide antibiotic
Clobetasol propionate,25122-46-7,CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist
Clodronate Disodium,22560-50-5,CH2Cl2Na2O6P2,Others,Others,
Clofarabine,123318-82-1,C1=NC2=C(N1C3C(C(C(O3)CO)O)F)N=C(N=C2N)Cl,DNA Damage/DNA Repair,DNA Synthesis,"Antimetabolite,inhibit DNA polymerase and ribonucleotide reductase"
Clofazimine,2030-63-9,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,Metabolism,Phospholipase,Tuberculosis drug
Clofibrate,637-07-0,ClC1=CC=C(C=C1)OC(C)(C)C(OCC)=O,Metabolism,PPAR,PPAR agonist
Clofibric Acid,882-09-7,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl,Metabolism,PPAR,PPAR agonist
Clomiphene citrate,50-41-9,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Endocrinology and Hormones,Estrogen/progestogen Receptor,Selective estrogen receptor modulator
Clomipramine HCl,17321-77-6,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl.Cl,Neuroscience,5-HT Receptor,SERT/NET dopamine transporter (DAT) blocker
Clonidine HCl,4205-91-8,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl,GPCR/G protein,Adrenergic Receptor,α2-adrenergic receptor agonist
Clopidogrel,120202-66-6,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O,Neuroscience,P2 Receptor,P2Y12 receptor antagonist
Clorgyline (hydrochloride),17780-75-5,C13H15Cl2NO ? HCl,Metabolism,MAO,
Clorprenaline HCL,6933-90-0,CC(C)NCC(C1=CC=CC=C1Cl)O.Cl,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist
Clorsulon,60200-06-8,C1=C(C(=CC(=C1N)S(=O)(=O)N)S(=O)(=O)N)C(=C(Cl)Cl)Cl,Microbiology & Virology,Anti-infection,Anthelmintic agent
Closantel,57808-65-8,CC1=CC(=C(C=C1NC(=O)C2=CC(=CC(=C2O)I)I)Cl)C(C#N)C3=CC=C(C=C3)Cl,Microbiology & Virology,Anti-infection,Gram positive antibacterial activity inhibitor
Closantel Sodium,61438-64-0,CC1=CC(=C(C=C1NC(=O)C2=CC(=CC(=C2[O-])I)I)Cl)C(C#N)C3=CC=C(C=C3)Cl.[Na+],Microbiology & Virology,Anti-infection,Gram positive antibacterial activity inhibitor
Clotrimazole,23593-75-1,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,Microbiology & Virology,Antibiotic,antifungal compound
Cloxacillin Sodium,7081-44-9,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+],Microbiology & Virology,Anti-infection,semisynthetic beta-lactamase resistant penicillin antibiotic
Clozapine,5786-21-0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,Neuroscience,Dopamine Receptor,5-HT receptor antagonist
CO-1686 (AVL-301),1374640-70-6,CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC,JAK/STAT Signaling,EGFR,EGFR inhibitor
Cobicistat (GS-9350),1004316-88-4,CC(C1=NC(CN(C(NC(C(NC(CC2=CC=CC=C2)CCC(NC(OCC3=CN=CS3)=O)CC4=CC=CC=C4)=O)CCN5CCOCC5)=O)C)=CS1)C,Metabolism,CYP3A/CYP450,Selective CYP3A inhibitor
Cobimetinib,934660-93-2,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,MAPK Signaling,MEK1/2,Selective MEK inhibitor
Coenzyme Q10,303-98-0,,Natural Products,Endogenous Metabolite; Reactive Oxygen Species,
Colchicine,64-86-8,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,Cell Cycle/Checkpoint,Microtubule/Tubulin,Tubulin Inhibitor
Colistin Sulfate,1264-72-8,,Microbiology & Virology,Anti-infection,Cationic polypeptide antibiotic
Conivaptan HCl,168626-94-6,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6.Cl,GPCR/G protein,Vasopressin Receptor,Vasopressin receptor antagonist
Corticosterone,50-22-6,,GPCR/G protein,Glucocorticoid Receptor,
Cortisone acetate,1950-4-4,CC(=O)OCC(=O)C1(CCC2C1(CC(=O)C3C2CCC4=CC(=O)CCC34C)C)O,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist
Costundide,553-21-9,,DNA Damage/DNA Repair,Telomerase,
Costunolide,553-21-9,,DNA Damage/DNA Repair,Telomerase,
Coumarin,91-64-5,C1=CC=C2C(=C1)C=CC(=O)O2,Natural Products,Immunology & Inflammation related,Precursor in chemical reaction
CP-945598 HCl,686347-12-6,CCNC1(CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl)C(=O)N.Cl,GPCR/G protein,Cannabinoid Receptor,"CB1 antagonist,selective and high affinity"
CP21R7,125314-13-8,NC1=CC=CC(C(C(N2)=O)=C(C3=CN(C)C4=C3C=CC=C4)C2=O)=C1,PI3K/Akt/mTOR Signaling,GSK-3,
Creatinine,60-27-5,,Others,Others,
Crenolanib (CP-868596),670220-88-9,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,Tyrosine Kinase,PDGFR,"PDGFR-β inhibitor,potent and selective"
Crizotinib hydrochloride,1415560-69-8,C[C@](OC(C=C(C(C=N1)=CN1C2CCNCC2)C=N3)=C3N)([H])C4=C(Cl)C=CC(F)=C4Cl.Cl,Tyrosine Kinase,ALK,inhibitor of the c-Met kinase and the NPM-ALK
Cromolyn sodium,15826-37-6,C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)[O-])O)C(=O)C=C(O2)C(=O)[O-].[Na+].[Na+],Membrane Transporter/Ion Channel,Calcium Channel,Mast cell membrane stabilizer
Crotaline,315-22-0,O=C([C@@](C([H])([H])[H])([H])[C@@]([C@@]1(C([H])([H])[H])O[H])(C([H])([H])[H])O[H])O[C@@]2([H])[C@](C(C([H])([H])OC1=O)=C([H])C3([H])[H])([H])N3C([H])([H])C2([H])[H],Natural Products,Others,
Crotamiton,483-63-6,,Microbiology & Virology,Parasite,Scabicidal and antipruritic agent
Crystal Violet,548-62-9,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-],Others,Others,triarylmethane dye
CUDC-101,1012054-59-9,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO,DNA Damage/DNA Repair,HDAC,Multitargeted HDAC inhibitor
Curculigoside,85643-19-2,,Natural Products,Immunology & Inflammation related,
Curcumin,458-37-7,COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O,Immunology/Inflammation,KEAP1-Nrf2,Tyrosinase inhibitor
CX-4945 (Silmitasertib),1009820-21-6,C1=CC(=CC(=C1)Cl)NC2=C3C=CN=CC3=C4C=CC(=CC4=N2)C(=O)O,PI3K/Akt/mTOR Signaling,CK2,CK2 inhibitor
Cyclamic acid,100-88-9,C1CCC(CC1)NS(=O)(=O)O,Others,Others,artificial sweetening agent
Cyclandelate,456-59-7,CC1CC(CC(C1)(C)C)OC(=O)C(C2=CC=CC=C2)O,Others,Others,Inhibitor of rat hepatic acycloenzyme A
Cyclo(RGDyK),250612-42-1,NCCCC[C@@]1([H])/C(O)=N/[C@@](/C(O)=N/C/C(O)=N/[C@@](/C(O)=N/[C@](/C(O)=N/1)([H])CC2=CC=C(O)C=C2)([H])CC(O)=O)([H])CCCNC(N)=N.FC(F)(F)C(O)=O.FC(F)(F)C(O)=O,Angiogenesis,Integrin,αVβ3 integrin inhibitor
Cyclobenzaprine HCl,6202-23-9,CN(CC/C=C1C2=CC=CC=C2C=CC3=CC=CC=C3\1)C.Cl,GPCR/G protein,5-HT Receptor,5-HT2 receptor antagonist
Cyclophosphamide,50-18-0,C1CNP(=O)(OC1)N(CCCl)CCCl,DNA Damage/DNA Repair,DNA Synthesis,Nitrogen mustard alkylating agent and prodrug.
Cyclophosphamide monohydrate,6055-19-2,C1CNP(=O)(OC1)N(CCCl)CCCl.O,Others,Others,"alkylating, cytotoxic agent,antitumor activity"
Cyclosporin A,59865-13-3,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Immunology/Inflammation,,Immunosuppressive agent
Cyclosporine,79217-60-0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Others,Others,Immunosuppressant drug
Cyproheptadine hydrochloride,969-33-5,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1.Cl,Neuroscience,Histamine Receptor,serotonin and histamine antagonist as well as antimuscarinic reagent
Cyproterone Acetate,427-51-0,ClC1=C([H])C(C(C([H])([H])C2([H])[H])([H])C(C2(C(C([H])([H])[H])=O)OC(C([H])([H])[H])=O)(C([H])([H])[H])C([H])([H])C3([H])[H])([H])C3([H])C(C1=C([H])C4=O)(C([H])([H])[H])C5([H])C4([H])C5([H])[H],Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonist
Cyromazine,66215-27-8,NC1=NC(NC2CC2)=NC(N)=N1,Others,Others,"insecticide, acaricide"
Cysteamine HCl,156-57-0,C(CS)N.Cl,Others,Others,Drug used to treat cystinosis
Cytarabine,147-94-4,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,DNA Damage/DNA Repair,DNA Synthesis,"cytotoxic agent, blocks DNA synthesis"
Cytarabine hydrochloride,69-74-9,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl,DNA Damage/DNA Repair,DNA Synthesis,DNA synthsis inhibitor
Cytidine,65-46-3,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,pyrimidine nucleoside
Cytisine,485-35-8,O=C1N(C2=C([H])C([H])=C1[H])C([H])([H])[C@@]3([H])C([H])([H])[C@]2([H])C([H])([H])N([H])C3([H])[H],Natural Products,AChR,
D-(-)-Salicin,138-52-3,,Natural Products,COX,
D-(+)-Raffinose (hydrate),17629-30-0,O[C@@H]1[C@@H](O)[C@@H](OC[C@@H]2[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@]3(CO)O[C@H](CO)[C@@H](O)[C@@H]3O)O2)O[C@H](CO)[C@@H]1O.O.O.O.O.O,Others,Others,
D-(−)-Fructose,57-48-7,OC[C@](O)([H])[C@](O)([H])[C@@](O)([H])C(CO)=O,Others,Others,
D-Cycloserine,68-41-7,C1C(C(=O)NO1)N,Microbiology & Virology,Anti-infection,NMDA receptor (NMDAR) partial agonist
D-Glutamine,5959-95-5,,Neuroscience,GluR,
D-Mannitol,69-65-8,C(C(C(C(C(CO)O)O)O)O)O,Others,Others,osmotic diuretic agent，weak renal vasodilator.
Dabigatran etexilate mesylate,872728-81-9,CCCCCCOC(NC(C1=CC=C(NCC2=NC3=C(C=CC(C(N(C4=CC=CC=N4)CCC(OCC)=O)=O)=C3)N2C)C=C1)=N)=O.CS(=O)(O)=O,Proteases,Thrombin,"Direct thrombin inhibitor,anticoagulant,prodrug of dabigatran"
Dabrafenib (GSK2118436),1195765-45-7,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,MAPK Signaling,Raf,Inhibitor of BRAF(V600) mutants
Dabrafenib Mesylate (GSK-2118436),1195768-06-9,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F.CS(=O)(=O)O,MAPK Signaling,Raf,Inhibitor of BRAF(V600) mutants
Dacarbazine,4342-03-4,CN(C)NN=C1C(=NC=N1)C(=O)N,DNA Damage/DNA Repair,DNA Synthesis,Antineoplastic( malignant melanoma and sarcomas)
Daclatasvir (BMS-790052),1214735-16-6,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,Proteases,HCV Protease,HCV NS5A inhibitor
"Dacomitinib (PF299804, PF299)",1110813-31-4,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,JAK/STAT Signaling,EGFR,HER inhibitor
Daidzein,486-66-8,C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O)O,Natural Products,Others,Anti-cancer reagent
Daminozide,1596-84-5,,DNA Damage/DNA Repair,HDAC,
Danazol,17230-88-5,O[C@@]1(C#C)CC[C@@]2([H])[C@]3([H])CCC4=CC5=C(C=NO5)C[C@]4(C)[C@@]3([H])CC[C@@]21C,Endocrinology and Hormones,Androgen Receptor,weak androgenic effects
Danoprevir (RG7227),850876-88-9,C35H46FN5O9S,Proteases,HCV Protease,
"Dantrolene, sodium salt",14663-23-1,O=C1N=C(N(C1)/N=C/C2=CC=C(C(C=C3)=CC=C3[N+]([O-])=O)O2)[O-].[Na+],Membrane Transporter/Ion Channel,Calcium Channel,ryanodine receptor (RYR) channels inhibitor
Dapagliflozin,461432-26-8,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,Metabolism,SGLT,"SGLT2 inhibitor,potent and selective"
Dapoxetine HCl,129938-20-1,CN(C)C(CCOC1=CC=CC2=CC=CC=C21)C3=CC=CC=C3.Cl,Neuroscience,5-HT Receptor,Selective serotonin reuptake inhibitor
Dapsone,80-08-0,NC1=CC=C(S(C2=CC=C(N)C=C2)(=O)=O)C=C1,Microbiology & Virology,Antibiotic,sulfone antibiotic
DAPT (GSI-IX),208255-80-5,CC(C(=O)NC(C1=CC=CC=C1)C(=O)OC(C)(C)C)NC(=O)CC2=CC(=CC(=C2)F)F,Neuroscience,Amyloid β,"γ-secretase inhibitor,potent and specific"
Daptomycin,103060-53-3,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,DNA Damage/DNA Repair,DNA Synthesis,Calcium-dependent antibiotic
Darifenacin HBr,133099-07-7,C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br,Neuroscience,Muscarinic Receptor,Selective M3 muscarinic receptor antagonist
Darunavir,206361-99-1,CC(CN(S(C1=CC=C(N)C=C1)(=O)=O)C[C@](O)([H])[C@](/N=C(O[C@@]2([H])CO[C@]3([H])[C@@]2([H])CCO3)\O)([H])CC4=CC=CC=C4)C,Proteases,HIV Protease,HIV-1 protease inhibitor
Darunavir Ethanolate,635728-49-3,C29H43N3O8S,Proteases,HIV Protease,
Dasatinib (BMS-354825),302962-49-8,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,TGF-β / Smad Signaling,Bcr-Abl,Src and BCR-Abl inhibitor
Dasatinib Monohydrate,863127-77-9,C22H28ClN7O3S,TGF-β / Smad Signaling,Bcr-Abl,
Daunorubicin HCl,23541-50-6,Cl[H].O=C(C([H])([H])[H])[C@@](C([H])([H])[C@]1([H])O[C@](C([H])([H])[C@]2([H])N([H])[H])([H])O[C@](C([H])([H])[H])([H])[C@@]2([H])O[H])(C([H])([H])C3=C1C(O[H])=C(C(C4=C5C([H])=C([H])C([H])=C4OC([H])([H])[H])=O)C(C5=O)=C3O[H])O[H],Microbiology & Virology,Antibiotic,DNA topoisomerase II inhibitor
DCA,2156-56-1,,Others,Others,
Decamethonium Bromide,541-22-0,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C.[Br-].[Br-],Neuroscience,AChR,Nicotinic AChR partial agonist
"Decitabine (NSC127716, 5AZA-CdR)",2353-33-5,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,Chromatin/Epigenetics,DNA Methyltransferase,Deoxycytidine analog and cellular diifferentiation inducer
Defactinib,1073154-85-4,CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F,Tyrosine Kinase,FAK,FAK phosphorylation inhibitor
Deferasirox,201530-41-8,C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,Oral iron chelator
Deferiprone,30652-11-0,CC1=C(C(=O)C=CN1C)O,Others,Others,Chelating agent
Deferoxamine mesylate,138-14-7,CC(N(O)CCCCC/N=C(O)/CCC(N(O)CCCCC/N=C(O)/CCC(N(O)CCCCCN)=O)=O)=O.CS(O)(=O)=O,Others,Others,iron-chelating agent
Deflazacort,14484-47-0,O=C(C([H])([H])OC(C([H])([H])[H])=O)[C@@]12N=C(C([H])([H])[H])O[C@]1([H])C([H])([H])[C@]([C@@](C([H])([H])C3([H])[H])([H])[C@@]4([H])[C@@](C([H])([H])[H])(C([H])=C5[H])C3=C([H])C5=O)([H])[C@]2(C([H])([H])[H])C([H])([H])[C@]4([H])O[H],GPCR/G protein,Glucocorticoid Receptor,anti-inflammatory and immunosuppressant
Dehydroandrographolide,134418-28-3,,Natural Products,Chloride Channel,
Dehydrocostus Lactone,477-43-0,,Natural Products,IκB/IKK,
Dehydroepiandrosterone (DHEA),53-43-0,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,Membrane Transporter/Ion Channel,Calcium Channel,Endogenous steroid hormone
delta-Gluconolactone,90-80-2,,Others,Others,
Deoxyarbutin,53936-56-4,C1CCOC(C1)OC2=CC=C(C=C2)O,Proteases,Tyrosinase,Tyrosinase inhibitor
Deoxycholic acid,83-44-3,CC(CCC(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C,Natural Products,Others,Bile Acid;proinflammatory agent
Deoxycorticosterone acetate,56-47-3,CC(=O)OCC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,GPCR/G protein,Adrenergic Receptor,Steroid hormone
Desipramine hydrochloride,58-28-6,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C13.Cl,GPCR/G protein,Adrenergic Transporters,noradrenalin transporters inhibitor
Desloratadine,100643-71-8,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,Neuroscience,Histamine Receptor,High affinity histamine H1 receptor antagonist
Desmopressin,16679-58-6,O=C(C1CSSCCC(NC(CC2=CC=C(O)C=C2)C(NC(CC3=CC=CC=C3)C(NC(CCC(N)=O)C(NC(CC(N)=O)C(N1)=O)=O)=O)=O)=O)N4C(C(NC(C(NCC(N)=O)=O)CCC/N=C(N)\N)=O)CCC4,GPCR/G protein,Vasopressin Receptor,Hemostatic and anti-diuretic
Desogestrel,54024-22-5,[H][C@@]12C(CC[C@]([C@@](CC[C@]3(C#C)O)([H])[C@]3(CC)C4)([H])[C@]2([H])C4=C)=CCCC1,Endocrinology and Hormones,Estrogen/progestogen Receptor,progestin used in hormonal contraceptives
Desonide,638-94-8,O=C(C([H])([H])O[H])[C@@]12OC(C([H])([H])[H])(C([H])([H])[H])O[C@]1([H])C([H])([H])[C@]([C@@](C([H])([H])C3([H])[H])([H])[C@@]4([H])[C@@](C([H])([H])[H])(C([H])=C5[H])C3=C([H])C5=O)([H])[C@]2(C([H])([H])[H])C([H])([H])[C@]4([H])O[H],GPCR/G protein,Glucocorticoid Receptor,nonfluorinated corticosteroid anti-inflammatory agent
Desvenlafaxine,93413-62-8,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,Neuroscience,5-HT Receptor,serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor
Desvenlafaxine Succinate,386750-22-7,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O.C(CC(=O)O)C(=O)O.O,Neuroscience,5-HT Receptor,serotonin (5-HT) transporter and norepinephrine (NE) transporter reuptake inhibitor
Detomidine HCl,90038-01-0,CC1=C(C(=CC=C1)CC2=CN=CN2)C.Cl,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist
Dexamethasone (DHAP),50-02-2,O=C1C=C[C@@]2(C)C(CC[C@@]3([H])[C@]2(F)[C@@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(C(CO)=O)O)=C1,Ubiquitination/Proteasome,Autophagy,Glucocorticoidan;anti-inflammatory
Dexamethasone acetate,1177-87-3,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)O)C)O)F)C,GPCR/G protein,Glucocorticoid Receptor,IL Receptor modulator
Dexlansoprazole,138530-94-6,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Membrane Transporter/Ion Channel,Proton Pump,Proton pump inhibitor
Dexmedetomidine,113775-47-6,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,GPCR/G protein,Adrenergic Receptor,α2-adrenergic receptor agonist
Dexmedetomidine HCl,145108-58-3,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.Cl,GPCR/G protein,Adrenergic Receptor,Highly selective and potent alpha-2 adrenoceptor agonist
Dexpanthenol,81-13-0,,Metabolism,Vitamin,
Dexrazoxane,24584-09-6,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,Others,Others,cardioprotective agent
"Dexrazoxane HCl (ICRF-187, ADR-529)",149003-01-0,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2.Cl,DNA Damage/DNA Repair,Topoisomerase,"Topoisomerase II inhibitor,intracellular ion chelator,cardioprotective agent"
Dextrose (D-glucose),50-99-7,C(C1C(C(C(C(O1)O)O)O)O)O,Others,Others,Simple sugar (monosaccharide)
Diacerein,13739-02-1,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C=C(C=C3C2=O)C(=O)O)OC(=O)C,Others,IL Receptor,IL receptor inhibitor
Diazoxide,364-98-7,ClC1=CC=C2NC(C)=NS(=O)(C2=C1)=O,Membrane Transporter/Ion Channel,AMPAR,positive allosteric modulator of the AMPA and kainate receptors
Dibenzothiophene,132-65-0,C1=CC=C2C(=C1)C3=CC=CC=C3S2,Others,Others,Intermediate of organic synthesis
Dibucaine,85-79-0,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,Others,Others,Local anesthetic
Dibucaine (Cinchocaine) HCl,61-12-1,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC.Cl,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor
"Dibutyryl-cAMP, sodium salt",16980-89-5,CCC/C([O-])=N/C1=C(N=CN2[C@@]3([H])[C@@](OC(CCC)=O)([H])[C@@](O4)([H])[C@@](O3)([H])COP4(O)=O)C2=NC=N1.[Na+],MAPK Signaling,cAMP,Cell-permeable cAMP analog that activates cAMP-dependent protein kinases
Dichlorphenamide,120-97-8,C6H6Cl2N2O4S2,Metabolism,Carbonic Anhydrase,
Diclazuril,101831-37-2,C1=CC(=CC=C1C(C#N)C2=C(C=C(C=C2Cl)N3C(=O)NC(=O)C=N3)Cl)Cl,Microbiology & Virology,Anti-infection,anti-coccidial drug
Diclofenac,15307-86-5,ClC1=C(NC2=CC=CC=C2CC(O)=O)C(Cl)=CC=C1,Neuroscience,COX,non-selective COX inhibitor
Diclofenac Diethylamine,78213-16-8,CCNCC.C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,Neuroscience,COX,non-selective COX inhibitor
Diclofenac Potassium,15307-81-0,C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[K+],Immunology/Inflammation,,nonsteroidal anti-inflammatory drug
Diclofenac Sodium,15307-79-6,C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+],Neuroscience,COX,COX inhibitor
Dicyclomine HCl,67-92-5,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2.Cl,Others,Others,Anticholinergic drug
Didanosine,69655-05-6,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,Microbiology & Virology,Reverse Transcriptase,Reverse transcriptase inhibitor
Dienogest,65928-58-7,CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2(CC#N)O,Endocrinology and Hormones,Estrogen/progestogen Receptor,Orally active synthetic progesterone
Diethylstilbestrol,56-53-1,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,Endocrinology and Hormones,Estrogen/progestogen Receptor,synthetic nonsteroidal estrogen
Difloxacin HCl,98106-17-3,CN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F,Others,Others,quinolone antimicrobial antibiotic
Diflunisal,22494-42-4,FC1=CC(F)=C(C2=CC(C(O)=O)=C(O)C=C2)C=C1,Neuroscience,COX,"COX inhibitor, nonsteroidal anti-inflammatory drug (NSAID)"
Difluprednate,23674-86-4,CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)COC(=O)C,Others,Others,Corticosteroid
Digoxin,20830-75-5,O[C@]1([C@]([C@@H](C2=CC(OC2)=O)CC1)(C)[C@@H]3O)[C@H]4[C@H](C3)[C@](CC[C@@H]5O[C@@H](C[C@@H]6O)O[C@H](C)[C@H]6O[C@@H](C[C@@H]7O)O[C@H](C)[C@H]7O[C@@H](C[C@@H]8O)O[C@H](C)[C@H]8O)(C)[C@@H](C5)CC4,Membrane Transporter/Ion Channel,ATPase,Na+/K+ ATPase pump inhibitor
Dihydroartemisinin,71939-50-9,[H][C@@]1(C([H])([H])C2([H])[H])[C@]3([C@@]([C@@]4([H])C([H])([H])[H])([H])C([H])([H])C([H])([H])[C@@]1([H])C([H])([H])[H])OO[C@@]2(C([H])([H])[H])O[C@@]3([H])O[C@@]4([H])O[H],Microbiology & Virology,Antimalaria,
Dihydrotestosterone(DHT),521-18-6,,Endocrinology and Hormones,Androgen Receptor,
Diltiazem HCl,33286-22-5,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl,Membrane Transporter/Ion Channel,Calcium Channel,inhibitor of L-type Ca2+ channels
Dimesna,16208-51-8,C(CS(=O)(=O)[O-])SSCCS(=O)(=O)[O-].[Na+].[Na+],Others,Others,Uroprotective agent
Dimethyl Fumarate,624-49-7,COC(=O)C=CC(=O)OC,Immunology/Inflammation,KEAP1-Nrf2,nuclear factor (erythroid-derived)-like 2 (Nrf2) pathway activator
Diminazene Aceturate,908-54-3,C14H15N7.2C4H7NO3,Others,Others,
Dinaciclib (SCH727965),779353-01-4,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,Potent CDK inhibitor
Diosimin,520-27-4,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O,Natural Products,Others,
Diosmetin,520-34-3,COC1=C(O)C=C(C2=CC(C3=C(O)C=C(O)C=C3O2)=O)C=C1,Metabolism,CYP3A/CYP450,CYP1A1 inhibitor
Diperodon HCl,537-12-2,O=C(NC1=CC=CC=C1)OC(COC(NC2=CC=CC=C2)=O)CN3CCCCC3.Cl,Others,Others,Local anaesthetics
Diphemanil Methylsulfate,62-97-5,C[N+]1(CCC(=C(C2=CC=CC=C2)C3=CC=CC=C3)CC1)C.COS(=O)(=O)[O-],Neuroscience,AChR,AChR antagonist
Diphenhydramine HCl,147-24-0,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl,Neuroscience,Histamine Receptor,H1 receptor antagonist
Diphenidol HCl,3254-89-5,OC(C1=CC=CC=C1)(C2=CC=CC=C2)CCCN3CCCCC3.Cl,Neuroscience,AChR,antagonist of muscarinic M2 and M3 receptor
Diphenylpyraline HCl,132-18-3,CN1CCC(CC1)OC(C2=CC=CC=C2)C3=CC=CC=C3.Cl,Others,Others,Histamine receptor antagonist
Dipyridamole,58-32-2,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,Metabolism,PDE,PDE inhibitor
Dirithromycin,62013-04-1,CCC1C(C2C(C(C(CC(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)(C)O)C)NC(O2)COCCOC)C)(C)O,Microbiology & Virology,Anti-infection,Macrolide glycopeptide antibiotic
Disulfiram,97-77-8,CCN(CC)C(=S)SSC(=S)N(CC)CC,Metabolism,Dopamine β-hydroxylase,Dopamine β-hydroxylase inhibitor
Divalproex Sodium,76584-70-8,CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+],Ubiquitination/Proteasome,Autophagy,Epilepsy/migraines/bipolar disorder medicine
DL-Carnitine HCl,461-05-2,C[N+](C)(C)CC(CC(=O)O)O.[Cl-],Others,Others,quaternary ammonium compound
DL-Serine,302-84-1,,Metabolism,PKM,
DL-α-Difluoromethylornithine (hydrochloride hydrate),96020-91-6,FC(F)C(C(O)=O)(N)CCCN.Cl.O,Metabolism,ornithine decarboxylase,"ornithine decarboxylase inhibitor, irreversible"
DL-α-Lipoic Acid,1077-28-7,OC(=O)CCCCC1SSCC1,Others,Others,
DL-α-Tocopherol,10191-41-0,,Metabolism,Vitamin,
Docetaxel,114977-28-5,O=C(N[C@H]([C@H](C(O[C@H]1C[C@]2(O)C(C)(C)C([C@@H](O)C([C@@]3(C)[C@]([C@@](CO4)(OC(C)=O)[C@@]4([H])C[C@@H]3O)([H])[C@@H]2OC(C5=CC=CC=C5)=O)=O)=C1C)=O)O)C6=CC=CC=C6)OC(C)(C)C,Cell Cycle/Checkpoint,Microtubule/Tubulin,Microtubulin disassembly inhibitor
Docetaxel Trihydrate,148408-66-6,CC([C@](OC([C@@](O)([H])[C@](NC(OC(C)(C)C)=O)([H])C1=CC=CC=C1)=O)([H])C[C@@]2(O)[C@](OC(C3=CC=CC=C3)=O)([H])[C@@]4([H])[C@@]([C@](O)([H])C[C@]5([H])[C@@]4(OC(C)=O)CO5)6C)=C(C(C)2C)[C@](O)([H])C6=O.O.O.O,Cell Cycle/Checkpoint,Microtubule/Tubulin,Depolymerisation of microtubules inhibitor
Docosahexaenoic Acid,6217-54-5,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,Others,Others,
Docosanol (Abreua),661-19-8,CCCCCCCCCCCCCCCCCCCCCCO,Others,Others,Saturated fatty alcohol
Dofetilide,115256-11-6,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel inhibitor
Dolasetron,115956-12-2,,GPCR/G Protein,5-HT3,Potent antagonist of the serotonin (5-HT) receptor subtype 5-HT3
Domiphen Bromide,538-71-6,CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1.[Br-],Others,Others,Quaternary ammonium antiseptic
Domperidone,57808-66-9,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,Neuroscience,Dopamine Receptor,Drug for gastroparesis
Donepezil HCl,120011-70-3,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC.Cl,Chromatin/Epigenetics,Histone Acetyltransferases,AChE inhibitor
Dopamine HCl,62-31-7,C1=CC(=C(C=C1CCN)O)O.Cl,Neuroscience,Dopamine Receptor,Dopamine D1-5 receptors agonist
Doramectin,117704-25-3,C50H74O14,Microbiology & Virology,Antibiotic,
Doripenem,148016-81-3,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,Microbiology & Virology,Antibiotic,Ultra-broad spectrum injectable antibiotic
Doripenem Hydrate,364622-82-2,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O.O,Microbiology & Virology,Antibiotic,"Injectable antibiotic,ultra-broad spectrum"
Dorzolamide HCl,130693-82-2,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.Cl,Metabolism,Carbonic Anhydrase,Carbonic anhydrase inhibitor
"Dovitinib (TKI-258, CHIR-258)",405169-16-6,CN1CCN(CC1)C2=CC3=C(C=C2)NC(=C4C(=C5C(=NC4=O)C=CC=C5F)N)N3,Tyrosine Kinase,FGFR,Multitargeted RTK inhibitor
Dovitinib (TKI258) Lactate,915769-50-5,FC1=C(C(N)=C(C2=O)C3=NC4=C(N3)C=C(N5CCN(C)CC5)C=C4)C(N2)=CC=C1.CC(O)C(O)=O.O,Tyrosine Kinase,VEGFR,"Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR)."
Dovitinib Dilactic acid,852433-84-2,CC(C(=O)O)O.CC(C(=O)O)O.CN1CCN(CC1)C2=CC3=C(C=C2)NC(=C4C(=C5C(=NC4=O)C=CC=C5F)N)N3,Tyrosine Kinase,VEGFR,FLT3 inhibitor
Doxapram HCl,7081-53-0,CCN1CC(CCN2CCOCC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)C1=O.O.Cl,Others,Others,Potassium channel inhibitor
Doxazosin Mesylate,77883-43-3,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC.CS(=O)(=O)O,GPCR/G protein,Adrenergic Receptor,α1-adrenergic receptor antagonist
Doxepin (hydrochloride),1229-29-4,CN(C)CC/C=C1C2=C(C=CC=C2)COC3=C/1C=CC=C3.Cl,Neuroscience,Histamine Receptor,"histamine, serotonin, adrenergic, and muscarinic receptors antagonist"
Doxercalciferol,54573-75-0,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,Vitamin D Related,VD/VDR,Vitamin D receptor activator
Doxifluridine,3094-9-5,CC1C(C(C(O1)N2C=C(C(=O)NC2=O)F)O)O,Apoptosis,Thymidylate Synthase,oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU)
Doxofylline,69975-86-6,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC3OCCO3,Metabolism,PDE,PDE inhibitor
Doxorubicin,23214-92-8,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,DNA Damage/DNA Repair,Topoisomerase,"Topo II inhibitor,immunosuppresive antineoplastic antibiotic"
Doxorubicin (Adriamycin) HCl,25316-40-9,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl,DNA Damage/DNA Repair,Topoisomerase,"Antitumour antibiotic,inhibits TOPO II."
Doxycycline HCl,10592-13-9,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl,Proteases,MMP,Tetracycline antibiotic;MMP inhibitor;cell selection reagent
Doxycycline hyclate,24390-14-5,O=C(C1=C(O)[C@]2(O)[C@]([C@@H](O)[C@@]3([H])C(C2=O)=C(O)C4=C(O)C=CC=C4[C@@H]3C)([H])[C@H](N(C)C)C1=O)N.Cl,Others,Others,MMP inhibitor
Doxylamine Succinate,562-10-7,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O,Neuroscience,Histamine Receptor,Histamine receptor inhibitor
Dronedarone,141626-36-0,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC,Metabolism,CYP3A/CYP450,"CYP3A4 and 2D6 inhibitor,moderate"
Dronedarone HCl,141625-93-6,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC.Cl,Membrane Transporter/Ion Channel,Potassium Channel,Antiarrhythmic drugs
Droperidol,548-73-2,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,Neuroscience,Dopamine Receptor,Dopamine-2 receptor antagonist
Dropropizine,17692-31-8,C1CN(CCN1CC(CO)O)C2=CC=CC=C2,Others,Others,Racemic non-opiate antitussive agent
Drospirenone,67392-87-4,O=C1OC2(C([H])([H])C1([H])[H])C3([H])C(C3([H])[H])([H])C4([H])C2(C([H])([H])[H])C([H])([H])C([H])([H])C(C(C([H])([H])C5([H])[H])(C([H])([H])[H])C6=C([H])C5=O)([H])C4([H])C7([H])C6([H])C7([H])[H],Endocrinology and Hormones,Estrogen/progestogen Receptor,Synthetic progestin
Duloxetine HCl,136434-34-9,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl,Neuroscience,5-HT Receptor,5-HT receptor inhibitor
Dutasteride,164656-23-9,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,Endocrinology and Hormones,5-alpha Reductase,5-alpha-reductase inhibitor
Dyclonine HCl,536-43-6,CCCCOC1=CC=C(C=C1)C(=O)CCN2CCCCC2.Cl,Membrane Transporter/Ion Channel,Sodium Channel,local anesthetic
Dydrogesterone,152-62-5,CC(=O)C1CCC2C1(CCC3C2C=CC4=CC(=O)CCC34C)C,Others,Progesterone Receptor,"Potent, orally active progestogen"
Dyphylline,479-18-5,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O,Metabolism,PDE,Pan-PDE inhibitor
E 64d,88321-09-9,CCOC(=O)C1C(O1)C(=O)NC(CC(C)C)C(=O)NCCC(C)C,Proteases,Cathepsin,Cysteine protease inhibitor
Ebastine,90729-43-4,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4,Neuroscience,Histamine Receptor,Histamine receptor antagonist
Echinacoside,82854-37-3,,Natural Products,Others,
Econazole nitrate,24169-02-6,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-],Membrane Transporter/Ion Channel,"Anti-infection,Calcium Channel",Calcium channel inhibitor
Edaravone,89-25-8,CC1=NN(C(=O)C1)C2=CC=CC=C2,Others,Others,A radical scavenger and antioxidant
Edoxaban,480449-70-5,C24H30ClN7O4S,Proteases,Thrombin,
Edoxaban tosylate monohydrate,1229194-11-9,CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C.O,Proteases,Thrombin,Oral factor Xa inhibitor
Edrophonium (chloride),116-38-1,OC1=CC([N+](C)(C)CC)=CC=C1.[Cl-],Neuroscience,AChE,acetylcholinesterase (AChE) inhibitor
Efaproxiral Sodium,170787-99-2,CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(C=C2)OC(C)(C)C(=O)[O-])C.[Na+],Others,Others,Synthetic allosteric modifier of hemoglobin
Efavirenz,154598-52-4,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,Microbiology & Virology,HIV,Reverse transcriptase inhibitor
Efinaconazole,164650-44-6,CC(C(CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCC(=C)CC3,Microbiology & Virology,Antifungal,novel triazole antifungal drug
Eicosapentaenoic Acid,10417-94-4,CC/C([H])=C([H])\C/C([H])=C([H])\C/C([H])=C([H])\C/C([H])=C([H])\C/C([H])=C([H])\CCCC(O)=O,Immunology/Inflammation,Immunology & Inflamm,EPA，omega-3 fatty acid
Elacridar,143664-11-3,COC1=CC=CC2=C1NC3=C(C2=O)C=CC=C3C(=O)NC4=CC=C(C=C4)CCN5CCC6=CC(=C(C=C6C5)OC)OC,Others,Others,BCRP inhibitor
Eletriptan HBr,177834-92-3,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4.Br,Neuroscience,5-HT Receptor,selective 5-HT1B and 5-HT1D receptor agonist
Ellagic acid,476-66-4,OC1=C(O)C2=C3C(C(OC4=C3C(C(O2)=O)=CC(O)=C4O)=O)=C1,DNA Damage/DNA Repair,Topoisomerase,Casein kinase 2 (CK2) inhibitor
Eltrombopag,496775-61-2,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)NN=C3C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C,Others,Thrombopoietin Receptor,nonpeptide agonist of the thrombopoietin receptor
Eltrombopag Olamine,496775-62-3,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)NN=C3C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C.C(CO)N.C(CO)N,Others,Thrombopoietin Receptor,C-mpl agonist
Elvitegravir (GS-9137),697761-98-1,CC(C)C(CO)N1C=C(C(=O)C2=CC(=C(C=C21)OC)CC3=C(C(=CC=C3)Cl)F)C(=O)O,Proteases,HIV Integrase,"HIV-1 integrase inhibitor,potent"
Embelin,550-24-3,CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O,Apoptosis,IAP,"XIAP inhibitor,cell-permeable"
EMD-1214063,1100598-32-0,CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC(=CC=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N,Tyrosine Kinase,c-MET,"C-Met inhibitor,potent and selective"
Emodin,518-82-1,,Immunology/Inflammation,NF-κB,
Empagliflozin (BI 10773),864070-44-0,C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,Metabolism,SGLT,SGLT-2 inhibitor for oral treatment of type 2 diabetes
Emtricitabine,143491-57-0,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,Microbiology & Virology,Reverse Transcriptase,Reverse transcriptase inhibitor
Enalapril Maleate,76095-16-4,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O,Endocrinology and Hormones,RAAS,angiotensin-converting enzyme (ACE) inhibitor
Enoxacin (Penetrex),74011-58-8,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,Microbiology & Virology,Antibiotic,Topoisomerase inhibitor
Enoxolone,471-53-4,CC([C@]1([H])CC[C@]23C)([C@](O)([H])CC[C@@]1([C@@]2([H])C(C=C4[C@]5([H])C[C@](CC[C@](CC[C@]43C)5C)(C(O)=O)C)=O)C)C,Others,Others,major component of licorice
Enrofloxacin,93106-60-6,CCN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F,Microbiology & Virology,Anti-infection,Fluoroquinolone antibiotic
Entacapone,130929-57-6,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,Chromatin/Epigenetics,Histone Methyltransferase,COMT inhibitor
Entecavir Hydrate,209216-23-9,C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N.O,Microbiology & Virology,Reverse Transcriptase,Antiviral drug used in hepatitis B infection
"Entinostat (MS-275,SNDX-275)",209783-80-2,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,DNA Damage/DNA Repair,HDAC,HDAC1 and HDAC3 inhibitor
Entrectinib,1108743-60-7,CN1CCN(C2=CC(NC3CCOCC3)=C(C(/N=C4C5=C(NN/4)C=CC(CC6=CC(F)=CC(F)=C6)=C5)=O)C=C2)CC1,Tyrosine Kinase,ALK,Orally active inhibitor of ALK kinase
Enzastaurin (LY317615),170364-57-5,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7,TGF-β / Smad Signaling,PKC,"PKC beta inhibitor,potent and selective"
Epalrestat,82159-09-9,CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O,Others,Others,aldose reductase inhibitor
Epiandrosterone,481-29-8,,Endocrinology and Hormones,Androgen Receptor,
Epinastine HCl,108929-04-0,Cl[H].[H]C1(C([H])([H])N=C2N([H])[H])N2C3=C([H])C([H])=C([H])C([H])=C3C([H])([H])C4=C([H])C([H])=C([H])C([H])=C14,Neuroscience,Histamine Receptor,Histamine receptor antagonist
Epinephrine Bitartrate,51-42-3,CNCC(C1=CC(=C(C=C1)O)O)O.C(C(C(=O)O)O)(C(=O)O)O,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist
Epinephrine HCl,55-31-2,CNCC(C1=CC(=C(C=C1)O)O)O.Cl,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist
Epirubicin HCl,56390-09-1,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl,DNA Damage/DNA Repair,Topoisomerase,Antibiotic antitumor agent
Epleremone,107724-20-9,O=C(C(C1([H])[H])([H])C2([H])C3(C(C([H])([H])C4([H])[H])(C([H])([H])[H])C1=C([H])C4=O)OC3([H])C([H])([H])C5(C([H])([H])[H])C2([H])C([H])([H])C([H])([H])[C@@]5(C([H])([H])C6([H])[H])OC6=O)OC([H])([H])[H],Others,Mineralocorticoid Receptor,Mineralocorticoid receptor antagonists
"Epothilone B (EPO906, Patupilone)",152044-54-7,CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,Cell Cycle/Checkpoint,Microtubule/Tubulin,Microtubule stabilizing macrolide
Eprazinone 2HCl,10402-53-6,CCOC(CN1CCN(CC1)CC(C)C(=O)C2=CC=CC=C2)C3=CC=CC=C3.Cl.Cl,Others,Others,Aucolytic
Eprosartan Mesylate,144143-96-4,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O.CS(=O)(=O)O,GPCR/G protein,Angiotensin Receptor,Angiotensin AT1 receptor antagonists
Eptifibatide,188627-80-7,O=C([C@@](C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12)([H])N([H])C([C@@](C([H])([H])C(O[H])=O)([H])N([H])C(C([H])([H])N([H])C3=O)=O)=O)N4[C@@](C(N([H])[C@@](C(N([H])[H])=O)([H])C([H])([H])SSC([H])([H])C([H])([H])C(N([H])[C@@]3([H])C([H])([H,Angiogenesis,Integrin,Glycoprotein (GP) IIb/IIIa inhibitor
Equol,531-95-3,,Endocrinology and Hormones,Estrogen/progestogen Receptor,
Erdosteine,84611-23-4,C1CSC(=O)C1NC(=O)CSCC(=O)O,Others,Others,mucolytic
Eriodictyol,552-58-9,,Natural Products,Others,
Erlotinib,183321-74-6,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,JAK/STAT Signaling,EGFR,EGFR tyrosine kinase inhibitor
Erlotinib Hydrochloride,183319-69-9,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl,JAK/STAT Signaling,EGFR,Selective EGFR inhibitor
Erythritol,149-32-6,,Others,Others,
Erythromycin,114-07-8,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Microbiology & Virology,Antibiotic,macrolide antibiotic
Erythromycin Ethylsuccinate,1264-62-6,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O,Microbiology & Virology,Anti-infection,Macrolide antibiotic
Escitalopram Oxalate,219861-08-2,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O,Neuroscience,SSRIs,Selective 5-HT reuptake inhibitor
Eslicarbazepine acetate,236395-14-5,CC(O[C@@]1([H])CC2=CC=CC=C2N(C(O)=N)C3=CC=CC=C31)=O,Others,Others,antiepileptic drug
Esmolol HCl,81161-17-3,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O.Cl,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor antagonist
Esomeprazole Magnesium,161973-10-0,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Mg+2],Membrane Transporter/Ion Channel,Proton Pump,Proton pump inhibitor
Esomeprazole Sodium,161796-78-7,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=C(C=C3)OC.[Na+],Membrane Transporter/Ion Channel,Proton Pump,Proton pump inhibitor
Estradiol,50-28-2,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Endocrinology and Hormones,Estrogen/progestogen Receptor,Sex hormone
Estradiol Benzoate,50-50-0,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)OC(=O)C5=CC=CC=C5,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen/progestogen receptor agonist
Estradiol Cypionate,313-06-4,CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=C3C=CC(=C5)O,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor inhibitor
Estradiol valerate,979-32-8,CCCCC(=O)OC1CCC2C1(CCC3C2CCC4=C3C=CC(=C4)O)C,Endocrinology and Hormones,Androgen Receptor,Estrogen receptor agonist
Estriol,50-27-1,CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor antagonist
Estrone,53-16-7,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogenic hormone
Estropipate,7280-37-7,O=C1[C@@]2(C)[C@H](CC1)[C@H](CCC3=CC(OS(O)(=O)=O)=CC=C43)[C@H]4CC2.N5CCNCC5,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor agonist
Ethacridine lactate monohydrate,6402-23-9,CCOC1=CC2=C(C3=C(C=C(C=C3)N)N=C2C=C1)N.CC(C(=O)O)O.O,Microbiology & Virology,Anti-infection,Antiseptic agent
Ethacrynic Acid,58-54-8,C13H12Cl2O4,Membrane Transporter/Ion Channel,NKCC,
Ethambutol HCl,1070-11-7,CCC(CO)NCCNC(CC)CO.Cl.Cl,Others,Others,Antitubercular agent
Ethamsylate,2624-44-4,CCNCC.C1=CC(=C(C=C1O)S(=O)(=O)O)O,Immunology/Inflammation,Prostaglandin Receptor,Haemostatic drug
Ethinyl Estradiol,57-63-6,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,Endocrinology and Hormones,Estrogen/progestogen Receptor,Oral contraceptive
Ethionamide,536-33-4,CCC1=NC=CC(=C1)C(=S)N,Microbiology & Virology,Antibiotic,Anti-tuberculosis antibiotic
Ethyl gallate,831-61-8,,Immunology/Inflammation,NF-κB,
Ethynodiol diacetate,297-76-7,CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progestogen receptor agonist
Etidronate,2809-21-4,CC(O)(P(=O)(O)O)P(=O)(O)O,Others,phosphatase,Protein tyrosine phosphatase inhibitor
Etodolac,41340-25-4,CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O,Neuroscience,COX,COX-2 inhibitor
Etofenamate,30544-47-9,C1=CC=C(C(=C1)C(=O)OCCOCCO)NC2=CC=CC(=C2)C(F)(F)F,Others,Others,Non-steroidal anti-inflammatory drug
Etomidate,33125-97-2,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,Neuroscience,GABA Receptor,General anesthetic with GABA modulatory and GABA-mimetic actions
Etomidate hydrochloride,53188-20-8,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2.Cl,Membrane Transporter/Ion Channel,GABA Receptor,GABAA receptors agonist
Etonogestrel,54048-10-1,CC[C@@]1([C@@]([C@]2([H])CCC3=CC(CC[C@]3([H])[C@@]42[H])=O)([H])CC[C@@]1(O)C#C)CC4=C,Endocrinology and Hormones,Estrogen/progestogen Receptor,steroidal progestin
Etoposide,33419-42-0,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,DNA Damage/DNA Repair,Topoisomerase,Topo II inhibitor
Etoricoxib,202409-33-4,CC1=NC=C(C=C1)C2=NC=C(C=C2C3=CC=C(C=C3)S(=O)(=O)C)Cl,Neuroscience,COX,Specific COX-2 inhibitor
Etravirine (TMC125),269055-15-4,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,Microbiology & Virology,HIV,Reverse transcriptase inhibitor
Etretinate,54350-48-0,CCOC(/C=C(/C=C/C=C(/C=C/C1=C(C=C(OC)C(C)=C1C)C)C)C)=O,Others,Retinoid X Receptors,retinoid receptor agonist
Eugenol,97-53-0,C=CCC1=CC(OC)=C(O)C=C1,Others,Others,naturally occuring scent chemical
Evacetrapib (LY2484595),1186486-62-3,CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,Metabolism,CETP,"CETP inhibitor,potent and selective"
Evans Blue tetrasodium salt,314-13-6,O=C1C(C(C=C/C1=N/NC(C(C)=C2)=CC=C2C3=CC=C(C(C)=C3)N/N=C4C(C(C(C=C\4)=C5S([O-])(=O)=O)=C(C(S([O-])(=O)=O)=C5)N)=O)=C6S([O-])(=O)=O)=C(C(S([O-])(=O)=O)=C6)N.[Na+].[Na+].[Na+].[Na+],Membrane Transporter/Ion Channel,Glutamate (EAAT) Transporters,L-glutamate uptake inhibitor
Everolimus (RAD001),159351-69-6,OCCO[C@H]1[C@H](OC)C[C@H](C[C@H](C)[C@H](CC([C@H](C)/C=C(C)/[C@@H](O)[C@H]2OC)=O)OC([C@@H]3CCCCN3C(C([C@@]4(O)[C@H](C)CC[C@@H](C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C2=O)O4)=O)=O)=O)CC1,PI3K/Akt/mTOR Signaling,mTOR,MTOR inhibitor
EX 527 (SEN0014196),49843-98-3,C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N,Chromatin/Epigenetics,Sirtuin,SIRT1 inhibitor
Exemestane,107868-30-4,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,Endocrinology and Hormones,Aromatase,"Steroidal aromatase inhibitor,selective and irreversible"
Ezetimibe,163222-33-1,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,Metabolism,Cholesterol absorption,Cholesterol transport inhibitor
Famciclovir,104227-87-4,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,Microbiology & Virology,HSV,Anti-herpesvirus oral prodrug of penciclovir
Famotidine,76824-35-6,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Neuroscience,Histamine Receptor,Histamine H2-receptor antagonist
Famprofazone,22881-35-2,CC(C)C1=C(N(N(C1=O)C2=CC=CC=C2)C)CN(C)C(C)CC3=CC=CC=C3,Others,Others,Non-steroidal anti-inflammatory agent
Fargesin,31008-19-2,,Natural Products,Others,
Fasudil (HA-1077) HCl,105628-07-7,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3.Cl,TGF-β / Smad Signaling,ROCK,Protein kinase inhibitor
Febuxostat,144060-53-7,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,Others,XAO,non-purine selective inhibitor of xanthine oxidase
Felbamate,25451-15-4,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,Membrane Transporter/Ion Channel,NMDA Receptor,antagonist at the NMDA-associated glycine binding site
Felodipine,72509-76-3,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,Membrane Transporter/Ion Channel,Calcium Channel,Selective L-type Ca2+ channel blocker
Fenbendazole,43210-67-9,COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=CC=C3,Others,Others,For pinworm treatment in animals
Fendiline (hydrochloride),13636-18-5,C23H25N • HCl,GPCR/G protein,Adrenergic Receptor,
Fenofibrate,49562-28-9,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Metabolism,PPAR,PPARα agonist
Fenofibric acid,42017-89-0,CC(C(O)=O)(OC1=CC=C(C(C2=CC=C(Cl)C=C2)=O)C=C1)C,Metabolism,PPAR,ppar inhibitor， lipid-lowering agent
Fenoldopam,67227-56-9,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,Neuroscience,Dopamine Receptor,D1-like dopamine receptor partial agonist
Fenoldopam (mesylate),67227-57-0,C17H20ClNO6S,Neuroscience,Dopamine Receptor,Agonist of dopamine D1A (D1R) and D1B (D5R) receptors
Fenoprofen Calcium,34597-40-5,CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].[Ca+2],Immunology/Inflammation,,"nonsteroidal, anti-inflammatory antiarthritic agent"
Fenoprofen calcium hydrate,71720-56-4,CC(C([O-])=O)C1=CC(OC2=CC=CC=C2)=CC=C1.CC(C([O-])=O)C3=CC(OC4=CC=CC=C4)=CC=C3.[Ca+2].O.O,Immunology/Inflammation,,"nonsteroidal, anti-inflammatory antiarthritic agent"
Fenretinide,65646-68-6,,Others,RAR/RXR,
Fenspiride HCl,5053-08-7,C1CN(CCC12CNC(=O)O2)CCC3=CC=CC=C3.Cl,Neuroscience,5-HT Receptor,α adrenergic and H1 histamine receptor antagonist
Fenticonazole Nitrate,73151-29-8,C1=CC=C(C=C1)SC2=CC=C(C=C2)COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl.[N+](=O)(O)[O-],Microbiology & Virology,Anti-infection,Antifungal drug
Fexofenadine HCl,153439-40-8,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl,Neuroscience,Histamine Receptor,Histamine H1 receptor inhibitor
FG-4592 (ASP1517),808118-40-3,CC1=NC(=C(C2=C1C=C(C=C2)OC3=CC=CC=C3)O)C(=O)NCC(=O)O,Angiogenesis,HIF,HIF prolyl-hydroxylase inhibitor
Fidaxomicin,873857-62-6,CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C,DNA Damage/DNA Repair,DNA/RNA Synthesis,macrocyclic antibiotic
Finasteride,98319-26-7,CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C,Endocrinology and Hormones,5-alpha Reductase,Inhibitor of Type II 5α-reductase
Fingolimod (FTY720),162359-56-0,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl,GPCR/G protein,S1P receptor,S1P receptors agonist
Flavin adenine dinucleotide disodium,84366-81-4,CC1=CC(N=C(C([O-])=N2)C3=NC2=O)=C(N3C[C@@](O)([H])[C@@](O)([H])[C@@](O)([H])COP([O-])(OP(O)(OC[C@](O4)([H])[C@](O)([H])[C@](O)([H])[C@]4([H])N5C=NC(C5=NC=N6)=C6N)=O)=O)C=C1C.[Na+].[Na+],Metabolism,Endogenous Metabolite,"Redox cofactor (electron carrier), involved in several important enzymatic reactions in metabolism"
Flavoxate hydrochloride,3717-88-2,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4.Cl,Neuroscience,AChR,muscarinic AChR antagonist
Flecainide acetate,54143-56-5,CC(=O)O.C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,Membrane Transporter/Ion Channel,Sodium Channel,Antiarrhythmic drug
Florfenicol,73231-34-2,CS(=O)(=O)C1=CC=C(C=C1)C(C(CF)NC(=O)C(Cl)Cl)O,Microbiology & Virology,Anti-infection,Antibacterial agent
Floxuridine,50-91-9,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,DNA Damage/DNA Repair,DNA Synthesis,Antineoplastic antimetabolite
Flubendazole,31430-15-6,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=C(C=C3)F,Ubiquitination/Proteasome,Autophagy,Autophagy activator
Fluconazole,86386-73-4,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,Microbiology & Virology,Antibiotic,Triazole antifungal agent
Fluconazole hydrate,155347-36-7,FC1=CC(F)=C(C(CN2C=NC=N2)(O)CN3C=NC=N3)C=C1.O,Microbiology & Virology,Antibiotic,Triazole antifungal drug
Flucytosine,2022-85-7,C1=NC(=O)NC(=C1F)N,Microbiology & Virology,Antibiotic,Antifungal drug
Fludarabine,21679-14-1,C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2N)F,DNA Damage/DNA Repair,DNA Synthesis,DNA synthsis inhibitor
Fludarabine Phosphate (Fludara),75607-67-9,C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(N=C2N)F,DNA Damage/DNA Repair,DNA Synthesis,Inhibits STAT1 activation and DNA synthesis
Flufenamic acid,530-78-9,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F,Immunology/Inflammation,AMPK; Calcium Channel; Chloride Channel; COX; Potassium Channel,TRPC activator
Flumazenil,78755-81-4,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,Neuroscience,GABA Receptor,Benzodiazepine antagonist
Flumequine,42835-25-6,FC1=C([H])C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)C(C([H])([H])[H])([H])C([H])([H])C2([H])[H],DNA Damage/DNA Repair,Topoisomerase,DNA topoisomerase II inhibitor，synthetic chemotherapeutic antibiotic
Flumethasone,2135-17-3,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C)F,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist
Flunarizine 2HCl,30484-77-6,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F.Cl.Cl,Membrane Transporter/Ion Channel,Calcium Channel,Calcium entry blocker
Flunisolide,3385-03-3,,≥250mg/mL (575.37 mM) in DMSO,,Fluorinated corticosteroid receptor agonist
Flunixin Meglumin,42461-84-7,CC1=C(C=CC=C1NC2=C(C=CC=N2)C(=O)O)C(F)(F)F.CNCC(C(C(C(CO)O)O)O)O,Neuroscience,COX,potent cyclooxygenase inhibitor
Fluocinolone Acetonide,67-73-2,F[C@@]1([C@@](C([H])([H])[H])(C([H])=C2[H])C3=C([H])C2=O)[C@](C([H])([H])[C@]3([H])F)([H])[C@@]4([H])[C@@](C([H])([H])[C@]1([H])O[H])(C([H])([H])[H])[C@]5(C(C([H])([H])O[H])=O)OC(C([H])([H])[H])(C([H])([H])[H])O[C@]5([H])C4([H])[H],GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist
Fluocinonide,356-12-7,F[C@@]1([C@@](C([H])([H])[H])(C([H])=C2[H])C3=C([H])C2=O)[C@](C([H])([H])[C@]3([H])F)([H])[C@@]4([H])[C@@](C([H])([H])[C@]1([H])O[H])(C([H])([H])[H])[C@]5(C(C([H])([H])OC(C([H])([H])[H])=O)=O)OC(C([H])([H])[H])(C([H])([H])[H])O[C@]5([H])C4([H])[H],GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist
Fluorescein,2321-07-5,,Others,Fluorescent Dyes/Probes,Fluorescein is a synthetic fluorescent tracer
Fluorometholone,426-13-1,,GPCR/G protein,Glucocorticoid Receptor,Synthetic glucocorticoid with anti-inflammatory and anti-allergic properties
Fluorouracil (Adrucil),51-21-8,C1=C(C(=O)NC(=O)N1)F,Proteases,HIV Integrase,Antitumor agent;inhibitor of thymidylate synthase
Fluoxetine HCl,56296-78-7,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl,Neuroscience,5-HT Receptor,"Serotonin reuptake inhibitor,selective"
Flupirtine maleate,75507-68-5,CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N.C(=CC(=O)O)C(=O)O,Membrane Transporter/Ion Channel,NMDA Receptor,NMDA receptor antagonist
Flurbiprofen,5104-49-4,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,Immunology/Inflammation,PGE synthase,Cyclooxygenase inhibitors
Flutamide,13311-84-7,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonists
Fluticasone propionate,80474-14-2,CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF,GPCR/G protein,Glucocorticoid Receptor,"High affinity, selective glucocorticoid receptor agonist"
Fluvastatin,93957-54-1,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,Metabolism,HMG-CoA Reductase,HMGCR inhibitor
Fluvastatin Sodium,93957-55-2,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+],Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor
Fluvoxamine maleate,61718-82-9,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O,Neuroscience,5-HT Receptor,"Serotonin reuptake inhibitor,selective,antidepressant"
Folic acid,59-30-3,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,Natural Products,Vitamin,
Fomepizole,7554-65-6,CC1=CNN=C1,Metabolism,Dehydrogenase,competitive inhibitor of the enzyme alcohol dehydrogenase
Foretinib (GSK1363089),849217-64-7,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,Tyrosine Kinase,VEGFR,VEGF and HGF receptor inhibitor
Formononetin,485-72-3,COC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)O,Natural Products,Others,O-methylated isoflavone
Fosaprepitant dimeglumine salt,265121-04-8,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)N(N3)P(=O)(O)O)C4=CC=C(C=C4)F.CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O,Neuroscience,Substance P/NK1 Receptor,Neurokinin-1 antagonist
Fosbretabulin (Combretastatin A4 Phosphate (CA4P)) Disodium,168555-66-6,COC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)OP(=O)([O-])[O-].[Na+].[Na+],Cell Cycle/Checkpoint,Microtubule/Tubulin,"microtubule destabilizing drug, water-soluble"
Foscarnet Sodium,63585-09-1,C(=O)([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+],Microbiology & Virology,Reverse Transcriptase,Reverse transcriptase inhibitor
Fostamatinib (R788),901119-35-5,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,Tyrosine Kinase,Spleen Tyrosine Kinase (Syk),Spleen tyrosine kinase (Syk) inhibitor
Fructose,7660-25-5,,Natural Products,Others,
Fruquintinib(HMPL-013),1194506-26-7,,Tyrosine Kinase,VEGFR,
FT-207 (NSC 148958),17902-23-7,C1CC(OC1)N2C=C(C(=O)NC2=O)F,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,DNA/RNA synthesis inhibitor
Fudosteine,13189-98-5,C(CO)CSCC(C(=O)O)N,Others,Others,MUC5AC mucin hypersecretion inhibitor
Fulvestrant,129453-61-8,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,Endocrinology and Hormones,Estrogen/progestogen Receptor,"Estrogen receptor antagonist,high affinity"
Fumagillin,23110-15-8,CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)C=CC=CC=CC=CC(=O)O)OC)C,Proteases,Aminopeptidase,Antibiotic and antiangiogenic agent
Fumalic acid,1135-24-6,,Natural Products,Others,
Furaltadone HCl,3759-92-0,C1COCCN1CC2CN(C(=O)O2)N=CC3=CC=C(O3)[N+](=O)[O-].Cl,Microbiology & Virology,Anti-infection,Antibacterial agent
Furazolidone,67-45-8,,Microbiology & Virology,Anti-infection,
Furfural,98-01-1,,Others,Others,
Furosemide,54-31-9,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Membrane Transporter/Ion Channel,NKCC,GABAA receptors antagonist
Fusidic Acid (sodium salt),751-94-0,O[C@@H]1CC[C@@]2(C)[C@](CC[C@@]3(C)[C@@]2([H])[C@H](O)C[C@]4([H])[C@]3(C)C[C@H](OC(C)=O)/C4=C(C([O-])=O)/CC/C=C(C)/C)([H])[C@@H]1C.[Na+],Microbiology & Virology,Antibiotic,steroidal antibiotic
Gabapentin,60142-96-3,C1CCC(CC1)(CC(=O)O)CN,Neuroscience,GABA Receptor,GABA enhancer
Gabapentin HCl,60142-95-2,C1CCC(CC1)(CC(=O)O)CN.Cl,Membrane Transporter/Ion Channel,Calcium Channel,GABA analog
Gabexate mesylate,56974-61-9,CCOC(=O)C1=CC=C(C=C1)OC(=O)CCCCCN=C(N)N.CS(=O)(=O)O,Proteases,Serine Protease,Trypsin-like serine proteinases inhibitor
Gadodiamide,122795-43-1,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3],Others,Others,Gadolinium-based MRI contrast agent
Galanthamine,357-70-0,[H][C@@]([C@@]1(C([H])=C2[H])C3=C(C([H])=C4[H])C([H])([H])N(C([H])([H])[H])C([H])([H])C1([H])[H])(C([H])([H])[C@@]2([H])O[H])OC3=C4OC([H])([H])[H],Neuroscience,AChR,Acetylcholinesterase inhibitor
Galanthamine HBr,1953-04-4,COC1=CC=C2C3=C1O[C@]4([H])[C@]3(C=C[C@H](O)C4)CCN(C)C2.Br,Neuroscience,AChR,Acetylcholinesterase inhibitor
Gallamine Triethiodide,65-29-2,CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-],Neuroscience,AChR,Cholinergic receptor blocker
Gallic acid,149-91-7,C1=C(C=C(C(=C1O)O)O)C(=O)O,Natural Products,ROS,
Ganciclovir,82410-32-0,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N,Microbiology & Virology,HSV,Antiviral drug for CMV infections
Ganetespib (STA-9090),888216-25-9,CC(C)C1=CC(=C2NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)C(=O)C=C1O,Proteases,HSP,"Hsp90 inhibitor,non-geldanamycin"
Gastrodin,62499-27-8,C1=CC(=CC=C1CO)OC2C(C(C(C(O2)CO)O)O)O,Natural Products,Immunology & Inflammation related,
Gatifloxacin,112811-59-3,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,DNA Damage/DNA Repair,Topoisomerase,"Fluoroquinolone antibiotic,inhibits bacterial TOPO II"
GDC-0449 (Vismodegib),879085-55-9,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,Stem Cell,Hedgehog,"Hedgehog antagonist,potent and selective"
GDC-0941,957054-30-7,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,PI3K/Akt/mTOR Signaling,PI3K,"PI3K inhibitor,potent and selective"
Gefitinib (ZD1839),184475-35-2,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,JAK/STAT Signaling,EGFR,Selective EGFR inhibitor
Gefitinib hydrochloride,184475-55-6,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4.Cl,JAK/STAT Signaling,EGFR,Potent EGFR inhibitor
Gemcitabine,95058-81-4,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,DNA Damage/DNA Repair,DNA Synthesis,inhibitor of DNA synthesis
Gemcitabine HCl,122111-03-9,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,DNA Damage/DNA Repair,DNA Synthesis,"Inhibits DNA synthesis,deoxycytidine analog"
Gemfibrozil,25812-30-0,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Metabolism,PPAR,PPARα activator
"Geneticin, G-418 Sulfate",108321-42-2,CC(C1C(C(C(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)O)O)O.OS(=O)(=O)O.OS(=O)(=O)O,Microbiology & Virology,Antibiotic,Aminoglycosidic antibiotic
Genipin,6902-77-8,COC(=O)C1=COC(C2C1CC=C2CO)O,Natural Products,Others,used to treat symptoms of type 2 diabetes
Geniposide,24512-63-8,COC(=O)C1=COC(C2C1CC=C2CO)OC3C(C(C(C(O3)CO)O)O)O,Natural Products,Others,Iridoid glycoside with various bioactivities
Geniposidic acid,27741-01-1,C1C=C(C2C1C(=COC2OC3C(C(C(C(O3)CO)O)O)O)C(=O)O)CO,Natural Products,Immunology & Inflammation related,
Genistein,446-72-0,C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O,DNA Damage/DNA Repair,Topoisomerase,ER agonist
Gentamycin Sulfate,1405-41-0,C[C@]1(O)CO[C@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@@]([H])([C@@H](C)NC)CC[C@H]3N)[C@@H]2O)[C@H](O)[C@H]1NC.C[C@]4(O)CO[C@H](O[C@H]5[C@H](N)C[C@H](N)[C@@H](O[C@H]6O[C@H](CN)CC[C@H]6N)[C@@H]5O)[C@H](O)[C@H]4NC.C[C@]7(O)CO[C@H](O[C@H]8[C@H](N)C[C@H](,Microbiology & Virology,Antibiotic,Aminoglycoside antibiotic
Geraniol,106-24-1,,Others,Others,
Germacrone,6902-91-6,,Natural Products,Others,
Gestodene,60282-87-3,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progestogen hormonal contraceptive
Gimeracil,103766-25-2,C1=C(C(=CNC1=O)Cl)O,Metabolism,Dehydrogenase,Dihydropyrimidine dehydrogenase inhibitor
Ginkgolide A,15291-75-5,O[C@@]1([C@]2(O[C@H]3OC4=O)[C@]5([C@]3([C@H](C[C@H]5OC2=O)C(C)(C)C)[C@H]4O)C[C@H]1OC6=O)[C@H]6C,Natural Products,GABA Receptor,
Ginkgolide C,15291-76-6,,Natural Products,Others,
Ginsenoside Rb1,41753-43-9,,Natural Products,Others,
Ginsenoside Re,52286-59-6,,Natural Products,Others,
Ginsenoside Rg1,22427-39-0,,Natural Products,Others,
Glibenclamide,10238-21-8,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,Metabolism,Saccharometabolism,Insulin production modulator
Gliclazide,21187-98-4,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel inhibitor
Glimepiride,93479-97-1,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,Proteases,DPP-4,Sulfonylurea compound
Glipizide,29094-61-9,CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,Membrane Transporter/Ion Channel,Potassium Channel,Oral anti-diabetic medication
Gliquidone,33342-05-1,CC1(C2=C(C=C(C=C2)OC)C(=O)N(C1=O)CCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C,Membrane Transporter/Ion Channel,Potassium Channel,ATP-sensitive K+ channel antagonist
GLPG0634,1206161-97-8,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,JAK/STAT Signaling,JAK,JAK1 inhibitor
glucuronate,6556-12-3,O=C[C@@](O)([H])[C@](O)([H])[C@@](O)([H])[C@@](O)([H])C(O)=O,Others,Others,
Glycine,56-40-6,,Others,Others,
Glycocholic Acid,475-31-0,C[C@H](CCC(NCC(O)=O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@@]21C,Others,Others,
Glycopyrrolate,596-51-0,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-],Neuroscience,AChR,Muscarinic competitive antagonist
Glycylglycine,556-50-3,,Others,Others,
Glycyrrhizic acid,1405-86-3,,Natural Products,"Dehydrogenase,MAO,High-mobility Group",
GM 6001,142880-36-2,CC(C)CC(CC(=O)NO)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC,Proteases,MMP,Broad spectrum MMP inhibitor
Gramine,87-52-5,,Natural Products,Others,
Granisetron HCl,107007-99-8,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl,Neuroscience,5-HT Receptor,5-HT3 receptor antagonist
Griseofulvin,126-07-8,ClC(C(O[C@]1(C(OC)=C2)[C@H](C)CC2=O)=C(C(OC)=C3)C1=O)=C3OC,Cell Cycle/Checkpoint,Microtubule/Tubulin,Microtubule associated inhibitor
GS-7340,379270-37-8,O=[P@@](N[C@H](C(OC(C)C)=O)C)(CO[C@H](C)CN1C2=NC=NC(N)=C2N=C1)OC3=CC=CC=C3,Microbiology & Virology,HIV,HIV reverse transcriptase inhibitor
GS-9973,1229208-44-9,C12=NC=CN1C=C(C3=CC=C(C=NN4)C4=C3)N=C2NC5=CC=C(N6CCOCC6)C=C5,Tyrosine Kinase,Spleen Tyrosine Kinase (Syk),"Syk inhibitor, orally bioavailable and selective"
GSK1349572 sodiuM salt,1051375-19-9,C[C@](N12)([H])CCO[C@@]1([H])CN(C(C2=O)=C3[O-])C=C(/C(O)=N/CC4=C(F)C=C(F)C=C4)C3=O.[Na+],Proteases,HIV Integrase,Next-generation HIV integrase (IN) inhibitor
GSK2126458,1086062-66-9,COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F,PI3K/Akt/mTOR Signaling,mTOR,PI3K/mTOR inhibitor
Guaiacol,90-05-1,COC1=C(O)C=CC=C1,Others,Others,
Guaifensin,93-14-1,COC1=CC=CC=C1OCC(CO)O,Others,Others,Expectorant agent
Guanabenz Acetate,23256-50-0,CC(=O)O.C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,GPCR/G protein,Adrenergic Receptor,α2-adrenergic receptor agonist
Guanethidine (sulfate),645-43-2,C10H24N4O4S,Others,Others,Antihypertensive agent
Guanethidine Sulfate,60-02-6,C20H44N8.H2O4S,Others,Others,
Guanfacine hydrochloride,29110-48-3,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl.Cl,GPCR/G protein,Adrenergic Receptor,α2A-adrenoceptor agonist
Guanidine HCl,1950-1-1,C(=N)(N)N.Cl,Others,Others,Protein denaturant
H-Cit-OH,372-75-8,,Amino Acids & Building Blocks,Unusual Amino Acids,
H-Cys-OH,52-90-4,C(C(C(=O)O)N)S,Amino Acids & Building Blocks,Amino Acids and Derivatives,
H-D-Ser-OH,312-84-5,C(C(C(=O)O)N)O,Others,Others,Endogenous ligand for the glycine site of the N-methyl D-aspartate receptor (NMDAR)
H-Ser-OH,56-45-1,C(C(C(=O)O)N)O,Amino Acids & Building Blocks,Amino Acids and Derivatives,
Halcinonide,3093-35-4,ClC([H])([H])C([C@@]12OC(C([H])([H])[H])(C([H])([H])[H])O[C@]1([H])C([H])([H])[C@]([C@@](C([H])([H])C3([H])[H])([H])[C@]4([C@](C([H])([H])C5([H])[H])(C([H])([H])[H])C3=C([H])C5=O)F)([H])[C@]2(C([H])([H])[H])C([H])([H])[C@]4([H])O[H])=O,Immunology/Inflammation,Smo,Anti-inflammatory agent
Halobetasol Propionate,66852-54-8,CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl,Metabolism,Phospholipase,Phospholipase (e.g. PLA) inhibitor
Haloperidol,52-86-8,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,Neuroscience,Dopamine Receptor,Antipsychotic drug
Haloperidol hydrochloride,1511-16-6,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F.Cl,Neuroscience,Dopamine Receptor,Antipsychotic drug
Harmine,442-51-3,CC1=NC=CC2=C1NC3=C2C=CC(OC)=C3,Metabolism,"PPAR,MAO","Potent and selective inhibitor of DYRK1A, 5-HT antagonist and MAO inhibitor"
Harmine hydrochloride,343-27-1,C13H13ClN2O,Natural Products,DYRK,
Harpagoside,19210-12-9,,Natural Products,"GMNN - geminin, DNA replication inhibitor (human)",
Helicid,80154-34-3,,Natural Products,Others,
Heparin sodium,9041-08-1,O[C@@H]1C(OS([O-])(=O)=O)[C@H](OC2[C@@H](COS([O-])(=O)=O)OC(O)C(NS([O-])(=O)=O)[C@H]2O)OC(C([O-])=O)C1O.[Na+].[Na+].[Na+].[Na+],Proteases,Thrombin,Antithrombin III activator
Hesperidin,520-26-3,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O,Natural Products,Others,Flavonoids from citrus species
Hexachlorophene,70-30-4,ClC1=CC(Cl)=C(Cl)C(CC2=C(Cl)C(Cl)=CC(Cl)=C2O)=C1O,Membrane Transporter/Ion Channel,Potassium Channel,KCNQ1/KCNE1 potassium channel activator
Hexamethonium Bromide,55-97-0,C[N+](C)(C)CCCCCC[N+](C)(C)C.[Br-].[Br-],Neuroscience,AChR,Selective antagonist of neuronal-type nicotinic AChR
Hexestrol,84-16-2,CCC(C1=CC=C(C=C1)O)C(CC)C2=CC=C(C=C2)O,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor agonist
hippurate,495-69-2,O=C(O)CNC(C1=CC=CC=C1)=O,Others,Others,
histamine,51-45-6,NCCC1=CN=CN1,Neuroscience,Histamine Receptor,
Histamine 2HCl,56-92-8,C1=C(NC=N1)CCN.Cl.Cl,Neuroscience,Histamine Receptor,Histamine receptor agonist
Histamine Phosphate,51-74-1,C1=C(NC=N1)CCN.OP(=O)(O)O.OP(=O)(O)O,Neuroscience,Histamine Receptor,Histamine receptor agonist
Homatropine Bromide,51-56-9,CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O.Br,Neuroscience,AChR,Muscarinic AChR antagonist
Homatropine Methylbromide,80-49-9,C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-],Neuroscience,AChR,Muscarinic AChR antagonist
Homoharringtonine,26833-87-4,,Natural Products,STAT,Cytotoxic alkaloid
Honokiol,35354-74-6,,Immunology/Inflammation,IκB/IKK,
Hydralazine HCl,304-20-1,C1=CC=C2C(=C1)C=NN=C2NN.Cl,Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel activator
Hydrochlorothiazide,58-93-5,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,Others,Others,diuretic drug of the thiazide class
Hydrocortisone,50-23-7,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,GPCR/G protein,Glucocorticoid Receptor,steroid hormone or glucocorticoid
Hydroquinone,123-31-9,,Immunology/Inflammation,ROS,
Hydroxychloroquine Sulfate,747-36-4,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO.OS(=O)(=O)O,Others,Others,Autophagy inhibitor
Hydroxyfasudil hydrochloride,155558-32-0,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CNC3=O.Cl,TGF-β / Smad Signaling,ROCK,Rho-kinase inhibitor and vasodilator
Hydroxyurea,127-07-1,C(=O)(N)NO,DNA Damage/DNA Repair,DNA/RNA Synthesis,DNA synthesis inhibitor
Hydroxyzine 2HCl,2192-20-3,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl,Neuroscience,Histamine Receptor,Histamine H1-receptor antagonist
Hygromycin B,31282-04-9,CNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N,Microbiology & Virology,Antibiotic,Suitable for mammalian cell selection
Hyodeoxycholic acid,83-49-8,CC(CCC(=O)O)C1CCC2C1(CCC3C2CC(C4C3(CCC(C4)O)C)O)C,Natural Products,Others,
Hyoscyamine,101-31-5,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,Neuroscience,AChR,AChR inhibitor
Hyperoside,482-36-0,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O,Natural Products,Others,
Hypoxanthine,68-94-0,,Others,Others,
Ibandronate sodium,138926-19-9,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].O.[Na+],Others,Others,Potent bisphosphonate drug
Ibudilast,50847-11-5,CC(C)C1=NN(C=CC=C2)C2=C1C(C(C)C)=O,Metabolism,PDE,inhibitor of PDE4
Ibuprofen,15687-27-1,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,Neuroscience,COX,inhibitor of cyclooxygenase 1 and cyclooxygenase 2
Ibuprofen Lysine,57469-77-9,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O.C(CCN)CC(C(=O)O)N,Neuroscience,COX,COX inhibitor
Ibutilide Fumarate,122647-32-9,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.C(=CC(=O)O)C(=O)O,Membrane Transporter/Ion Channel,Sodium Channel,Class III antiarrhythmic agent
Icotinib,610798-31-7,[H]C1=C2OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC2=C([H])C3=NC([H])=NC(N([H])C4=C([H])C([H])=C([H])C(C#C[H])=C4[H])=C31,JAK/STAT Signaling,EGFR,EGFR tyrosine kinase inhibitor
Idarubicin HCl,57852-57-0,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl,DNA Damage/DNA Repair,Topoisomerase,"Anthracycline and daunorubicin analog,topoisomerase inhibitor"
Idebenone,58186-27-9,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,Immunology/Inflammation,ROS,synthetic analog of coenzyme Q10 (CoQ10)
Idoxuridine,54-42-2,C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O,Microbiology & Virology,Anti-infection,Antiviral agent
Ifenprodil Tartrate,23210-58-4,CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3.C(C(C(=O)O)O)(C(=O)O)O,Neuroscience,GluR,NMDA receptor antagonist
Ifosfamide,3778-73-2,C1CN(P(=O)(OC1)NCCCl)CCCl,DNA Damage/DNA Repair,DNA Synthesis,Cytostatic agent
Iloperidone,133454-47-4,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,Neuroscience,5-HT Receptor,Dopamine (D2) and serotonin (5HT2) receptor antagonist
Imatinib (STI571),152459-95-5,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,Tyrosine Kinase,c-Kit,Protein-tyrosine kinase inhibitor
Imatinib Mesylate (STI571),220127-57-1,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,TGF-β / Smad Signaling,Bcr-Abl,Abl/c-kit/PDGFR inhibitor
Imidapril HCl,89396-94-1,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C(CN(C2=O)C)C(=O)O.Cl,Endocrinology and Hormones,RAAS,RAAS inhibitor
Imidazole,288-32-4,,Metabolism,phosphatases,
Imipenem (hydrate),74431-23-5,C10H12N2O3S,Microbiology & Virology,Anti-infection,Intravenous β-lactam antibiotic
Imipramine (hydrochloride),113-52-0,CN(C)CCCN1C2=C(C=CC=C2)CCC3=C1C=CC=C3.Cl,Neuroscience,5-HT Receptor,serotonin and norepinephrine transporters inhibitor
INCB-024360,1204669-58-8,BrC1=C(F)C=CC(/N=C(NO)\C2=NON=C2NCCNS(N)(=O)=O)=C1,Metabolism,IDO,potent and selective inhibitor of IDO1
Indacaterol,312753-06-3,C24H28N2O3,GPCR/G protein,Adrenergic Receptor,
Indacaterol Maleate,753498-25-8,CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC.C(=CC(=O)O)C(=O)O,GPCR/G protein,Adrenergic Receptor,Ultra-long-acting β-adrenoceptor agonist
Indapamide,26807-65-8,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,Membrane Transporter/Ion Channel,Potassium Channel,thiazide-like diuretic drug
Indigo,482-89-3,C1=CC=C2C(=C1)C(=O)C(=C3C(=O)C4=CC=CC=C4N3)N2,Natural Products,Others,
Indomethacin,53-86-1,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Neuroscience,COX,Cox inhibitor
Iniparib (BSI-201),160003-66-7,C1=CC(=C(C=C1C(=O)N)[N+](=O)[O-])I,Chromatin/Epigenetics,PARP,"PARP1 inhibitor,intravenously adminsitered"
Inosine,58-63-9,O[C@H]1[C@H](N2C(NC=NC3=O)=C3N=C2)O[C@H](CO)[C@H]1O,Others,Others,endogenous purine nucleoside
Inulin,9005-80-5,C6nH10n+2O5n+1,Others,Others,starchy substance
Iohexol,66108-95-0,CC(N(C1=C(I)C(/C(O)=N/CC(O)CO)=C(I)C(/C(O)=N/CC(O)CO)=C1I)CC(O)CO)=O,Ubiquitination/Proteasome,Autophagy; Mitophagy,contrast agent
Iopromide,73334-07-3,O=C(N(CC(O)CO)C)C1=C(I)C(C(NCC(O)CO)=O)=C(I)C(NC(COC)=O)=C1I,Others,Others,
IPI-145 (INK1197),1201438-56-3,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,PI3K/Akt/mTOR Signaling,PI3K,PI3K-δ/PI3K-γ inhibitor
Ipratropium Bromide,22254-24-6,CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C.[Br-],Neuroscience,AChR,AChR antagonist
Irbesartan,138402-11-6,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,GPCR/G protein,Angiotensin Receptor,Angiotensin II inhibitor
Irinotecan,97682-44-5,O=C(OC1)C(O)(CC)C2=C1C(N(CC3=C4N=C5C(C=C(OC(N6CCC(N7CCCCC7)CC6)=O)C=C5)=C3CC)C4=C2)=O,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase I inhibitor
Irinotecan HCl Trihydrate,136572-09-3,O=C(N1CCC(CC1)N2CCCCC2)OC3=CC4=C(CC)C5=C(C(N6C5)=CC(C7(CC)O)=C(COC7=O)C6=O)N=C4C=C3.Cl.O.O.O,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase 1 inhibitor
Irinotecan hydrochloride,100286-90-6,C33H39ClN4O6,DNA Damage/DNA Repair,Autophagy; Topoisomerase,DNA topoisomerase I inhibitor
Irisflorentin,41743-73-1,,Natural Products,Others,
Irsogladine,57381-26-7,C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl,Metabolism,PDE,PDE4 inhibitor
Isatin,91-56-5,O=C(C1=O)C2=C(N1)C=CC=C2,Metabolism,MAO,endogenous monoamine oxidase inhibitor
Isavuconazole,241479-67-4,CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=CC(=C4)F)F)O,Microbiology & Virology,Antifungal,triazole antifungal drug
Isoconazole nitrate,24168-96-5,C1=CC(=C(C(=C1)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-],Microbiology & Virology,Anti-infection,azole antifungal reagent
Isoniazid,54-85-3,C1=CN=CC=C1C(=O)NN,Metabolism,Fatty Acid Synthase,antibiotic used for the treatment of tuberculosis
Isonicotinic acid,55-22-1,,Others,Others,
Isoprenaline HCl,51-30-9,CC(C)NCC(C1=CC(=C(C=C1)O)O)O.Cl,GPCR/G protein,Adrenergic Receptor,β-adrenergic receptor agonist
Isorhamnetin,480-19-3,COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O,Natural Products,PXR,
Isosorbide,652-67-5,C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O)O,Others,Others,Diuretic
Isosorbide 5-mononitrate,16051-77-7,,Others,Others,
Isosorbide Dinitrate,87-33-2,,Others,Others,Organic nitrate ester and nitric oxide (NO) donor
Isotretinoin,4759-48-2,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,Metabolism,Dopamine β-hydroxylase,Dopamine β-hydroxylase activator
Isovaleramide,541-46-8,CC(C)CC(=O)N,Metabolism,Dehydrogenase,Dehydrogenase inhibitor
Isoxsuprine (hydrochloride),579-56-6,C18H23NO3 • HCl,GPCR/G protein,Adrenergic Receptor,
Ispinesib (SB-715992),336113-53-2,CC1=CC=C(C=C1)C(=O)N(CCCN)C(C2=NC3=C(C=CC(=C3)Cl)C(=O)N2CC4=CC=CC=C4)C(C)C,Cell Cycle/Checkpoint,Ksp,Kinesin spindle protein (KSP)inhibitor
Isradipine (Dynacirc),75695-93-1,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker
Istradefylline (KW-6002),155270-99-8,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C,GPCR/G protein,Adenosine Receptor,Selective A2A receptor antagonist
Itraconazole,84625-61-6,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,Microbiology & Virology,Antibiotic,antifungal agent
Ivabradine HCl,148849-67-6,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC.Cl,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor inhibitor
Ivacaftor (VX-770),873054-44-5,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,Membrane Transporter/Ion Channel,CFTR,Potent CFTR potentiator
Ivermectin,70288-86-7,C/C([C@@H](O[C@H]1C[C@H](OC)[C@@H](O[C@H]2C[C@H](OC)[C@@H](O)[C@H](C)O2)[C@H](C)O1)[C@@H](C)/C=C/C=C(CO3)/[C@@]([C@@]3([H])[C@H](O)C(C)=C4)(O)[C@@H]4C5=O)=C\C[C@@H]6C[C@H](O5)C[C@@]7(O[C@@]([C@@H](C)CC)([H])[C@@H](C)CC7)O6,Membrane Transporter/Ion Channel,P2X purinergic receptor,NAChR/purinergic P2X4 receptor modulator
Ixabepilone,219989-84-1,C27H42N2O5S,Tyrosine Kinase,EGFR,
K-115,887375-67-9,CC1CNCCCN1S(=O)(=O)C2=CC=CC3=CN=CC(=C32)F.O.O.Cl,Cell Cycle/Checkpoint,Rho,Selective Rho kinase inhibitor
Kaempferol,520-18-3,,Apoptosis,Apoptosis Inducers,
Kanamycin Sulfate,25389-94-0,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N.OS(=O)(=O)O,Microbiology & Virology,Antibiotic,Water-soluble antibiotic
Kasugamycin (hydrochloride),19408-46-9,O[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2([H])O[C@H](C)[C@@H](NC(C(O)=O)=N)C[C@@H]2N)[C@@H]1O.Cl,Microbiology & Virology,Antibiotic,aminoglycosidic antibiotic
Ketanserin,74050-98-9,C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O,Neuroscience,5-HT Receptor,specific 5-HT2A serotonin receptor antagonist
Ketoconazole,65277-42-1,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,Metabolism,P450,Inhibitor of cyclosporine oxidase and testosterone 6 beta-hydroxylase
Ketoprofen,22071-15-4,CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O,Neuroscience,COX,Dual COX1/2 inhibitor
Ketorolac tromethamine salt,74103-07-4,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O,Neuroscience,COX,Non-selective COX inhibitor
Ketotifen Fumarate,34580-14-8,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1.C(=CC(=O)O)C(=O)O,Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist
Kinetin,525-79-1,C1=COC(=C1)CNC2=NC=NC3=C2NC=N3,Others,Others,Plant growth hormones
KPT-330,1393477-72-9,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,Cell Cycle/Checkpoint,CRM1,"CRM1 inhibitor, orally bioavailable and selective"
L-(−)-Fucose,2438-80-4,C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C=O,Immunology/Inflammation,Immunology & Inflamm,
L-Adrenaline,51-43-4,CNCC(C1=CC(=C(C=C1)O)O)O,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist
L-Alanine,56-41-7,,Others,Others,
L-Arabinose,5328-37-0,O[C@@]1([H])COC(O)([H])[C@@](O)([H])[C@@]1([H])O,Others,Others,"Aldopentose,component of biopolymers like hemicellulose and pectin"
L-Arginine (hydrochloride),1119-34-2,C6H15ClN4O2,Immunology/Inflammation,NOS,Precursor of nitric oxide synthesis
L-Asparagine,70-47-3,,Others,Others,
L-Aspartic acid,56-84-8,,Others,Others,
L-Carnitine inner salt,541-15-1,C[N+](C)(C)CC(CC(=O)[O-])O,Natural Products,Others,Quaternary amine found in mammalian tissue
L-Cycloserine,339-72-0,,Metabolism,Transferase,Potent inhibitor of serine palmitoyl transferase (SPT)
L-Glutamine,56-85-9,C(CC(=O)N)C(C(=O)O)N,GPCR/G protein,mGluR,Non-essential amino acid
L-Glutathione Reduced,70-18-8,SC[C@@H](C(NCC(O)=O)=O)NC(CC[C@@H](C(O)=O)N)=O,Others,Antioxidants,used to elute glutathione S-transferase (GST) from glutathione agarose.
L-Hydroxyproline,51-35-4,,Others,Others,
L-Leucine,61-90-5,,Others,Others,
L-Lysine hydrochloride,657-27-2,C6H15ClN2O2,Others,Others,
L-Menthol,2216-51-5,,Endocrinology and Hormones,Opioid Receptor,
L-Methionine,63-68-3,,Others,Others,
L-Proline,147-85-3,,Others,Others,
L-Selenomethionine,3211-76-5,OC([C@@H](N)CC[Se]C)=O,Immunology/Inflammation,ROS,
L-Theanine,3081-61-6,,Natural Products,Others,
L-Threonine,72-19-5,,Others,Others,
L-Thyroxine,51-48-9,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,Others,Others,Iodine containing hormone
L-Tryptophan,73-22-3,,Others,Others,
L-Valine,72-18-4,,Others,Others,
Labetalol HCl,32780-64-6,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O.Cl,GPCR/G protein,Adrenergic Receptor,mixed alpha/beta adrenergic antagonist
Lacidipine,103890-78-4,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,Membrane Transporter/Ion Channel,Calcium Channel,L-type calcium channel blocker
Lactulose,4618-18-2,C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O,Others,Others,Stimulator of health-promoting bacterium growth
Lafutidine,118288-08-7,C1CCN(CC1)CC2=CC(=NC=C2)OCC=CCNC(=O)CS(=O)CC3=CC=CO3,Neuroscience,Histamine Receptor,Histamine H2-receptor antagonist
Lamivudine,134678-17-4,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,Microbiology & Virology,Reverse Transcriptase,Nucleoside analog reverse transcriptase inhibitor
Lamotrigine,84057-84-1,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Membrane Transporter/Ion Channel,Sodium Channel,5-HT inhibitor， sodium channel blocker
Lannaconitine,32854-75-4,,Natural Products,Sodium Channel,
Lansoprazole,103577-45-3,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Membrane Transporter/Ion Channel,Proton Pump,"H+,K+-ATPase inhibitor"
Lansoprazole sodium,226904-00-3,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCC(F)(F)F.[Na+],Membrane Transporter/Ion Channel,Proton Pump,PPI/cytochrome P450 inhibitor
Lapatinib,231277-92-2,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,JAK/STAT Signaling,EGFR,"EGFR/HER2 inhibitor,potent,selective and reversible"
Lapatinib Ditosylate,388082-78-8,CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,JAK/STAT Signaling,EGFR,"EGFR/HER2 inhibitor,potent and selective"
Lapatinib ditosylate,388082-78-8,C41H40ClFN4O11S3,Others,Others,
Laquinimod (ABR-215062),248281-84-7,CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O,Others,Others,"Immunomodulator,orally-available,quinolinone-based and broad spectrum"
Latanoprost,130209-82-4,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,Others,Others,FP prostaglandin receptor agonist
Lathyrol,34420-19-4,,Natural Products,Others,
Latrepirdine,97657-92-6,CC1=CC2=C(C=C1)N(C3=C2CN(CC3)C)CCC4=CN=C(C=C4)C.Cl.Cl,Neuroscience,GluR,Brain cell death inhibitor
Lauric Acid,143-07-7,CCCCCCCCCCCC(O)=O,Metabolism,Lipid Metabolism,saturated medium-chain fatty acid
LCZ696,936623-90-4,CCCCC(N([C@@](C([O-])=O)([H])C(C)C)CC1=CC=C(C2=CC=CC=C2C3=N[N-]N=N3)C=C1)=O.CCOC([C@](C[C@@](/N=C([O-])/CCC([O-])=O)([H])CC4=CC=C(C5=CC=CC=C5)C=C4)([H])C)=O.[3Na+].[2.5H2O],GPCR/G protein,Angiotensin Receptor,A first in class ARNi (angiotensin receptor neprilysin inhibitor)
"LDE225 (NVP-LDE225,Erismodegib)",956697-53-3,CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,Stem Cell,Smoothened,"Smoothened inhibitor,potent and selective"
LDE225 Diphosphate,1218778-77-8,C26H32F3N3O11P2,Stem Cell,Smoothened,
LDK378,1032900-25-6,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,Tyrosine Kinase,ALK,Potent ALK inhibitor
Ledipasvir,1256388-51-8,CC([C@@](/N=C(OC)\O)([H])C(N1CC2(C[C@@]1([H])C3=NC=C(N3)C4=CC5=C(C6=C(C5(F)F)C=C(C7=CC(N8)=C(N=C8[C@]9([H])[C@@]%1 ([H])CC[C@](N9C([C@](/N=C(OC)\O)([H])C(C)C)=O)([H])C%1 )C=C7)C=C6)C=C4)CC2)=O)C,Microbiology & Virology,HCV,HCV NS5A protein inhibitor
LEE011,1211441-98-3,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,CDK4/6 inhibitor
Leflunomide,75706-12-6,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,"AHR agonist,immunosuppressive agent"
Lenalidomide (CC-5013),191732-72-6,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,Apoptosis,TNF-α,"Antineoplastic agent,inhibits angiogenesis"
Lenvatinib (E7080),417716-92-8,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,Tyrosine Kinase,VEGFR,VEGFR inhibitor
Lesinurad,878672-00-5,C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)O,Membrane Transporter/Ion Channel,URAT1,URAT1 inhibitor
Letrozole,112809-51-5,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,Endocrinology and Hormones,Aromatase,Non-steroidal aromatase inhibitor
Leucovorin Calcium,6035-45-6,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].O.O.O.O.O.[Ca+2],Metabolism,Folate Analogue,Derivative of folic acid
Leuprolide Acetate,74381-53-6,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O,Endocrinology and Hormones,GnRH,Pituitary GnRH receptors agonist
Levetiracetam,102767-28-2,CCC(C(=O)N)N1CCCC1=O,Membrane Transporter/Ion Channel,Calcium Channel,Antiepileptic drug
Levobetaxolol HCl,116209-55-3,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor antagonist
Levobupivacaine HCl,27262-48-2,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor
Levodopa,59-92-7,C9H11NO4,Neuroscience,Dopamine Receptor,
Levofloxacin,100986-85-4,FC1=C(C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)[C@](C([H])([H])[H])([H])C([H])([H])O2)N4C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C4([H])[H],Microbiology & Virology,Antibiotic,synthetic fluoroquinolone antibiotic
Levomefolate calcium,151533-22-1,CN1C(CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O.[Ca+2],Metabolism,Folate Analogue,Artificial form of folate
Levonorgestrel,797-63-7,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen/progestogen receptor agonist
Levosimendan,141505-33-1,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,Membrane Transporter/Ion Channel,Calcium Channel,calcium sensitiser
Levosulpiride,23672-07-3,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,Neuroscience,Dopamine Receptor,Antipsychotic drug
Levulinic acid,123-76-2,,Others,Others,
Licofelone,156897-06-2,CC1(CC2=C(C(=C(N2C1)CC(=O)O)C3=CC=C(C=C3)Cl)C4=CC=CC=C4)C,Neuroscience,COX,"COX-1, COX-2 and 5-LOX inhibitor"
Lidocaine,137-58-6,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,Neuroscience,Histamine Receptor,Anasthetic and class Ib antiarrhythmic agent
Ligustrazine Hydrochloride,76494-51-4,C8H12N2.HCl.2H2O,Natural Products,Immunology & Inflammation related,
Linagliptin (BI-1356),668270-12-0,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,Proteases,DPP-4,"DDP-4 inhibitor,highly potent and competitive"
Linalool,78-70-6,CC(=CCCC(C)(C=C)O)C,Natural Products,NMDAR,
Linezolid,165800-03-3,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,Microbiology & Virology,Antibiotic,Antibacterial reagent
Linifanib (ABT-869),796967-16-3,CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N,Tyrosine Kinase,VEGFR,VEGFR/PDGFR inhibitor
Linoleic Acid,60-33-3,CCCCC/C=C\C/C=C\CCCCCCCC(=O)O,Others,Others,"Essential fatty acid, precursor of arachidonic acid (AA) and various prostaglandins"
Linsitinib,867160-71-2,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,Tyrosine Kinase,Insulin Receptor,"IGF1R/IR inhibitor,potent and novel"
Liothyronine Sodium,55-06-1,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.[Na+],Others,Others,Potent agonist of both thyroid hormone receptors TRα and TRβ
Lisinopril dihydrate,83915-83-7,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O.O.O,Endocrinology and Hormones,RAAS,ACE inhibitor
Lithium carbonate,554-13-2,,Membrane Transporter/Ion Channel,ATPase,
Lithium Citrate,6080-58-6,[Li+].[Li+].[Li+].C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.O.O.O.O,Others,Others,Mood stabilizer
Lithocholic Acid,434-13-9,CC(CCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,Others,Others,"Activator of vitamin D receptor,PXR and FXR"
Loganin,18524-94-2,CC1C(CC2C1C(OC=C2C(=O)OC)OC3C(C(C(C(O3)CO)O)O)O)O,Natural Products,"BACE,AChR",Cox-1 inhibitor
Lomefloxacin HCl,98079-52-8,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O.Cl,Microbiology & Virology,Anti-infection,Fluoroquinolone antibiotic
Lomerizine HCl,101477-54-7,COC1=C(C(=C(C=C1)CN2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)OC)OC.Cl.Cl,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel inhibitor
Lomitapide,182431-12-5,C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F,Others,Others,"MTP inhibitor, orally active"
Lomustine,13010-47-4,C1CCC(CC1)NC(=O)N(CCCl)N=O,DNA Damage/DNA Repair,DNA Alkylating,Antineoplastic drug
Lonafarnib,193275-84-2,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(C=C(C=C4CCC5=CC(=CN=C35)Br)Cl)Br)C(=O)N,Metabolism,Transferase,"Ftase inhibitor,potent and selective"
Lonidamine,50264-69-2,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,Others,Others,hexokinase inactivator
Loperamide HCl,34552-83-5,C29H33ClN2O2.HCl,Neuroscience,"Opioid Receptor,Autophagy","μ opioid receptors agonist, voltage-sensitive sodium channels blocker"
Lopinavir,192725-17-0,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,Proteases,HIV Protease,"HIV protease inhibitor,highly potent"
Loratadine,79794-75-5,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Neuroscience,Histamine Receptor,Peripheral HH1R antagonist
Lornoxicam,70374-39-9,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,Neuroscience,COX,COX-1/COX-2 inhibitor
Losartan,114798-26-4,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,GPCR/G protein,Angiotensin Receptor,Angiotensin II receptor antagonist
Losartan Potassium (DuP 753),124750-99-8,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+],Endocrinology and Hormones,RAAS,Angiotensin AT1 receptor antagonist
Losmapimod,585543-15-3,FC1=C(C)C(C(C=C2)=NC=C2C(NCC(C)(C)C)=O)=CC(C(NC3CC3)=O)=C1,MAPK Signaling,p38,"p38 MAPK inhibitor, orally active"
Loteprednol etabonate,82034-46-6,CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl,Microbiology & Virology,Antibiotic,potent glucocorticoid receptor agonist
Lovastatin,75330-75-5,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor
Loxapine Succinate,27833-64-3,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O,Neuroscience,"5-HT Receptor, Dopamine Receptor",Dopamine receptor antagonist
LOXO-101,1223405-08-0,C21H24F2N6O6S,Tyrosine Kinase,Trk,
Lubiprostone,136790-76-6,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,Membrane Transporter/Ion Channel,Chloride Channel,activator of ClC-2 chloride channels
Luliconazole,187164-19-8,C1C(SC(=C(C#N)N2C=CN=C2)S1)C3=C(C=C(C=C3)Cl)Cl,Microbiology & Virology,Antibiotic,Azole antifungal agent(interdigital tinea pedis)
Lumefantrine,82186-77-4,OC(CN(CCCC)CCCC)C1=C(C(C=CC(Cl)=C2)=C2/C3=C/C4=CC=C(Cl)C=C4)C3=CC(Cl)=C1,Microbiology & Virology,Anti-infection,
Lumiracoxib,220991-20-8,C15H13ClFNO2,Neuroscience,COX,
Lurasidone HCl,367514-88-3,C28H37ClN4O2S,Neuroscience,5-HT Receptor,
Lutein,127-40-2,O[C@@H]1CC(C)([C@H](C(C)=C1)/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C[C@H](CC2(C)C)O)C)C,Others,Others,
LY2157299,700874-72-2,CC1=CC=CC(=N1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,TGF-β / Smad Signaling,TGF-βR1(ALK5),"TGF-βR1 inhibitor,potent and selective"
LY2228820,862507-23-1,CC(C)(C)CN1C2=C(C=CC(=N2)C3=C(N=C(N3)C(C)(C)C)C4=CC=C(C=C4)F)N=C1N.CS(=O)(=O)O.CS(=O)(=O)O,MAPK Signaling,p38,P38 MAP kinase inhibitor
LY2784544,1229236-86-5,CC1=CC(=NN1)NC2=NN3C(=C(N=C3C(=C2)CN4CCOCC4)C)CC5=C(C=C(C=C5)Cl)F,Chromatin/Epigenetics,JAK,"JAK2 inhibitor,highly potent and selective"
LY2835219,1231930-82-7,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F.CS(=O)(=O)O,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK4/6 inhibitor,potent and selective"
LY2835219 free base,1231929-97-7,CCN1CCN(CC2=CN=C(NC3=NC=C(F)C(C4=CC5=C(N=C(C)N5C(C)C)C(F)=C4)=N3)C=C2)CC1,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,CDK inhibitor
LY2940680,1258861-20-9,CN1C(=CC=N1)C2=NN=C(C3=CC=CC=C32)N4CCC(CC4)N(C)C(=O)C5=C(C=C(C=C5)F)C(F)(F)F,Stem Cell,Hedgehog,"Hedgehog/SMO antagonist,inhibits Hh signaling"
LY335979 (Zosuquidar 3HCL),167465-36-3,FC1([C@H](C2=CC=CC=C23)[C@@H]1C4=CC=CC=C4[C@H]3N5CCN(C[C@H](COC6=C7C(N=CC=C7)=CC=C6)O)CC5)F.Cl.Cl.Cl,Membrane Transporter/Ion Channel,P-gp,Pgp (P-glycoprotein) inhibitor
m-Cresol,108-39-4,,Others,Others,
Macitentan,441798-33-0,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,GPCR/G protein,Endothelin Receptor,Endothelin (ET)(A) and ET(B) receptor antagonist
Madecassic acid,18449-41-7,,Natural Products,Others,
Madecassoside,34540-22-2,,Natural Products,Others,
Magnolol,528-43-8,,Natural Products,NF-κB,
Malic acid,6915-15-7,,Others,Others,
Malotilate,59937-28-9,CC(C)OC(=O)C(=C1SC=CS1)C(=O)OC(C)C,Metabolism,5-Lipoxygenase,Stimulates hepatocyte regeneration
Maltotriose,1109-28-0,OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@]([C@H](O)CO)([H])[C@H](O)[C@@H](O)C=O)O[C@@H]2CO)([H])O1,Others,Others,
Manidipine,89226-50-6,CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker
Manidipine 2HCl,89226-75-5,CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC.Cl.Cl,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker
Maprotiline HCl,10347-81-6,Cl[H].[H]C12C([H])([H])C([H])([H])C(C3=C([H])C([H])=C([H])C([H])=C23)(C([H])([H])C([H])([H])C([H])([H])N([H])C([H])([H])[H])C4=C([H])C([H])=C([H])C([H])=C14,GPCR/G protein,Adrenergic Receptor,Selective noradrenalin re-uptake inhibitor
Maraviroc,376348-65-1,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,Microbiology & Virology,HIV,"Selective CCR5 antagonist,antiretroviral agent"
Marbofloxacin,115550-35-1,FC1=C(C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)N(C([H])([H])[H])C([H])([H])O2)N4C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C4([H])[H],Microbiology & Virology,Antibiotic,Fluoroquinolone antibiotic for veterinary use
Marimastat,154039-60-8,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,Proteases,MMP,"MMPs inhibitor,board spectrum"
Masitinib (AB1010),790299-79-5,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,Tyrosine Kinase,c-Kit,"Tyrosine kinase inhibitor, potent and selective"
MDV3100 (Enzalutamide),915087-33-1,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonist
Mebendazole,31431-39-7,O=C(C1=CC=C(NC(NC(OC)=O)=N2)C2=C1)C3=CC=CC=C3,Cell Cycle/Checkpoint,Microtubule/Tubulin,broad-spectrum anthelmintic that inhibits intestinal microtubule synthesis
Mecamylamine hydrochloride,826-39-1,CC([C@@H]1C[C@H]2CC1)(C)[C@@]2(C)NC.Cl,Neuroscience,Nicotinic Receptor,nicotinic acetylcholine receptor antagonist
Mecarbinate,15574-49-9,CCOC(=O)C1=C(N(C2=C1C=C(C=C2)O)C)C,Others,Others,chemical intermediate of arbidol hydrochloride
Mechlorethamine HCl,55-86-7,CN(CCCl)CCCl.Cl,DNA Damage/DNA Repair,DNA/RNA Synthesis,DNA synthesis inhibitor
Meclizine 2HCl,1104-22-9,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.Cl.Cl,Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist
Meclofenamate Sodium,6385-02-0,CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)[O-])Cl.[Na+],Neuroscience,COX,dual COX-1/COX-2 inhibitor
Medetomidine HCl,86347-15-1,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.Cl,GPCR/G protein,Adrenergic Receptor,Selective α2-adrenoceptor agonist
Medroxyprogesterone,520-85-4,C[C@@](C1=CC(CC[C@]21C)=O)([H])C[C@]([C@]3([H])CC[C@]4(O)C(C)=O)([H])[C@]2([H])CC[C@@]34C,Endocrinology and Hormones,Estrogen/progestogen Receptor,potent progesterone receptor agonist
Medroxyprogesterone acetate,71-58-9,CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,Endocrinology and Hormones,Estrogen/progestogen Receptor,Steroidal progestin
Mefenamic Acid,61-68-7,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,Neuroscience,COX,Anti-inflammatory agent
Mefloquine hydrochloride,51773-92-3,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O.Cl,Microbiology & Virology,Antimalaria,"Quinoline methanol antimalarial agent,"
Megestrol Acetate,595-33-5,CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,Endocrinology and Hormones,Estrogen/progestogen Receptor,Anti-estrogen agent
Meglumine,6284-40-8,CNCC(C(C(C(CO)O)O)O)O,Others,Others,amino sugar
"MEK162 (ARRY-162, ARRY-438162)",606143-89-9,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,MAPK Signaling,MEK1/2,"MEK1/2 inhibitor,potent and selective"
Melamine,108-78-1,,Others,Others,
Melatonin,73-31-4,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,Others,Others,Melatonin receptors agonist
Melibiose,585-99-9,O=C[C@@](O)([H])[C@](O)([H])[C@@](O)([H])[C@@](O)([H])CO[C@]1([H])[C@@](O)([H])[C@](O)([H])[C@](O)([H])[C@@](O1)([H])CO,Others,Others,"Reducing disaccharide, carbon substrate"
Meloxicam (Mobic),71125-38-7,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,Neuroscience,COX,Nonsteroidal anti-inflammatory drug
Melphalan,148-82-3,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,Apoptosis,Other Apoptosis,DNA alkylating agent
Memantine hydrochloride,41100-52-1,CC12CC3CC(C1)(CC(C3)(C2)N)C.Cl,Neuroscience,"P450, AMPA Receptor-kainate Receptor-NMDA Receptor",NMDA receptor antagonist
Menadione,58-27-5,CC1=CC(=O)C2=CC=CC=C2C1=O,Others,"DNA/RNA Synthesis,phosphatase",precursor to vitamin K2
Menaquinone 4,863-61-6,O=C1C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/C)=C(C)C(C2=CC=CC=C21)=O,Metabolism,Vitamin,
Mepenzolate Bromide,76-90-4,C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C.[Br-],Others,Others,mAChR antagonist
Mepiroxol,6968-72-5,C1=CC(=C[N+](=C1)[O-])CO,Others,Others,Antihyperlipidemic drug
Mepivacaine HCl,1722-62-9,CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl,Membrane Transporter/Ion Channel,Sodium Channel,local anesthetic
Meptazinol HCl,59263-76-2,CCC1(CCCCN(C1)C)C2=CC(=CC=C2)O.Cl,Endocrinology and Hormones,Opioid Receptor,Partial agonist at the μ1 opioid receptor
Mepyramine maleate,59-33-6,CN(C)CCN(C1=NC=CC=C1)CC(C=C2)=CC=C2OC.OC(/C=C\C(O)=O)=O,Neuroscience,Histamine Receptor,inverse agonist for the H1 receptor
Mequinol,150-76-5,COC1=CC=C(C=C1)O,Others,Others,depigmentation agent
Mercaptopurine (6-MP),50-44-2,C1=NC2=C(N1)C(=S)N=CN2,DNA Damage/DNA Repair,DNA Synthesis,Purine synthesis inhibitor
Meropenem,96036-03-2,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,Microbiology & Virology,Antibiotic,β-lactam antibiotic of the carbapenem subclass
Meropenem trihydrate,119478-56-7,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O.O.O.O,Microbiology & Virology,Antibiotic,Broad-spectum β-lactam antibiotic
Mesalamine,89-57-6,C1=CC(=C(C=C1N)C(=O)O)O,Immunology/Inflammation,PGE synthase,IKK inhibitor
Mesna,19767-45-4,C(CS(=O)(=O)[O-])S.[Na+],Others,Others,Chemotherapy adjuvant;potential antioxidant
Mesoridazine Besylate,32672-69-8,O=S(C)C1=CC=C2SC3=CC=CC=C3N(C2=C1)CC[C@H]4N(C)CCCC4.OS(=O)(C5=CC=CC=C5)=O,Others,Others,Phenothiazine dopamine receptor anatagonist
Mestranol,72-33-3,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen used in contraceptives
Metaxalone,1665-48-1,CC1=CC(C)=CC(OCC(O2)CN=C2O)=C1,Others,Others,muscle relaxant
Metformin HCl,1115-70-4,CN(C)C(=N)N=C(N)N.Cl,Others,Others,Anti-diabetic drug
Methacycline HCl,3963-95-9,CN(C)C1C2C(C3C(=C)C4=C(C(=CC=C4)O)C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O.Cl,Microbiology & Virology,Anti-infection,tetracycline antibiotic
Methazolamide,554-57-4,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C,Metabolism,Carbonic Anhydrase,Carbonic anhydrase inhibitor
Methenamine,100-97-0,[H]C1([H])N(C2([H])[H])C([H])([H])N3C([H])([H])N2C([H])([H])N1C3([H])[H],Microbiology & Virology,Anti-infection,antibiotic
Methicillin (sodium salt),132-92-3,O=C(N[C@@H]1C(N2[C@]1([H])SC(C)(C)[C@@H]2C([O-])=O)=O)C3=C(OC)C=CC=C3OC.[Na+],Microbiology & Virology,Antibiotic,semisynthetic penicillin antibiotic
Methimazole,60-56-0,CN1C=CNC1=S,Others,Others,ICAM-1 inhibitor
Methotrexate,59-05-2,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Metabolism,DHFR,"Folate antagonist,inhibits DFHR"
Methscopolamine,155-41-9,O=C(C(C1=C([H])C([H])=C([H])C([H])=C1[H])([H])C([H])([H])O[H])O[C@@]2([H])C([H])([H])[C@]3([H])[N+](C([H])([H])[H])(C([H])([H])[H])[C@@](C2([H])[H])([H])[C@@]4([H])O[C@@]34[H].[Br-],Neuroscience,AChR,Muscarinic acetylcholine receptor blocker
Methyl salicylate,119-36-8,,Membrane Transporter/Ion Channel,TRPV,
Methylcobalamin,13422-55-4,[CH3-].CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[Co+3],Others,Others,a form of vitamin B12
Methyldopa,555-30-6,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,GPCR/G protein,Adrenergic Receptor,alpha-2 adrenergic receptor agonist
Methylparaben,99-76-3,,Others,Others,
Methylprednisolone,83-43-2,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,GPCR/G protein,Glucocorticoid Receptor,"Apoptosis inducer,GR agonist"
Methylprednisolone Sodium Succinate,2375-03-3,O[C@@]1(C(COC(CCC([O-])=O)=O)=O)[C@](C2)(C)[C@@H](CC1)[C@H](C[C@@H]3C)[C@@H]([C@@](C)(C=C4)C3=CC4=O)[C@H]2O.[Na+],GPCR/G protein,Glucagon Receptor,glucocorticoid
Methylthiouracil,1956-4-2,CC1=CC(=O)NC(=S)N1,Others,Others,antithyroid preparation
Methyocarbamol,532-03-6,COC1=CC=CC=C1OCC(COC(=O)N)O,Others,Others,Carbonic anhydrase inhibitor
Meticrane,1084-65-7,CC1=C(C=C2C(=C1)CCCS2(=O)=O)S(=O)(=O)N,Others,Others,Peripheral-type benzodiazepine receptor (PBR) inhibitor
Metoclopramide,364-62-5,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist
Metolazone,17560-51-9,ClC1=C(C=C2C(NC(C)N(C3=CC=CC=C3C)C2=O)=C1)S(=O)(N)=O,Others,Others,thiazide-like diuretic
Metoprolol Succinate,98418-47-4,OC(COC(C=C1)=CC=C1CCOC)CNC(C)C.OC(COC(C=C2)=CC=C2CCOC)CNC(C)C.OC(CCC(O)=O)=O,GPCR/G protein,Adrenergic Receptor,beta-1 selective adrenergic receptor antagonist
Metoprolol Tartrate,56392-17-7,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.C(C(C(=O)O)O)(C(=O)O)O,GPCR/G protein,Adrenergic Receptor,β1-adrenergic blocking agent
Metronidazole,443-48-1,CC1=NC=C(N1CCO)[N+](=O)[O-],DNA Damage/DNA Repair,DNA/RNA Synthesis,nitroimidazole antibiotic
Metyrapone,54-36-4,O=C(C1=CC=CN=C1)C(C)(C)C2=CC=CN=C2,Others,Hydroxylases,11-β hydroxylase (CYP11B1) inhibitor
Mevastatin,73573-88-3,CCC(C)C(=O)OC1CCC=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor
Mexiletine HCl,5370-01-4,CC1=C(C(=CC=C1)C)OCC(C)N.Cl,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor
Mezlocillin Sodium,42057-22-7,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)O)C.[Na],Microbiology & Virology,Anti-infection,Penicillin beta-lactam antibiotic
Mianserin HCl,21535-47-7,CN1CC2C3=C(C=CC=C3)CC4=C(C=CC=C4)N2CC1.Cl,Neuroscience,Histamine Receptor,5-HT2 receptor antagonist
Micafungin sodium,208538-73-2,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)[O-])O)O)C(CC(=O)N)O)C)O)O)O.[Na+],Others,"β(1,3)-D-Glucan Synthase","Inhibitor of β-(1,3)-D-glucan synthesis;fungicide"
Miconazole,22916-47-8,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,Microbiology & Virology,Anti-infection,imidazole antifungal agent
Miconazole Nitrate,22832-87-7,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl.[N+](=O)(O)[O-],Microbiology & Virology,Anti-infection,Antifungal agent
Midodrine (hydrochloride),43218-56-0,C12H18N2O4 • HCl,GPCR/G protein,Adrenergic Receptor,
Midostaurin (PKC412),120685-11-2,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,TGF-β / Smad Signaling,PKC,PKC inhibitor
Mifepristone,84371-65-3,CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,GPCR/G protein,Glucocorticoid Receptor,Progesterone receptor antagonist
Miglitol,72432-03-2,C1C(C(C(C(N1CCO)CO)O)O)O,Others,Others,Inhibitor of α-glucosidase
Milnacipran HCl,101152-94-7,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2.Cl,Neuroscience,SSRIs,Orally active 5-HT and noradrenalin re-uptake inhibitor
Milrinone,78415-72-2,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2,Metabolism,PDE,PDE-3 inhibitor
Miltefosine,58066-85-6,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,PI3K/Akt/mTOR Signaling,Akt,PI3K/Akt inhibitor
Minocycline HCl,13614-98-7,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl,Microbiology & Virology,Antibiotic,Tetracycline antibiotic
Minoxidil,38304-91-5,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,Membrane Transporter/Ion Channel,Potassium Channel,Kir6 channel (KATP) activator.
Mirabegron (YM178),223673-61-8,C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,GPCR/G protein,Adrenergic Receptor,Selective β3-adrenoceptor agonist
Mirtazapine,85650-52-8,[H]C1(C2=C([H])C([H])=C([H])C([H])=C2C([H])([H])C3=C4N=C([H])C([H])=C3[H])N4C([H])([H])C([H])([H])N(C([H])([H])[H])C1([H])[H],Neuroscience,5-HT Receptor,"5-HT2, 5-HT3, histamine H1 receptor and  α2-adrenoceptor antagonist"
Misoprostol,59122-46-2,,GPCR/G protein,Prostaglandin Receptor,synthetic prostaglandin E1 (PGE1) analog
Mitiglinide Calcium,145525-41-3,C1CCC2CN(CC2C1)C(=O)CC(CC3=CC=CC=C3)C(=O)[O-].C1CCC2CN(CC2C1)C(=O)CC(CC3=CC=CC=C3)C(=O)[O-].[Ca+2],Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel inhibitor
Mitomycin C,50-07-7,NC(C1=O)=C(C)C(C2=C1[C@@H](COC(N)=O)[C@]3(OC)N2C[C@H]4[C@@H]3N4)=O,Apoptosis,Apoptosis Inducers,"Inhibits DNA synthesis,antibiotic and antitumor agent"
Mitotane (Lsodren),53-19-0,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,Others,Others,Antineoplastic agents against adrenocortical carcinoma
Mitoxantrone HCl,70476-82-3,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO.Cl.Cl,DNA Damage/DNA Repair,Topoisomerase,"Topoisomerase II inhibitor, anti-neoplastic drug"
Mizolastine,108612-45-9,C24H25FN6O,Neuroscience,Histamine Receptor,
Mizoribine,50924-49-7,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)O)C(=O)N,Others,IMPDH,DNA/RNA synthesis inhibitor
MK-2048,869901-69-9,C21H21ClFN5O4,Proteases,HIV Integrase,
MK-4827,1038915-60-4,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,Chromatin/Epigenetics,PARP,"PARP-1/-2 inhibitor,potent and selective"
MK-5172,1350514-68-9,COC1=CC2=C(N=C(CCCCC[C@@H]3C[C@H]3OC(N[C@@H](C(C)(C)C)C(N4[C@H](C(N[C@@]5(C(NS(=O)(C6CC6)=O)=O)[C@H](C5)C=C)=O)C[C@@H]7C4)=O)=O)C(O7)=N2)C=C1,Proteases,NS3/4a protease,HCV NS3/4a protease inhibitor
MK3102,1226781-44-7,CS(N1C=C2CN([C@](CO3)([H])C[C@@](N)([H])[C@@]3([H])C4=C(F)C=CC(F)=C4)CC2=N1)(=O)=O,Proteases,DPP-4,Novel long-acting DPP-4 inhibitor
MLN2238,1072833-77-2,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,Ubiquitination/Proteasome,Proteasome,β5 site of the 20S proteasome inhibitor
MLN8237 (Alisertib),1028486-01-2,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,Chromatin/Epigenetics,Aurora Kinase,"Aurora A Kinase inhibitor, Potent and selective"
MLN9708,1201902-80-8,B1(OC(=O)CC(O1)(CC(=O)O)C(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl,Ubiquitination/Proteasome,Proteasome,Proteasome inhibitor
"Mocetinostat (MGCD0103, MG0103)",726169-73-9,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4,DNA Damage/DNA Repair,HDAC,"HDAC inhibitor,isotype-selective and potent"
Moclobemide (Ro 111163),71320-77-9,C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl,Metabolism,MAO,Reversible inhibitor of MAO-A
Moguisteine,119637-67-1,CCOC(=O)CC(=O)N1CCSC1COC2=CC=CC=C2OC,Others,Others,novel peripheral non-narcotic antitussive drug
Molidustat (BAY85-3934),1154028-82-6,O=C1C(N2C=CN=N2)=CNN1C3=NC=NC(N4CCOCC4)=C3,Chromatin/Epigenetics,HIF,Novel HIF-PH inhibitor
Mometasone furoate,83919-23-7,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C,GPCR/G protein,Glucocorticoid Receptor,glucocorticoid receptor agonist
Monobenzone,103-16-2,C1=CC=C(C=C1)COC2=CC=C(C=C2)O,Others,Others,Skin depigmenting agent
Monomethyl auristatin E,474645-27-7,C39H67N5O7,Cell Cycle/Checkpoint,Microtubule/Tubulin,
Montelukast Sodium,151767-02-1,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)[O-])O.[Na+],GPCR/G protein,CysLT1 receptor,Leukotriene receptor antagonist
Morin,480-16-0,OC1=CC(O)=C2C(C(O)=C(OC2=C1)C3=C(C=C(C=C3)O)O)=O,Others,Others,
Moroxydine HCl,3160-91-6,C1COCCN1C(=N)N=C(N)N.Cl,Microbiology & Virology,Anti-infection,synthetic antiviral compound
Mosapride Citrate,112885-42-4,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Neuroscience,5-HT Receptor,5-HT receptor agonist
Motolimod (VTX-2337),926927-61-9,CCCN(C(C(CC1=N)=CC2=C(N1)C=C(C3=CC=C(C(N4CCCC4)=O)C=C3)C=C2)=O)CCC,Immunology/Inflammation,TLR,TLR8 agonist
Moxalactam (sodium salt),64953-12-4,OC1=CC=C([C@@H](C([O-])=O)C(N[C@@]2(OC)[C@](OCC(CSC3=NN=NN3C)=C4C([O-])=O)([H])N4C2=O)=O)C=C1.[Na+].[Na+],Microbiology & Virology,Antibiotic,β-lactam antibiotic
Moxidectin,113507-06-5,CC(/C([H])=C([C@](O1)([H])[C@@](/C(C[C@@]21C[C@](O3)([H])C[C@@](O2)([H])C/C([H])=C(C[C@@](/C([H])=C([H])/C([H])=C([C@@]45O)\CO[C@]5([H])[C@@](O)([H])C(C)=C[C@@]4([H])C3=O)([H])C)\C)=N\OC)([H])C)\C)C,Microbiology & Virology,Antibiotic,anthelmintic drug
Moxifloxacin HCl,186826-86-8,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl,DNA Damage/DNA Repair,Topoisomerase,Fluoroquinolone antibiotic
Moxonidine,75438-57-2,CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC,Others,Imidazoline Receptors,I1R/α2AR agonist
MPEP,96206-92-7,,GPCR/G protein,mGluR,
Mubritinib (TAK 165),366017-09-6,C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)C=CC4=CC=C(C=C4)C(F)(F)F,Tyrosine Kinase,HER2,Potent inhibitor of HER2/ErbB2
Mupirocin,12650-69-0,CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,DNA Damage/DNA Repair,DNA Synthesis,isoleucyl t-RNA synthetase inhibitor
Mycophenolate Mofetil,128794-94-5,CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)OCCN3CCOCC3)OC,Metabolism,Dehydrogenase,IMPDH inhibitor
Mycophenolic acid,24280-93-1,CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)O)OC,Metabolism,Dehydrogenase,Dehydrogenase inhibitor
myo-Inositol,87-89-8,OC1C(O)C(O)C(O)C(O)C1O,Others,Others,
N-acetyl-D-Glucosamine,7512-17-6,O=CC(C(C([C@@H](CO)O)O)O)NC(C)=O,Others,Others,
N-Acetylneuraminic acid,131-48-6,,Others,Others,
N-Carbamyl-L-glutamic acid,1188-38-1,N=C(O)N[C@@](C(O)=O)([H])CCC(O)=O,Others,Others,
Nabumetone,42924-53-8,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,Neuroscience,COX,COX inhibitor
NAD+,53-84-9,C21H27N7O14P2,Others,Others,
Nadifloxacin,124858-35-1,FC1=C(C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)C(C([H])([H])[H])([H])C([H])([H])C2([H])[H])N(C([H])([H])C4([H])[H])C([H])([H])C([H])([H])C4([H])O[H],Microbiology & Virology,Anti-infection,topical fluoroquinolone antibiotic
Nafamostat Mesylate(FUT-175),82956-11-4,CS(=O)(=O)O.CS(=O)(=O)O.C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N,Proteases,Serine Protease,Serine protease inhibitor
Nafcillin Sodium,7177-50-6,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+],Microbiology & Virology,Anti-infection,"narrow-spectrum, beta-lactam antibiotic"
Naftifine HCl,65473-14-5,CN(CC=CC1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32.Cl,Microbiology & Virology,Fungal,Allylamine antifungal agent
Naftopidil,57149-07-2,COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O,GPCR/G protein,Adrenergic Receptor,α1-adrenergic receptor antagonist
Nalidixic acid,389-08-2,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,DNA Damage/DNA Repair,Topoisomerase,synthetic quinolone antibiotic
Naloxone HCl,357-08-4,C19H22ClNO4,Endocrinology and Hormones,Opioid Receptor,μ opioid receptors antagonist
Naltrexone HCl,16676-29-2,C20H24ClNO4,Endocrinology and Hormones,Opioid Receptor,Opioid receptors antagonist
Napabucasin,83280-65-3,CC(C(O1)=CC2=C1C(C3=CC=CC=C3C2=O)=O)=O,JAK/STAT Signaling,STAT,STAT3 inhibitor
Naphazoline HCl,550-99-2,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist
Naproxen Sodium,26159-34-2,C[C@@](C([O-])=O)([H])C1=CC2=CC=C(OC)C=C2C=C1.[Na+],Neuroscience,COX,cyclooxygenase inhibitor
Naratriptan,143388-64-1,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C.Cl,Neuroscience,5-HT Receptor,selective 5-HT1 receptor subtype agonist
Natamycin,7681-93-8,O[C@](C1)(C[C@H](C[C@H]2O[C@@H]2/C=C\C(O[C@H](C)C/C=C\C=C/C=C\C=C/[C@@H]3O[C@@H]([C@H]([C@H]4N)O)O[C@H](C)[C@H]4O)=O)O)O[C@](C3)([H])[C@H](C(O)=O)[C@H]1O,Microbiology & Virology,Antibiotic,Antifungal macrolide polyene
Nateglinide,105816-04-4,CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O,Membrane Transporter/Ion Channel,Potassium Channel,Insulin secretagog agent
Nebivolol,152520-56-4,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O.Cl,GPCR/G protein,Adrenergic Receptor,Highly selective β1-adrenoceptor antagonist
Nedaplatin,95734-82-0,C(C(=O)O)O.[NH2-].[NH2-].[Pt+2],GPCR/G protein,Adrenergic Receptor,DNA synthesis inhibitor
Nefiracetam,77191-36-7,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O,Neuroscience,GABA Receptor,GABA receptor activator
Nelarabine,121032-29-9,COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N,DNA Damage/DNA Repair,DNA Synthesis,Prodrug of ara-G for T-LBL/T-ALL
Nelfinavir,159989-64-7,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,Proteases,HIV Integrase,HIV-1 protease inhibitor
Nelfinavir Mesylate,159989-65-8,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O)O,Proteases,HIV Protease,"HIV protease inhibitor,antiretroviral drug for HIV treatment"
Neomycin sulfate,1405-10-3,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O,Microbiology & Virology,Anti-infection,Aminoglycoside antibiotic
Neostigmine Bromide,114-80-7,CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.[Br-],Neuroscience,AChR,Cholinesterase inhibitor
Nepafenac,78281-72-8,C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)N)N,Neuroscience,COX,COX-1 and COX-2 inhibitor
Neratinib (HKI-272),698387-09-6,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,JAK/STAT Signaling,EGFR,"HER2/EGFR inhibitor,potent and irreversible"
Netilmicin Sulfate,56391-57-2,CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N.CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,Microbiology & Virology,Anti-infection,Active aminoglycoside antibiotic
Nevirapine,129618-40-2,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Microbiology & Virology,Reverse Transcriptase,Non-nucleoside reverse transcriptase inhibitor
Nicaraven,79455-30-4,C15H16N4O2,Others,Others,
Nicardipine HCl,54527-84-3,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC.Cl,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel inhibitor
Nicergoline,27848-84-6,CN1C=C2C[C@]3([H])[C@](C4=C2C1=CC=C4)(OC)C[C@](COC(C5=CC(Br)=CN=C5)=O)([H])CN3C,GPCR/G protein,Adenosine Receptor,vasodilator
Niclosamide,50-65-7,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,JAK/STAT Signaling,STAT,Inhibitor of the STAT3 signaling pathway
Nicorandil,65141-46-0,C1=CC(=CN=C1)C(=O)NCCO[N+](=O)[O-],Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel activator
Nicotinamide,98-92-0,C1=CC(=CN=C1)C(=O)N,Natural Products,Sirtuin,PARP-1 inhibitor
Nicotine,54-11-5,CN1CCCC1C2=CN=CC=C2,Natural Products,Others,
Nicotine Difartrate,65-31-6,CN1CCCC1C2=CN=CC=C2.C(C(C(=O)O)O)(C(=O)O)O.C(C(C(=O)O)O)(C(=O)O)O,Others,Others,Nicotinic acetylcholine receptor (nAChR) agonist
Nicotinic Acid,59-67-6,C1=CC(=CN=C1)C(=O)O,Others,Others,water-soluble vitamin belonging to the vitamin B family
Nifedipine,21829-25-4,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Membrane Transporter/Ion Channel,Calcium Channel,L-type calcium channel blocker
Nifenazone,2139-47-1,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=O)C3=CN=CC=C3,Others,Others,Analgesic
Niflumic acid,4394-00-7,C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F,Neuroscience,GABA Receptor,Ca2+-activated Cl- channel blocker
Nifuroxazide,965-52-6,C1=CC(=CC=C1C(=O)NN=CC2=CC=C(O2)[N+](=O)[O-])O,JAK/STAT Signaling,STAT,STAT inhibitor
Nilotinib monohydrochloride monohydrate,923288-90-8,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5.O.Cl,TGF-β / Smad Signaling,Bcr-Abl,Bcr-Abl inhibitor
Nilotinib(AMN-107),641571-10-0,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,TGF-β / Smad Signaling,Bcr-Abl,"Bcr-Abl kinase inhibitor,selective"
Nilutamide,63612-50-0,C12H10F3N3O4,Endocrinology and Hormones,Androgen Receptor,Antagonist of the androgen receptor
Nilvadipine,75530-68-6,CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel inhibitor
Nimesulide,51803-78-2,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,Neuroscience,COX,Non-steroidal anti-inflammatory drug
Nimodipine,66085-59-4,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,Ubiquitination/Proteasome,Autophagy,Calcium Channel inhibitor & Autophagy activator
Nintedanib (BIBF 1120),656247-17-5,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)NC(=C3C4=C(C=C(C=C4)C(=O)OC)NC3=O)C5=CC=CC=C5,Tyrosine Kinase,PDGFR,VEGFR/PDGFR/FGFR inhibitor
Nisoldipine,63675-72-9,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,Membrane Transporter/Ion Channel,Calcium Channel,calcium channel blocker
Nitazoxanide,55981-09-4,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],Others,Others,Antiprotozoal agent
Nithiamide,140-40-9,CC(=O)NC1=NC=C(S1)[N+](=O)[O-],Microbiology & Virology,Anti-infection,Antibiotic used in veterinary
Nitisinone,104206-65-7,FC(F)(F)C1=CC(N(=O)=O)=C(C(C2C(CCCC2=O)=O)=O)C=C1,Others,Others,inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase
Nitrendipine,39562-70-4,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker
Nitrofurantoin,67-20-9,,Microbiology & Virology,Anti-infection,"Nitrofuran antibiotic, substrate of bacterial nitrofuran reductase"
Nitrofurazone,59-87-0,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,Microbiology & Virology,Antibiotic,Antibiotic
Nitroxoline,4008-48-4,OC1=C2C(C=CC=N2)=C(N(=O)=O)C=C1,Microbiology & Virology,Antibiotic,antibacterial agent
Nizatidine,76963-41-2,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,Neuroscience,Histamine Receptor,Histamine H2 receptor antagonist
Noradrenaline bitartrate monohydrate,108341-18-0,C1=CC(=C(C=C1C(CN)O)O)O.C(C(C(=O)O)O)(C(=O)O)O.O,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist
Nordihydroguaiaretic acid,500-38-9,,PI3K/Akt/mTOR Signaling,mTOR,
Norethindrone,68-22-4,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,Others,Others,synthetic progestin
Nortriptyline (hydrochloride),894-71-3,CNCC/C=C1C2=C(C=CC=C2)CCC3=C/1C=CC=C3.Cl,Neuroscience,5-HT Receptor,norepinephrine and serotonin transporters blocker
Noscapine HCl,912-60-7,CN1CCC2=CC3=C(C(=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3.Cl,Others,Others,Multi-action opioid alkaloid
Novobiocin Sodium,1476-53-5,CC1=C(C=CC2=C1OC(=O)C(=C2O)NC(=O)C3=CC(=C(C=C3)[O-])CC=C(C)C)OC4C(C(C(C(O4)(C)C)OC)OC(=O)N)O.[Na+],DNA Damage/DNA Repair,Topoisomerase,aminocoumarin antibiotic
Nuciferine,475-83-2,,Natural Products,Others,
Nystatin (Fungicidin),1400-61-9,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,Microbiology & Virology,Antibiotic,antifungal antibiotic
o-Cresol,95-48-7,,Others,Others,
o-Toluic acid,118-90-1,,Others,Others,
Obeticholic Acid,459789-99-2,CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCC(=O)O)C)C)O,Others,FXR,FXR agonist with anticholeretic activity
Octreotide acetate,83150-76-9,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O.CC(=O)O,GPCR/G protein,Somatostatin Receptor,octapeptide congener of native somatostatin
ODM-201,1297538-32-9,C19H19ClN6O2,Endocrinology and Hormones,Androgen Receptor,
Ofloxacin,82419-36-1,FC1=C(C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)C(C([H])([H])[H])([H])C([H])([H])O2)N4C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C4([H])[H],DNA Damage/DNA Repair,Topoisomerase,"Fluoroquinolones,antibiotics"
Olanzapine,132539-06-1,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,Neuroscience,5-HT Receptor,Antagonist of 5-HT2A and dopamine D2 receptors
"Olaparib (AZD2281, Ku-0059436)",763113-22-0,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,Chromatin/Epigenetics,PARP,Potent PARP1/PARP2 inhibitor
Oleanolic acid,508-02-1,,Natural Products,Anti-infection,
Oleic Acid,112-80-1,CCCCCCCC/C=C\CCCCCCCC(O)=O,Others,Others,
Olmesartan,144689-24-7,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,GPCR/G protein,Angiotensin Receptor,Angiotensin II receptor antagonist
Olmesartan medoxomil,144689-63-4,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,Proteases,ACE,AT1 receptor antagonist
Olopatadine HCl,140462-76-6,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O.Cl,Neuroscience,Histamine Receptor,Histamine blocker
Olprinone Hydrochloride,119615-63-3,CC1=C(C=C(C(=O)N1)C#N)C2=CN3C=CN=C3C=C2.Cl,Metabolism,PDE,"Phosphodiesterase 3 (PDE3) inhibitor, selective"
Olsalazine Sodium,6054-98-4,C1=CC(=C(C=C1NN=C2C=CC(=O)C(=C2)C(=O)O)C(=O)[O-])[O-].[Na+].[Na+],Microbiology & Virology,Antibiotic,Anti-inflammatory prodrug
Oltipraz,64224-21-1,CC(C1=S)=C(SS1)C2=CN=CC=N2,Immunology/Inflammation,Nrf2,Nrf2 activator;An antischistosomal agent
Omeprazole,73590-58-6,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,Ubiquitination/Proteasome,Autophagy,"H+,K+-ATPase inhibitor"
Ondansetron,99614-02-5,,Neuroscience,5-HT Receptor,
Ondansetron HCl,99614-01-4,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl,Neuroscience,5-HT Receptor,5-HT3 receptor antagonist
Ondansetron hydrochloride dihydrate,103639-04-9,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.O.O.Cl,Neuroscience,5-HT Receptor,5-HT3 receptor antagonist
Orlistat,96829-58-2,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,Others,Others,Lipase inhibitor for obesity treatment
Ornidazole,16773-42-5,CC1=NC=C(N1CC(CCl)O)[N+](=O)[O-],Microbiology & Virology,Anti-infection,anti-bacterial and anti-protozoal drug
Orotic acid,65-86-1,C1=C(NC(=O)NC1=O)C(=O)O,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,Pyrimidinecarboxylic acid
Orphenadrine Citrate,4682-36-4,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Neuroscience,AChR,Antiparkinsonian and analgesic drug
Oseltamivir,196618-13-0,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,Microbiology & Virology,NA,inhibitor of influenza neuraminidase
Oseltamivir acid,187227-45-8,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)O,Microbiology & Virology,NA,Influenza neuraminidase inhibitor
Oseltamivir phosphate,204255-11-8,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC.OP(=O)(O)O,Microbiology & Virology,NA,Potent and selective inhibitor of the neuraminidase
Ospemifene,128607-22-7,C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=C(C=C3)OCCO)CCCl,Endocrinology and Hormones,Estrogen/progestogen Receptor,non-hormonal selective estrogen receptor modulator (SERM)
Osthole,484-12-8,,Natural Products,Others,
Otilonium Bromide,26095-59-0,CCCCCCCCOC1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C(=O)OCC[N+](C)(CC)CC.[Br-],Neuroscience,AChR,AChR inhibitor
Ouabain,630-60-4,CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O,Membrane Transporter/Ion Channel,Sodium Channel,selective Na+/K+-ATPase inhibitor
Ouabain Octahydrate,11018-89-6,CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O,Others,Others,selective Na+/K+-ATPase inhibitor
Oxacillin sodium monohydrate,7240-38-2,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+],Microbiology & Virology,Anti-infection,an antibiotic used in resistant staphylococci infections
Oxaliplatin,61825-94-3,C1CCC(C(C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+2],DNA Damage/DNA Repair,DNA Synthesis,Antitumor agent
Oxaprozin,21256-18-8,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,Neuroscience,COX,COX inhibitor
Oxcarbazepine,28721-07-5,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,Membrane Transporter/Ion Channel,Sodium Channel,BTX inhibitor
Oxeladin Citrate,52432-72-1,CCC(CC)(C1=CC=CC=C1)C(=O)OCCOCCN(CC)CC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Others,Others,Cough suppressant
Oxethazaine,126-27-2,CC(C)(CC1=CC=CC=C1)N(C)C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC2=CC=CC=C2,Others,Others,Topical anesthetic
Oxfendazole,53716-50-0,COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3,Microbiology & Virology,Anti-infection,broad spectrum benzimidazole anthelmintic
Oxibendazole,20559-55-1,C12H15N3O3,Microbiology & Virology,Anti-infection,
Oxiconazole (nitrate),64211-46-7,ClC1=CC(Cl)=C(/C(CN2C=NC=C2)=N/OCC3=C(Cl)C=C(Cl)C=C3)C=C1.[O-][N+](O)=O,Microbiology & Virology,Antibiotic,antifungal imidazole
Oxiracetam,62613-82-5,N=C(O)CN1CC(O)CC1=O,Others,Others,cyclic derivative of gamma-aminobutyric acid (GABA)
Oxybenzone,131-57-7,,Others,Others,sunscreen agent
Oxybuprocaine HCl,5987-82-6,CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N.Cl,Membrane Transporter/Ion Channel,Sodium Channel,Local anesthetic
Oxybutynin,5633-20-5,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,Neuroscience,AChR,AChR antagonist
Oxybutynin chloride,1508-65-2,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl,Neuroscience,AChR,Anticholinergic medication
Oxytetracycline (Terramycin),79-57-2,CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O,Microbiology & Virology,Antibiotic,broad-spectrum tetracycline antibiotic
Oxytetracycline Dihydrate,6153-64-6,CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O.O.O,Microbiology & Virology,Anti-infection,prescription antibiotic
Oxytocin,50-56-6,,Others,Others,mammalian neurohypophysial hormone
Ozagrel,82571-53-7,C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)O,Metabolism,Factor Xa,Thromboxane A2 synthetase inhibitor
Ozagrel HCl,78712-43-3,C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)O.Cl,Metabolism,P450 (e.g. CYP17),Potent and selective inhibitor of thromboxane (TXA2) synthetase
Ozanimod (RPC1063),1306760-87-1,CC(OC1=C(C#N)C=C(C2=NC(C3=CC=CC4=C3CC[C@]4([H])NCCO)=NO2)C=C1)C,GPCR/G protein,S1P receptor,agonist of the sphingosine-1-phosphate receptor subtypes 1 and 5
p-Anisaldehyde,123-11-5,,Microbiology & Virology,Anti-infection,
p-Cresol,106-44-5,,Others,Others,
PA-824,187235-37-6,C14H12F3N3O5,Others,Others,
Paclitaxel (Taxol),33069-62-4,O=C(N[C@H]([C@H](C(O[C@H]1C[C@]2(O)C(C)(C)C([C@@H](OC(C)=O)C([C@@]3(C)[C@]([C@@](CO4)(OC(C)=O)[C@H]4C[C@@H]3O)([H])[C@@H]2OC(C5=CC=CC=C5)=O)=O)=C1C)=O)O)C6=CC=CC=C6)C7=CC=CC=C7,Cell Cycle/Checkpoint,Microtubule/Tubulin,Antineoplastic agent
Palbociclib (PD0332991) Isethionate,827022-33-3,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C.C(CS(=O)(=O)O)O,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK4/6 inhibitor,highly selective"
Paliperidone,144598-75-4,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist
Palmitic acid,57-10-3,,Natural Products,Others,
Palmitic Acid methyl ester,112-39-0,CCCCCCCCCCCCCCCC(OC)=O,Others,Others,
Palonosetron HCl,135729-62-3,C1CC2CN(C(=O)C3=C2C(=CC=C3)C1)C4CN5CCC4CC5.Cl,Neuroscience,5-HT Receptor,5-HT receptor antagonist
Pamidronate,40391-99-9,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,Stem Cell,Wnt/β-catenin,Supportive care drug in the category of bisphosphonates
Pamidronate Disodium,57248-88-1,C(CN)C(O)(P(=O)(O)[O-])P(=O)(O)[O-].[Na+].[Na+],Others,Others,Bisphosphonate antiresorptive agent & bone resorption inhibitor
Panaxtriol,32791-84-7,,Natural Products,Others,
Pancuronium dibromide,15500-66-0,CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-],Neuroscience,AChR,AChR antagonist
Panobinostat (LBH589),404950-80-7,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,DNA Damage/DNA Repair,HDAC,HDAC inhibitor
Pantoprazole,102625-70-7,,Membrane Transporter/Ion Channel,Proton Pump,H+/K+-ATPase inhibitor
Parecoxib Sodium,198470-85-8,CCC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C.[Na+],Neuroscience,COX,COX-2 inhibitor
Pargyline (hydrochloride),306-07-0,CN(CC#C)CC1=CC=CC=C1.Cl,Metabolism,MAO,MAO inhibitor
Paromomycin Sulfate,1263-89-4,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O,Microbiology & Virology,Anti-infection,Aminoglycoside antibiotic
Paroxetine HCl,78246-49-8,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.Cl,Neuroscience,AChR,Antidepressant agents
Parthenolide,20554-84-1,,DNA Damage/DNA Repair,HDAC,
Pasiniazid,2066-89-9,C1=CC(=C(C=C1N)O)C(=O)O.C1=CN=CC=C1C(=O)NN,Others,Others,Anti-TB and anti-leprosy drug
Pazopanib (GW-786034),444731-52-6,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl,Tyrosine Kinase,PDGFR,VEGFR/PDGFR/FGFR inhibitor
Pazopanib Hydrochloride,635702-64-6,C21H24ClN7O2S,Tyrosine Kinase,VEGFR,
PCI-24781 (CRA-024781),783355-60-2,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,DNA Damage/DNA Repair,HDAC,Pan-HDAC inhibitor
PCI-32765 (Ibrutinib),936563-96-1,C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N,Angiogenesis,BTK,Bruton's tyrosine kinase (BTK) inhibitor
PD 0332991 (Palbociclib) HCl,827022-32-2,O=C1N(C2=NC(NC3=NC=C(C=C3)N4CCNCC4)=NC=C2C(C)=C1C(C)=O)C5CCCC5.Cl,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK4/6 inhibitor,highly selective"
Pefloxacin Mesylate,70458-95-6,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O.CS(=O)(=O)O,Microbiology & Virology,Antibiotic,synthetic chemotherapeutic agent， antibacterial agent
Pefloxacin Mesylate Dihydrate,149676-40-4,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O.CS(=O)(=O)O.O.O,Microbiology & Virology,Antibiotic,third generation of fluoroquinolone class of antibacterials
Pelitinib (EKB-569),257933-82-7,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)C=CCN(C)C,JAK/STAT Signaling,EGFR,"EGFR inhibitor,potent and irreversible"
Pemetrexed,150399-23-8,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+],Metabolism,DHFR,"TS, DHFR,GARFT and AICARFT inhibitor"
Pemetrexed disodium hemipenta hydrate,357166-30-4,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O.O.[Na+],Apoptosis,Thymidylate Synthase,Antifolate and antimetabolite agent
Pemirolast potassium,100299-08-9,CC1=CC=CN2C1=NC=C(C2=O)C3=NN=N[N-]3.[K+],Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist
Penciclovir,39809-25-1,C1=NC2=C(N1CCC(CO)CO)NC(=NC2=O)N,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,HSV-1 DNA synthesis inhibitor
Penfluridol,26864-56-2,C1CN(CCC1(C2=CC(=C(C=C2)Cl)C(F)(F)F)O)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist
Penicillamine,52-67-5,,Others,Others,"Orally bioavailable copper chelator, antirheumatic"
Penicillin G Sodium,69-57-8,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[Na+],Microbiology & Virology,Anti-infection,penicillin antibiotic
Pentadecanoic Acid,1002-84-2,OC(CCCCCCCCCCCCCC)=O,Others,Others,
Pentamidine isethionate,140-64-7,NC(C1=CC=C(OCCCCCOC2=CC=C(C(N)=N)C=C2)C=C1)=N.OCCS(O)(=O)=O.OCCS(O)(=O)=O,Microbiology & Virology,Antibiotic,Drug to treat protozoal diseases
Pentostatin,53910-25-1,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,GPCR/G protein,Adenosine Receptor,Irreversible adenosine deaminase inhibitor
Pentoxifylline,6493-05-6,CC(CCCCN1C(N(C)C(N=CN2C)=C2C1=O)=O)=O,Others,Others,
Pentoxyverine Citrate,23142-01-0,CCN(CC)CCOCCOC(=O)C1(CCCC1)C2=CC=CC=C2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Neuroscience,AChR,AChR antagonist
Peramivir,330600-85-6,CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C,Microbiology & Virology,NA,Aeuraminidase inhibitor;antiviral drug
Peramivir Trihydrate,1041434-82-5,CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C.O.O.O,Microbiology & Virology,NA,"potent, specific influenza viral neuraminidase inhibitor"
Pergolide mesylate,66104-23-2,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC.CS(=O)(=O)O,Neuroscience,Dopamine Receptor,Dopaminergic agonist
Perifosine,157716-52-4,C25H52NO4P,PI3K/Akt/mTOR Signaling,Akt,
Perindopril Erbumine,107133-36-8,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O.CC(C)(C)N,Endocrinology and Hormones,RAAS,ACE inhibitor
Perphenazine,58-39-9,ClC1=CC(N(C2=CC=CC=C2S3)CCCN4CCN(CCO)CC4)=C3C=C1,Neuroscience,Dopamine Receptor,dopamine antagonist
Pexidartinib (PLX3397),1029044-16-3,ClC(C=N1)=CC2=C1NC=C2CC3=CN=C(NCC4=CN=C(C(F)(F)F)C=C4)C=C3,Tyrosine Kinase,CSF-1R,CSF-1R inhibitor
Pexmetinib (ARRY-614),945614-12-0,CC1=CC=C(N2C(NC(NCC3=CC(F)=CC=C3OC4=CC=C5C(C=NN5CCO)=C4)=O)=CC(C(C)(C)C)=N2)C=C1,MAPK Signaling,p38,dual inhibitor of p38 MAPK and Tie2/Tek receptor tyrosine kinase
PF-04449913,1095173-27-5,,Stem Cell,Smoothened,
PF-06463922,1454846-35-5,C21H19FN6O2,Tyrosine Kinase,ALK,
Phenacetin,62-44-2,CCOC1=CC=C(C=C1)NC(=O)C,Neuroscience,COX,Non-opioid analgesic
Phenazopyridine HCl,136-40-3,C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N.Cl,Membrane Transporter/Ion Channel,Sodium Channel,Local analgesic
Phenformin HCl,834-28-6,C1=CC=C(C=C1)CCN=C(N)N=C(N)N.Cl,Others,Others,biguanidine drug with anti-diabetic activity
Phenindione,83-12-5,C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,Metabolism,Vitamin,Anticoagulant
Pheniramine Maleate,132-20-7,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,Neuroscience,Histamine Receptor,Histamine receptor antagonist
Phenoxybenzamine HCl,63-92-3,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2.Cl,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor antagonist
Phentolamine Mesylate,65-28-1,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O,GPCR/G protein,Adrenergic Receptor,Alpha 1/2-blocking agent
Phenylbutazone,50-33-9,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,Others,Others,non-steroidal anti-inflammatory agent
Phenylephrine HCl,61-76-7,CNCC(C1=CC(=CC=C1)O)O.Cl,GPCR/G protein,Adrenergic Receptor,Selective α1-adrenergic receptor agonist
Phenylpiracetam,77472-70-9,O=C1N(CC(N)=O)CC(C2=CC=CC=C2)C1,Others,Others,Nootropic derivative of piracetam
Phenytoin,57-41-0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,Membrane Transporter/Ion Channel,Sodium Channel,inactive voltage-gated sodium channel stabilizer
Phenytoin sodium,630-93-3,C1=CC=C(C=C1)C2(C(=O)NC(=N2)[O-])C3=CC=CC=C3.[Na+],Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel stabilizer
Phloridzin,60-81-1,C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2OC3C(C(C(C(O3)CO)O)O)O)O)O)O,Natural Products,SGLT,
Phosphocreatine disodium salt,922-32-7,OC(CN(C)/C(N)=N/P([O-])([O-])=O)=O.[Na+].[Na+],Others,Miscellaneous Compounds,used to regenerate ATP during skeletal muscle contraction
Phthalic acid,88-99-3,,Others,Others,
Phytol,150-86-7,CC(CCC[C@@H](C)CCC[C@@H](C)CCC/C(C)=C/CO)C,Others,RAR/RXR,activator of retinoid X receptors (RXRs)
Pidotimod,121808-62-6,C1CC(=O)NC1C(=O)N2CSCC2C(=O)O,Immunology/Inflammation,,immunostimulant
Pilocarpine HCl,54-71-7,Cl[H].O=C1OC([H])([H])[C@@](C([H])([H])C2=C([H])N=C([H])N2C([H])([H])[H])([H])[C@]1([H])C([H])([H])C([H])([H])[H],Neuroscience,AChR,Nonselective muscarinic acetylcholine receptor agonist
Pimasertib (AS-703026),1236699-92-5,C1=CC(=C(C=C1I)F)NC2=C(C=CN=C2)C(=O)NCC(CO)O,MAPK Signaling,MEK1/2,MEK1/2 inhibitor
Pimavanserin,706779-91-1,FC1=CC=C(C=C1)CN(C(NCC(C=C2)=CC=C2OCC(C)C)=O)C3CCN(C)CC3,GPCR/G protein,5-HT Receptor,5-HT2A inverse agonist
Pimecrolimus,137071-32-0,CO[C@@H]1C[C@H](/C=C(C)/[C@@H](OC([C@]2([H])CCCCN2C(C([C@]3(O)O[C@H]([C@@H](OC)C[C@H](C/C(C)=C/4)C)[C@@H](OC)C[C@H]3C)=O)=O)=O)[C@H](C)[C@H](CC([C@@H]4CC)=O)O)CC[C@@H]1Cl,Immunology/Inflammation,,"inhibitor of inflammatory cytokines secretion, cell-selective"
Pimobendan,74150-27-9,CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC,Metabolism,PDE,Selective PDE3 inhibitor.Ca2+ channel sensitizer
Pimozide,2062-78-4,FC1=CC=C(C(CCCN2CCC(N3C(NC4=C3C=CC=C4)=O)CC2)C5=CC=C(F)C=C5)C=C1,Neuroscience,Dopamine Receptor,dopamine receptors inhibitor
Pioglitazone,111025-46-8,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,Metabolism,PPAR,PPAR agonist
Pioglitazone HCl,112529-15-4,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl,Metabolism,PPAR,PPARγ agonist
Piperacillin Sodium,59703-84-3,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+],Microbiology & Virology,Anti-infection,"Semisynthetic, broad-spectrum, ampicillin derived ureidopenicillin antibiotic"
Piperazine,110-85-0,,Neuroscience,GABA Receptor,
Piperine,94-62-2,C1CCN(CC1)C(=O)C=CC=CC2=CC3=C(C=C2)OCO3,Natural Products,P450 (e.g. CYP17),MAPK inhibitor
Pirarubicin,72496-41-4,,DNA Damage/DNA Repair,Topoisomerase,
Pirfenidone,53179-13-8,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,TGF-β / Smad Signaling,SMAD,TGF-β production inhibitor
Piromidic Acid,19562-30-2,CCN1C=C(C(=O)C2=CN=C(N=C21)N3CCCC3)C(=O)O,Others,Others,Quinolone antibiotic
Piroxicam,36322-90-4,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,Neuroscience,COX,Prostaglandin synthesis/Coxinhibitor
Pitavastatin,147511-69-1,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)O)O)O)C4=CC=C(C=C4)F,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor
Pitavastatin Calcium,147526-32-7,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.[Ca+2],Metabolism,HMG-CoA Reductase,Enzyme HMGCR inhibitor
Pitolisant hydrochloride,903576-44-3,C1CCN(CC1)CCCOCCCC2=CC=C(C=C2)Cl.Cl,Neuroscience,Histamine Receptor,Nonimidazole inverse agonist
Pizotifen,15574-96-6,CN1CCC(=C2C3=C(CCC4=CC=CC=C42)SC=C3)CC1,Neuroscience,5-HT Receptor,Highly selective 5-HT receptor blocking agent
Pizotifen Malate,5189-11-7,CN1CCC(=C2C3=C(CCC4=CC=CC=C42)SC=C3)CC1.C(C(C(=O)O)O)C(=O)O,Neuroscience,5-HT Receptor,5-HT receptor antagonist
Plerixafor (AMD3100),110078-46-1,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,GPCR/G protein,CXCR,CXCR4 chemokine receptor antagonist
Plerixafor 8HCl (AMD3100 8HCl),155148-31-5,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3.Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl,GPCR/G protein,CXCR,CXCR4 antagonist
PMSF,329-98-6,C1=CC=C(C=C1)CS(=O)(=O)F,Proteases,Serine Protease,"Serine proteinases inhibitor, irreversible"
Podophyllotoxin,518-28-5,,DNA Damage/DNA Repair,Topoisomerase,
Polydatin,27208-80-6,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)OC3C(C(C(C(O3)CO)O)O)O)O)O,Natural Products,Phospholipase (e.g. PLA),
Pomalidomide (CC-4047),19171-19-8,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,Apoptosis,TNF-α,"Immunomodulator,antumor/anti-angiogenic"
Ponatinib (AP24534),943319-70-8,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,TGF-β / Smad Signaling,Bcr-Abl,"pan-BCR-ABL inhibitor,multi-kinase inhibitor"
Posaconazole,171228-49-2,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,Metabolism,C14ɑ demethylase,Sterol C14ɑ demethylase inhibitor
Potassium Canrenoate,2181-04-6,CC12CCC(=O)C=C1C=CC3C2CCC4(C3CCC4(CCC(=O)[O-])O)C.[K+],Others,Others,Aldosterone antagonist
Potassium Iodide,7681-11-0,[K+].[I-],Others,Others,metal halide with thyroid protecting and expectorant properties
Poziotinib,1092364-38-9,C=CC(N1CCC(OC2=C(OC)C=C3C(C(NC4=C(F)C(Cl)=C(Cl)C=C4)=NC=N3)=C2)CC1)=O,Tyrosine Kinase,HER2,irreversible pan-HER inhibitor
Pracinostat (SB939),929016-96-6,CCCCC1=NC2=C(N1CCN(CC)CC)C=CC(=C2)C=CC(=O)NO,DNA Damage/DNA Repair,HDAC,Pan-HDAC inhibitor
Pralatrexate,146464-95-1,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Metabolism,DHFR,"Antifolate,a folate analog"
Pramipexole,104632-26-0,CCCNC1CCC2=C(C1)SC(=N2)N,Neuroscience,Dopamine Receptor,Dopamine agonist
Pramipexole 2HCl Monohydrate,191217-81-9,CCCNC1CCC2=C(C1)SC(=N2)N.O.Cl.Cl,Neuroscience,Dopamine Receptor,Novel non-ergoline dopamine receptor agonist
Pramipexole dihydrochloride,104632-25-9,CCCNC1CCC2=C(C1)SC(=N2)N.Cl.Cl,Neuroscience,Dopamine Receptor,Dopamine receptor agonist
Pramiracetam,68497-62-1,CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C,Others,Others,nootropic drug
Pramoxine HCl,637-58-1,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2.Cl,Others,Others,Local anesthetic
Pranlukast,103177-37-3,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,Immunology/Inflammation,Leukotriene Receptor,"selective antagonist of the cysteinyl leukotrienes (LT) C(4), LTD(4) and LTE(4),"
Pranoprofen,52549-17-4,CC(C1=CC2=C(C=C1)OC3=C(C2)C=CC=N3)C(=O)O,Neuroscience,COX,non-steroidal COX inhibitor
Prasugrel,150322-43-3,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,Neuroscience,P2 Receptor,ADP receptor inhibitor
Prasugrel hydrochloride,389574-19-0,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4.Cl,GPCR/G protein,P2Y Receptor,P2 Receptor inhibitor
Pravastatin,81093-37-0,,Metabolism,HMG-CoA Reductase,
Pravastatin sodium,81131-70-6,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)[O-])O)O)O.[Na+],Metabolism,HMG-CoA Reductase,"HMG-CoA reductase inhibitor,highly selective and competitive"
Praziquantel,55268-74-1,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,Microbiology & Virology,Antibiotic,anthelmintic
Prazosin HCl,19237-84-4,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC.Cl,GPCR/G protein,Adrenergic Receptor,α1 and α2B-adrenoceptor antagonist
Prednisolone,50-24-8,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,GPCR/G protein,Glucocorticoid Receptor,synthetic glucocorticoid
Prednisolone Acetate,52-21-1,CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O,GPCR/G protein,Glucocorticoid Receptor,synthetic corticosteroid drug
Prednisone,1953-3-2,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Others,Others,Glucocorticoid receptor agonist
Pregnenolone,145-13-1,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C,Neuroscience,AChR,steroid hormone
Pridinol Methanesulfonate,6856-31-1,CS(=O)(=O)O.C1CCN(CC1)CCC(C2=CC=CC=C2)(C3=CC=CC=C3)O,Others,Others,Anticholinergic / antiparkinsonian agent
Prilocaine,721-50-6,CCCNC(C)C(=O)NC1=CC=CC=C1C,Others,Others,local anesthetic of the amino amide type
Prilocaine hydrochloride,1786-81-8,CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl,Others,Others,Local anesthetic of the amino amide type
Primaquine Diphosphate,63-45-6,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2.OP(=O)(O)O.OP(=O)(O)O,Microbiology & Virology,Antimalaria,"antimalarial agent,blocks protein synthesis"
Primidone,125-33-7,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,Membrane Transporter/Ion Channel,Sodium Channel,anticonvulsant of the pyrimidinedione class
Probenecid,57-66-9,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,Membrane Transporter/Ion Channel,TRPV,"inhibitor of organic anion transport, MRP and pannexin-1 channel"
Probucol,23288-49-5,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,Metabolism,LDL,"Antioxidant, anti-inflammatory and hypocholesterolemic agent"
Procainamide HCl,614-39-1,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl,Membrane Transporter/Ion Channel,Sodium Channel,sodium channel blocker
Procaine,59-46-1,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N,Others,Others,Sodium channel inhibitor
Procarbazine HCl,366-70-1,CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl,DNA Damage/DNA Repair,DNA Synthesis,Antineoplastic chemotherapy drug
Prochlorperazine,58-38-8,CN(CC1)CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4,Others,Others,Dopamine (D2) receptor antagonist
Proflavine Hemisulfate,1811-28-5,C1=CC(=CC2=NC3=C(C=CC(=C3)[NH3+])C=C21)N.C1=CC(=CC2=NC3=C(C=CC(=C3)[NH3+])C=C21)N.[O-]S(=O)(=O)[O-],Microbiology & Virology,Anti-infection,Slow-acting disinfectant with bacteriostatic action
Progesterone,57-83-0,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progesterone
Promethazine HCl,58-33-3,CC(N(C)C)CN1C2=CC=CC=C2SC3=CC=CC=C31.Cl,Neuroscience,Histamine Receptor,histamine H1 receptor antagonist
Propafenone HCl,34183-22-7,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O.Cl,Membrane Transporter/Ion Channel,Sodium Channel,classic anti-arrhythmic medication
Proparacaine HCl,5875-6-9,CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N.Cl,Membrane Transporter/Ion Channel,Sodium Channel,voltage-gated sodium channels antagonist
Propofol,2078-54-8,,,,
Propranolol HCl,318-98-9,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl,GPCR/G protein,Adrenergic Receptor,Competitive non-selective beta-adrenergic receptors inhibitor
Propylparaben,94-13-3,,Others,others,
Propylthiouracil,51-52-5,CCCC1=CC(=O)NC(=S)N1,Others,Others,thyroperoxidase and 5'-deiodinase inhibitor
Prostaglandin E2,363-24-6,,GPCR/G protein,Prostanoid Receptors,
Prostaglandin F2&#945;,38562-01-5,O[C@@H](C1)[C@H](C/C=C\CCCC(O)=O)[C@@H](/C=C/[C@H](CCCCC)O)[C@@H]1O.OCC(CO)(CO)N,GPCR/G protein,Prostanoid Receptors,Prostaglandin E2 and F2α receptor agonist
Protionamide,14222-60-7,CCCC1=NC=CC(=C1)C(=S)N,Microbiology & Virology,Anti-infection,thioamide derivative with antitubercular activity
Protopine,130-86-9,,Natural Products,Calcium Channel,
Protoporphyrin IX,553-12-8,O=C(CCC1=C2/C=C3C(CCC(O)=O)=C(C(/C=C(C(C)=C/4C=C)\NC4=C/C5=N/C(C(C=C)=C5C)=C\C(N2)=C1C)=N/3)C)O,Others,Others,
Proxyphylline,603-00-9,CN(C(N1C)=O)C2=C(N(CC(O)C)C=N2)C1=O,GPCR/G protein,Adenosine Receptor,A1 adenosine receptor antagonist
Prucalopride,179474-81-8,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,Neuroscience,5-HT Receptor,5-HT4A and 5-HT4B receptor agonist
Prulifloxacin (Pruvel),123447-62-1,C21H20FN3O6S,Others,APIs,
PSI-7977,1190307-88-0,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,DNA Damage/DNA Repair,DNA Synthesis,Antiviral agents for chronic HCV infection
Psoralen,66-97-7,,Natural Products,TGFβ1,
PTC124 (Ataluren),775304-57-9,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,Membrane Transporter/Ion Channel,CFTR,CFTR-G542X nonsense allele inhibitor
Puromycin dihydrochloride,58-58-2,O[C@H]1[C@H]([C@@H](CO)O[C@H]1N2C3=NC=NC(N(C)C)=C3N=C2)NC([C@H](CC(C=C4)=CC=C4OC)N)=O.Cl.Cl,DNA Damage/DNA Repair,DNA Synthesis,allows selection for cells expressing the resistance gene puromycin N-acetyl-transferase (PAC) and successful Cas9-induced knock-in with puromycin resistance gene.
Pyrantel Pamoate,22204-24-6,CN1CCCN=C1C=CC2=CC=CS2.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O,Microbiology & Virology,Anti-infection,anthelmintic agent
Pyrazinamide,98-96-4,C1=CN=C(C=N1)C(=O)N,Microbiology & Virology,Antibiotic,antitubercular agent
Pyridostigmine Bromide,101-26-8,C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-],Neuroscience,AChE,Reversible cholinesterase inhibitor
Pyridoxal 5 phosphate,54-47-7,,Metabolism,Vitamin,
Pyridoxine,65-23-6,CC1=C(O)C(CO)=C(CO)C=N1,Metabolism,Vitamin,
Pyridoxine HCl,58-56-0,CC1=NC=C(C(=C1O)CO)CO.Cl,Metabolism,Vitamin,a form of vitamin B6
Pyrimethamine,58-14-0,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,Metabolism,DHFR,DHFR inhibitor
Pyrocatechol,120-80-9,,Others,Others,
Pyrogallol,87-66-1,OC1=C(O)C(O)=CC=C1,Immunology/Inflammation,ROS,
Quercetin,117-39-5,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,PI3K/Akt/mTOR Signaling,PI3K,Antitumor agent
Quercetin dihydrate,6151-25-3,C15H10O7.2H2O,PI3K/Akt/mTOR Signaling,PI3K,
Quercitrin,522-12-3,,Natural Products,Immunology & Inflammation related,
Quetiapine,111974-69-7,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist
Quetiapine Fumarate,111974-72-2,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C(=CC(=O)O)C(=O)O,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist
Quinacrine 2HCl,69-05-6,C23H30ClN3O.2HCl,Metabolism,Phospholipase,
Quinapril HCl,82586-55-8,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O.Cl,Endocrinology and Hormones,RAAS,angiotensin-converting enzyme (ACE) inhibitor
Quinestrol,152-43-2,C[C@@]12[C@@]([H])(CC[C@@]2(O)C#C)[C@]([C@]3([H])CC1)([H])CCC4=C3C=CC(OC5CCCC5)=C4,Endocrinology and Hormones,Estrogen/progestogen Receptor,synthetic estrogen that is effective in hormone replacement therapy
Quinidine,56-54-2,O[C@H](C(C1=C2)=CC=NC1=CC=C2OC)[C@@H]3[N@@]4C[C@@H](C=C)[C@@H](CC4)C3,Membrane Transporter/Ion Channel,Other Channel Modulators,reduces both Na+ and K+ channel currents
Quinine,130-95-0,,Microbiology & Virology,Parasite; Potassium Channel,"Potassium channel blocker, orally active"
Quinine HCl Dihydrate,6119-47-7,C20H24N2O2.HCl.2H2O,Membrane Transporter/Ion Channel,Potassium Channel,
Quizartinib (AC220),950769-58-1,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,Tyrosine Kinase,FLT3,"FLT3 inhibitor,potent and selective"
R-(−)-Mandelic Acid,611-71-2,,Others,Others,Used as a building block to synthesize pharmaceutical drugs such as penicillin and cephalosporin
R788 disodium,1025687-58-4,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)([O-])[O-])C.[Na+].[Na+],Tyrosine Kinase,Spleen Tyrosine Kinase (Syk),"Syk inhibitor,ATP competitive and potent"
Rabeprazole,117976-89-3,CC(C(OCCCOC)=CC=N1)=C1CS(C2=NC3=CC=CC=C3N2)=O,Membrane Transporter/Ion Channel,Proton Pump,proton pump inhibitor
Rabeprazole sodium,117976-90-6,CC(C(OCCCOC)=CC=N1)=C1CS(C2=NC3=CC=CC=C3[N-]2)=O.[Na+],Membrane Transporter/Ion Channel,Proton Pump,proton pump inhibitor
Racecadotril,81110-73-8,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2,Others,Endopeptidase,Potent enkephalinase inhibitor
Radotinib(IY-5511),926037-48-1,CC1=C(NC2=NC=CC(C3=CN=CC=N3)=N2)C=C(/C(O)=N/C4=CC(N(C=N5)C=C5C)=CC(C(F)(F)F)=C4)C=C1,Apoptosis,Bcl-2 Family,Bcr-Abl tyrosine kinase inhibitor
Raloxifene HCl,82640-04-8,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O.Cl,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor (ER)
Raltegravir (MK-0518),518048-05-0,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,Proteases,HIV Integrase,HIV-1 integrase inhibitor
Raltitrexed,112887-68-0,CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O,DNA Damage/DNA Repair,DNA Synthesis,Thymidylate synthase inhibitor
Ramelteon,196597-26-9,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,GPCR/G protein,MT Receptor,"Agonist of melatonin receptor(M1-M2),highly selective"
Ramipril,87333-19-5,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Proteases,ACE,angiotensin-converting enzyme (ACE) inhibitor
Ranitidine,66357-59-3,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C.Cl,Neuroscience,Histamine Receptor,Histamine H2-receptor antagonist
Ranolazine,95635-55-5,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,Others,Others,Anti-ischemic
Ranolazine 2HCl,95635-56-6,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O.Cl.Cl,Membrane Transporter/Ion Channel,Calcium Channel,Partial fatty acid oxidation inhibitor
Rapamycin (Sirolimus),53123-88-9,O[C@H]1[C@H](OC)C[C@H](C[C@@H](C)[C@H](CC([C@H](C)/C=C(C)/[C@H]([C@@H](OC)C([C@@H](C[C@@H](/C=C/C=C/C=C(C)/[C@@H](OC)C[C@@H]2CC[C@@H](C)[C@@](C(C(N3[C@H]4CCCC3)=O)=O)(O)O2)C)C)=O)O)=O)OC4=O)CC1,PI3K/Akt/mTOR Signaling,mTOR,Original antifungal antibiotic
Rasagiline,136236-51-6,,Metabolism,MAO,Selective and irreversible propargylamine inhibitor of monoamine oxidase (MAO) B
Rasagiline Mesylate,161735-79-1,CS(=O)(=O)O.C#CCNC1CCC2=CC=CC=C12,Metabolism,MAO,Irreversible MAO-B inhibitor
Rebamipide,90098-04-7,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl,Others,Others,cholecystokinin type 1 (CCK1) receptor inhibitor
Reboxetine mesylate,98769-84-7,CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3.CS(=O)(=O)O,Others,Others,Potent and selective inhibitor of noradrenalin uptake
Regadenoson,313348-27-5,C/N=C(O)/C(C=N1)=CN1C2=NC(N)=C(N=CN3[C@@]4([H])[C@@](O)([H])[C@@](O)([H])[C@@](O4)([H])CO)C3=N2,GPCR/G protein,Adenosine Receptor,Highly selective and low affinity A2A adenosine agonist
Regorafenib,755037-03-7,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,Tyrosine Kinase,c-RET,Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
Regorafenib hydrochloride,835621-07-3,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F.Cl,Tyrosine Kinase,c-RET,Tyrosine kinase inhibitor
Regorafenib monohydrate,1019206-88-2,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F.O,Tyrosine Kinase,c-RET,Tyrosine kinase inhibitor
Repaglinide,135062-02-1,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,Membrane Transporter/Ion Channel,Potassium Channel,Kir6 (KATP) channel blocker
Reserpine,50-55-5,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,Natural Products,Others,
Reserpine hydrochloride,16994-56-2,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC.Cl,Membrane Transporter/Ion Channel,Monoamine transporter,Blocker of VMAT
Resiquimod (R-848),144875-48-9,,Immunology/Inflammation,TLR,
Resorcinol,108-46-3,,Microbiology & Virology,Anti-infection,
Resveratrol,501-36-0,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,Chromatin/Epigenetics,Sirtuin,SIRT1 activator
Retapamulin,224452-66-8,O[C@H]([C@](C)(C=C)C1)[C@H](C)[C@]2(CCC3=O)[C@]3([H])[C@@]([C@@H]1OC(CSC4C[C@](CC5)([H])N(C)[C@]5([H])C4)=O)(C)[C@H](C)CC2,Microbiology & Virology,Antibiotic,"Pleuromutilin antibiotic,protein synthesis inhibitor"
Retigabine,150812-12-7,C16H18FN3O2,Membrane Transporter/Ion Channel,Potassium Channel,
Retigabine dihydrochloride,150812-13-8,C16H20Cl2FN3O2,Membrane Transporter/Ion Channel,GABA Receptor,
Retinyl (Vitamin A) Palmitate,79-81-2,CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C,Metabolism,Vitamin,ester of retinol (vitamin A) and palmitic acid
RG7388,1229705-06-9,CC(C)(C)CC1C(C(C(N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,Apoptosis,p53,"MDM2 antagonist, oral, selective"
Rhynchophylline,76-66-4,,Natural Products,potassium voltage-gated channel subfamily H member 2,
Ribavirin,36791-04-5,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,Microbiology & Virology,Anti-infection,Antiviral guanosine ribonucleoside analog
Ribostamycin Sulfate,53797-35-6,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)O)O)O)N.OS(=O)(=O)O,Microbiology & Virology,Anti-infection,aminoglycoside antibiotic
"Ridaforolimus (Deforolimus, MK-8669)",572924-54-0,C53H84NO14P,PI3K/Akt/mTOR Signaling,mTOR,
Rifabutin,72559-06-9,O[C@H]([C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(C)\C(NC1=C2C3=NC4(CCN(CC(C)C)CC4)N2)=O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)/C=C/O[C@@]5(C)OC6=C(C5=O)C3=C(C(O)=C6C)C1=O,Microbiology & Virology,Antibiotic,anti-TB(tuberculosis) medicine
Rifampin,13292-46-1,O[C@H]([C@H](C)[C@H]([C@H](/C=C/C=C(C)/C(NC1=C2O)=O)C)O)[C@@H](C)[C@@H]([C@H](C)[C@H](/C=C/O[C@@]3(C)OC4=C(C)C(O)=C2C(C(/C1=C/NN5CCN(C)CC5)=O)=C4C3=O)OC)OC(C)=O,Microbiology & Virology,Antibiotic,DNA-dependent RNA polymerase inhibitor
Rifapentine,61379-65-5,O[C@H]([C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C1/C)[C@@H](C)[C@@](OC(C)=O)([H])[C@H](C)[C@@H](OC)/C=C/O[C@@]2(C)OC3=C(C2=O)C(C(O)=C4/C=N/N5CCN(C6CCCC6)CC5)=C(C(O)=C3C)C(O)=C4NC1=O,Microbiology & Virology,Antibiotic,antibiotic drug used in the treatment of tuberculosis
Rifaximin (Xifaxan),80621-81-4,O[C@@H]([C@H](C)[C@H]([C@H](/C=C/C=C(C)\C(NC1=C2O)=O)C)O)[C@@H](C)[C@@H]([C@H](C)[C@H](/C=C/O[C@@](C3=O)(C)OC4=C3C(C5=C1N(C=CC(C)=C6)C6=N5)=C2C(O)=C4C)OC)OC(C)=O,DNA Damage/DNA Repair,DNA Synthesis,"RNA synthesis inhibitor, PXR activator"
"Rigosertib (ON-01910,Estybon)",1225497-78-8,COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)NCC(=O)[O-].[Na+],Cell Cycle/Checkpoint,PLK,Plk1 inhibitor
Rilmenidine Phosphate,85409-38-7,C10H19N2O5P,Others,Imidazoline Receptors,
Rilpivirine,500287-72-9,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,Microbiology & Virology,HIV,Inhibitor of next-generation nonnucleoside reverse transcriptase
Riluzole,1744-22-5,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel protein inhibitor
Riluzole (hydrochloride),850608-87-6,NC1=NC2=C(C=C(C=C2)OC(F)(F)F)S1.Cl,Neuroscience,GABA Receptor; Sodium Channel,
Rimantadine,13392-28-4,CC(C12CC3CC(C1)CC(C3)C2)N,Microbiology & Virology,Anti-infection,anti-influenza virus drug
Rimantadine Hydrochloride,1501-84-4,CC(C12CC3CC(C1)CC(C3)C2)N,Microbiology & Virology,Influenza A virus,anti-influenza virus drug
Rimonabant,168273-06-1,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl,GPCR/G protein,Cannabinoid Receptor,CB1 receptor antagonist
Riociguat,625115-55-1,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,Others,Guanylate Cyclase,Soluble guanylate cyclase (sGC) stimulator
Risedronate Sodium,115436-72-1,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+],Others,Others,FPP synthase inhibitor
Risperidone,106266-06-2,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,Neuroscience,5-HT Receptor,SR-2A inhibitor
Ritodrine HCl,23239-51-2,CC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O.Cl,GPCR/G protein,Adrenergic Receptor,β-2 adrenergic receptor agonist
Ritonavir,155213-67-5,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,Proteases,HIV Protease,HIV protease inhibitor
Rivaroxaban,366789-02-8,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,Metabolism,Factor Xa,Factor Xa inhibitor
Rivastigmine,123441-03-2,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,Neuroscience,AChR,Cholinesterase inhibitor
Rivastigmine Tartrate,129101-54-8,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C.C(C(C(=O)O)O)(C(=O)O)O,Neuroscience,AChR,AChR inhibitor
Rizatriptan Benzoate,145202-66-0,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O,Neuroscience,5-HT Receptor,5-HT Receptor agonist
Rocilinostat (ACY-1215),1316214-52-4,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,DNA Damage/DNA Repair,HDAC,Selective HDAC6 inhibitor
Rocuronium Bromide,119302-91-9,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],Neuroscience,AChR,TGF-βR I kinase inhibitor
Rofecoxib,162011-90-7,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Neuroscience,COX,COX-2 inhibitor
Roflumilast,162401-32-3,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,Metabolism,PDE,PDE-4 inhibitor
Rolipram,61413-54-5,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,Metabolism,PDE,PDE4-inhibitor and an anti-inflammatory agent
"Romidepsin (FK228, depsipeptide)",128517-07-7,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,DNA Damage/DNA Repair,HDAC,"HDAC1/HDAC2 inhibitor,potent and selective"
Ronidazole,7681-76-7,CN1C(=CN=C1COC(=O)N)[N+](=O)[O-],Microbiology & Virology,Anti-infection,antiprotozoal agent
Ropinirole HCl,91374-20-8,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1.Cl,Neuroscience,Dopamine Receptor,selective dopamine D2-receptor agonist
Ropivacaine HCl,98717-15-8,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor
Ropivacaine hydrochloride monohydrate,132112-35-7,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.O.Cl,Membrane Transporter/Ion Channel,Sodium Channel,"anaesthetic, long-acting and local"
"Roscovitine (Seliciclib,CYC202)",186692-46-6,CCC(CO)NC1=NC2=C(C(=N1)NCC3=CC=CC=C3)N=CN2C(C)C,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK inhibitor,potent and selective"
Rosiglitazone,122320-73-4,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,Metabolism,PPAR,Potent PPARγ agonist
Rosiglitazone HCl,302543-62-0,CN(C1=CC=CC=N1)CCOC2=CC=C(CC3C(NC(S3)=O)=O)C=C2.Cl,Metabolism,PPAR,PPARγ agonist
Rosiglitazone maleate,155141-29-0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O,Metabolism,PPAR,"PPARγ agonist,high-affinity and selective,potent insulin sensitizer"
Rosmarinic acid,20283-92-5,C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)O)O,Natural Products,IκB/IKK,Anti-inflammatory and antimicrobial reagent
Rosuvastatin,287714-41-4,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,Metabolism,HMG-CoA Reductase,Competitive inhibitor of HMG-CoA reductase
Rosuvastatin Calcium,147098-20-2,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Ca+2],Endocrinology and Hormones,RAAS,HMG-CoA reductase inhibitor
Rotundine,483-14-7,COC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2)OC)OC)C=C1)OC,Neuroscience,Dopamine Receptor,"Dopamine D1 receptor antagonist,potent and selective"
Roxatidine Acetate HCl,93793-83-0,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2.Cl,Neuroscience,Histamine Receptor,Specific and competitive histamin H2-receptor antagonist
Roxithromycin,80214-83-1,CCC1C(C(C(C(=NOCOCCOC)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Microbiology & Virology,Anti-infection,semi-synthetic macrolide antibiotic
"Rucaparib (AG-014699,PF-01367338)",459868-92-9,OP(O)(O)=O.FC1=CC2=C3C(CCNC2=O)=C(C4=CC=C(CNC)C=C4)NC3=C1,Chromatin/Epigenetics,PARP,Potent PARP inhibitor
Rufinamide,106308-44-5,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,Membrane Transporter/Ion Channel,GABA Receptor,voltage-gated sodium channel blocker
Rupatadine Fumarate,182349-12-8,CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2.C(=CC(=O)O)C(=O)O,Neuroscience,Histamine Receptor,Inhibitor of PAF and histamine (H1) receptor
Rutin,153-18-4,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O,Natural Products,Immunology & Inflammation related,
Ruxolitinib (INCB018424),941678-49-5,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,Chromatin/Epigenetics,JAK,JAK inhibitor
Ruxolitinib phosphate,1092939-17-7,[HH].C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OOP(=O)=O,Chromatin/Epigenetics,JAK,JAK1/JAK2 inhibitor
S- (+)-Rolipram,85416-73-5,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,Metabolism,PDE,CAMP-specific PDE4 inhibitor
S/GSK1349572,1051375-16-6,CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,Proteases,HIV Integrase,"HIV integrase inhibitor, novel and potent"
Safinamide Mesylate,202825-46-5,CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O,Metabolism,MAO,"MAO-B inhibitor,potent,selective and reversible"
Saikosaponin A,20736-09-8,,Natural Products,NF-κB,
Salbutamol Sulfate,51022-70-9,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O,GPCR/G protein,Adrenergic Receptor,β-2 adrenergic receptor agonist
Salicylamide,65-45-2,,Immunology/Inflammation,Immunology & Inflamm,
Salicylanilide,87-17-2,C1=CC=C(C=C1)NC(=O)C2=CC=CC=C2O,Microbiology & Virology,"Reverse Transcriptase, Integrase, Anti-infection","Antiviral,antibacterial,antifungal reagent"
Salicylic acid,69-72-7,C1=CC=C(C(=C1)C(=O)O)O,Neuroscience,COX,COX inhibitor
Salidroside,10338-51-9,,Natural Products,Others,
Salinomycin,53003-10-4,CCC(C1CCC(C(O1)C(C)C(C(C)C(=O)C(CC)C2C(CC(C3(O2)C=CC(C4(O3)CCC(O4)(C)C5CCC(C(O5)C)(CC)O)O)C)C)O)C)C(=O)O,Stem Cell,Wnt/β-catenin,Polyether ionophore antibiotic;anti-cancer
Salirasib,162520-00-5,CC(=CCCC(=CCCC(=CCSC1=CC=CC=C1C(=O)O)C)C)C,MAPK Signaling,RasGAP (Ras- P21),Inhibitor of active Ras protein
Salmeterol xinafoate,94749-08-3,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O.C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O,GPCR/G protein,Adrenergic Receptor,β2-adrenergic receptor agonist
Sanguinarine,2447-54-3,C[N+]1=CC2=C3OCOC3=CC=C2C(C=C4)=C1C(C4=C5)=CC6=C5OCO6,Natural Products,Antioxidant,
Sanguinarine chloride,5578-73-4,C[N+]1=C2C(C=CC3=CC(OCO4)=C4C=C32)=C5C=CC(OCO6)=C6C5=C1.[Cl-],Chromatin/Epigenetics,Protein Ser/Thr Phosphatases,Inhibitor of PP2C and MKP-1
Saquinavir mesylate,149845-06-7,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O.CS(=O)(=O)O,Proteases,HIV Protease,HIV Protease Inhibitor
SAR245409 (XL765),1349796-36-6,CC1=C(C=C(C=C1)C(=O)NC2=CC=C(C=C2)S(=O)(=O)NC3=NC4=CC=CC=C4N=C3NC5=CC(=CC(=C5)OC)OC)OC,PI3K/Akt/mTOR Signaling,PI3K,mTOR/PI3K inhibitor
Saracatinib (AZD0530),379231-04-6,CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6,TGF-β / Smad Signaling,Bcr-Abl,"Src/Abl inhibitor,potent and selective"
Sarpogrelate hydrochloride,135159-51-2,O=C(OC(COC1=CC=CC=C1CCC2=CC(OC)=CC=C2)CN(C)C)CCC(O)=O.Cl,GPCR/G protein,5-HT Receptor,5-HT2A receptor inhibitor
Sasapyrine,552-94-3,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,Immunology/Inflammation,Reactive Oxygen Species,Nonsteroidal oral anti-inflammatory agent
Saxagliptin,361442-04-8,C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N,Proteases,DPP-4,Selective DPP4 inhibitor
Sclareol,515-03-7,CC1(CCCC2(C1CCC(C2CCC(C)(C=C)O)(C)O)C)C,Natural Products,Others,
Scopine,498-45-3,[H][C@]12O[C@@]1([H])[C@@](C3([H])[H])([H])N(C([H])([H])[H])[C@]2([H])C([H])([H])[C@@]3([H])O[H],GPCR/G protein,Adrenergic Receptor,α1-adrenergic receptor agonist
Scopolamine butylbromide,149-64-4,O=C([C@H](C1=CC=CC=C1)CO)O[C@H]2C[C@@H]3[N@@+](CCCC)(C)[C@H](C2)[C@H]4O[C@@H]34.[Br-],Natural Products,Others,
Scopolamine hydrobromide,114-49-8,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4.Br,Natural Products,AChR,
Scopoletin,92-61-5,O=C1C=CC2=CC(OC)=C(C=C2O1)O,Immunology/Inflammation,AChE,
Scutellarin,27740-01-8,,Natural Products,Others,
Secnidazole,3366-95-8,CC1=NC=C(N1CC(C)O)[N+](=O)[O-],Microbiology & Virology,Anti-infection,nitroimidazole anti-infective
Semagacestat (LY450139),425386-60-3,CC(C)C(C(=O)NC(C)C(=O)NC1C2=CC=CC=C2CCN(C1=O)C)O,Neuroscience,Amyloid β,γ-secretase inhibitor
Sennoside A,81-27-6,,Natural Products,MAO,
Sennoside B,128-57-4,,Natural Products,PDGFR,
Serotonin HCl,153-98-0,C1=CC2=C(C=C1O)C(=CN2)CCN.Cl,Neuroscience,5-HT Receptor,Endogenous 5-HT receptor agonist
Sertaconazole nitrate,99592-39-9,C1=CC2=C(C(=C1)Cl)SC=C2COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl.[N+](=O)(O)[O-],Microbiology & Virology,Anti-infection,Broad-spectrum antifungal
Sertraline HCl,79559-97-0,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl.Cl,Neuroscience,SSRIs,selective serotonin re-uptake inhibitor (SSRI)
Sildenafil,139755-83-2,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,Metabolism,PDE,"PDE5 inhibitor, selective"
Sildenafil Citrate,171599-83-0,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Metabolism,PDE,Treat erectile dysfunction and PAH
Sildenafil mesylate,1308285-21-3,C23H34N6O7S2,Metabolism,PDE,
Silodosin,160970-54-7,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,GPCR/G protein,Adrenergic Receptor,α1-adrenoceptor antagonist
Silymarin,22888-70-6,COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O,Natural Products,Others,
Simeprevir,923604-59-5,COC1=CC=C(C(O[C@H]2CC(C(N(C)CCCC/C=C\[C@H]3C[C@@]3(C(NS(=O)(C4CC4)=O)=O)NC5=O)=O)[C@H]5C2)=CC(C6=NC(C(C)C)=CS6)=N7)C7=C1C,Proteases,HCV Protease,Inhibitor of HCV NS3/4A protease
Simvastatin (Zocor),79902-63-9,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,Metabolism,HMG-CoA Reductase,HMGCR (HMG-CoA reductase) inhibitor
Sinomenine,115-53-7,,Natural Products,Others,
Sinomenine Hydrochloride,6080-33-7,C19H24ClNO4,Natural Products,"Immunology & Inflammation related,Autophagy",
Sitafloxacin Hydrate,163253-35-8,C1CC12CN(CC2N)C3=C(C=C4C(=C3Cl)N(C=C(C4=O)C(=O)O)C5CC5F)F.O,Microbiology & Virology,Anti-infection,"new-generation, broad-spectrum oral fluoroquinolone antibiotic"
Sitagliptin,486460-32-6,C16H15F6N5O,Proteases,DPP-4,
Sitagliptin phosphate monohydrate,654671-77-9,[HH].C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.O.OOP(=O)=O,Proteases,DPP-4,Potent DPP-4 inhibitor
Sivelestat (ONO-5046),127373-66-4,O=C(O)CNC(C1=CC=CC=C1NS(=O)(C2=CC=C(OC(C(C)(C)C)=O)C=C2)=O)=O,Proteases,Elastase,neutrophil elastase inhibitor
SKF 525A (hydrochloride),62-68-0,O=C(OCCN(CC)CC)C(C1=CC=CC=C1)(CCC)C2=CC=CC=C2.Cl,Metabolism,P450,cytochrome P (CYP)450 inhibitor
sn-Glycero-3-phosphocholine,28319-77-9,C[N+](C)(C)CCOP(=O)([O-])OCC(CO)O,Others,Others,Nootropic phospholipid
Sodium 4-Aminosalicylate,6018-19-5,C1=CC(=C(C=C1N)O)C(=O)[O-].O.O.[Na+],Immunology/Inflammation,NF-κB,NF-κB inhibitor
Sodium 4-amiropparaty Hyalrate,94-16-6,C1=CC(=CC=C1C(=O)NCC(=O)[O-])N.[Na+],Others,Others,Sodium 4-amiropparaty Hyalrate
Sodium Aescinate,20977-05-3,C55H85NaO24,Natural Products,Others,
Sodium ascorbate,134-03-2,O=C1C(O)=C([O-])[C@@H]([C@@H](O)CO)O1.[Na+],Metabolism,Vitamin,mineral salts of ascorbic acid
Sodium benzoate,532-32-1,,Others,Others,
Sodium butyrate,156-54-7,CCCC(=O)[O-].[Na+],DNA Damage/DNA Repair,HDAC,Histone deacetylase inhibitor
Sodium Danshensu,67920-52-9,C1=CC(=C(C=C1CC(C(=O)[O-])O)O)O.[Na+],Natural Products,P450 (e.g. CYP17),
Sodium dodecyl sulfate,151-21-3,C12H25NaO4S,Others,Others,
sodium fluoride,7681-49-4,,Metabolism,phosphatases,
Sodium Monensin,22373-78-0,O[C@H]1C[C@]2(O[C@H]([C@H](C)[C@@H]([C@@H](C([O-])=O)C)OC)[C@@H]1C)O[C@@](CC2)(C)[C@@H]3O[C@](CC3)(CC)[C@H]4O[C@H]([C@H]([C@@H](C)C[C@H]5C)O[C@]5(CO)O)C[C@H]4C.[Na+],Others,Others,naturally polyether ionophore antibiotic
Sodium Monofluorophosphate,10163-15-2,[O-]P(=O)([O-])F.[Na+].[Na+],Others,phosphatase,Pyruvate kinase/alkaline phosphatase inhibitor
Sodium Nitrite,7632-00-0,N(=O)[O-].[Na+],Immunology/Inflammation,ROS,myeloperoxidase inhibitor
Sodium Nitroprusside,14402-89-2,,Others,Others,nitric oxide (NO) donor
Sodium Phenylbutyrate,1716-12-7,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+],DNA Damage/DNA Repair,HDAC,Histone deacetylase inhibitor
Sodium phosphate dibasic,7558-79-4,OP([O-])([O-])=O.[Na+].[Na+],Others,Reagents,Commonly used in biological assay buffers
Sodium Picosulfate,10040-45-6,C1=CC=NC(=C1)C(C2=CC=C(C=C2)OS(=O)(=O)[O-])C3=CC=C(C=C3)OS(=O)(=O)[O-].[Na+].[Na+],Others,Others,laxative
Sodium salicylate,54-21-7,C1=CC=C(C(=C1)C(=O)[O-])O.[Na+],Immunology/Inflammation,NF-κB,NF-κB inhibitor
Sodium Tauroursodeoxycholate (TUDC),35807-85-3,C[C@]([C@@]1([H])CC[C@@]2([H])[C@@]([C@](O)([H])C[C@]3([H])C[C@@](O)([H])CC[C@@]34C)([H])[C@]4([H])CC[C@]12C)([H])CC/C([O-])=N/CCS(O)(=O)=O.[Na+],Others,Others,water soluble bile salt
Solifenacin succinate,242478-38-2,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5.C(CC(=O)O)C(=O)O,Neuroscience,Muscarinic Receptor,Muscarinic receptor antagonist
Sorafenib,284461-73-0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,MAPK Signaling,Raf,Raf kinases and tyrosine kinases inhibitor
Sorafenib Tosylate,475207-59-1,CC1=CC=C(C=C1)S(=O)(=O)O.CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,Tyrosine Kinase,PDGFR,
Sorbitol,50-70-4,C(C(C(C(C(CO)O)O)O)O)O,Others,Others,sugar alcohol
Sotalol,959-24-0,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.Cl,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor antagonist
Sotalol hydrochloride,959-24-0,C12H21ClN2O3S,GPCR/G protein,Adrenergic Receptor,
Sotrastaurin (AEB071),425637-18-9,CN1CCN(CC1)C2=NC3=CC=CC=C3C(=N2)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,TGF-β / Smad Signaling,PKC,PKC inhibitor
Spectinomycin (hydrochloride hydrate),22189-32-8,[H][C@@]12[C@@](C(C[C@@H](C)O2)=O)(O)O[C@]3([H])[C@@H](NC)[C@@H](O)[C@@H](NC)[C@H](O)[C@@]3([H])O1.Cl.Cl.O.O.O.O.O,Microbiology & Virology,Antibiotic,aminocyclitol antibiotic
Spectinomycin dihydrochloride,21736-83-4,Cl[H].Cl[H].O=C1[C@]2(O[H])O[C@@]([C@@]([C@@]3([H])O[H])([H])N([H])C([H])([H])[H])([H])[C@]([C@@]([C@]3([H])N([H])C([H])([H])[H])([H])O[H])([H])O[C@]2([H])O[C@@](C([H])([H])[H])([H])C1([H])[H],Microbiology & Virology,Anti-infection,new parenteral antibiotic
Spermine,71-44-3,NCCCNCCCCNCCCN,Neuroscience,NMDA,Mixed NMDA glutamate receptor agonist/antagonist at the polyamine site
Spermine tetrahydrochloride,306-67-2,C10H26N4.4HCl,Membrane Transporter/Ion Channel,NMDA Receptor,
Spiramycin,8025-81-8,CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C,Microbiology & Virology,Anti-infection,16-membered ring macrolide (antibiotic)
Spironolactone,52-01-7,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Endocrinology and Hormones,Androgen Receptor,Competitive mineralocorticoid (aldosterone) receptor antagonist
Stavudine (d4T),3056-17-5,CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,Microbiology & Virology,HIV,Reverse transcriptase inhibitor
Stearic Acid,57-11-4,CCCCCCCCCCCCCCCCCC(O)=O,Others,NF-kB,
Stearic Acid methyl ester,112-61-8,CCCCCCCCCCCCCCCCCC(OC)=O,Others,Others,
Stevioside,57817-89-7,,Natural Products,Others,
Stiripentol,49763-96-4,,Metabolism,Dehydrogenase,
Streptomycin sulfate,3810-74-0,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,Microbiology & Virology,Anti-infection,aminoglycoside antibiotic
Streptozocin,18883-66-4,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,Apoptosis,Apoptosis Inducers,Antibiotic and antitumor agent
Succinylcholine Chloride Dihydrate,6101-15-1,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.O.O.[Cl-].[Cl-],Neuroscience,AChR,Nicotinic AChR agonist
Sucralose,56038-13-2,C(C1C(C(C(C(O1)OC2(C(C(C(O2)CCl)O)O)CCl)O)O)Cl)O,Others,Others,artificial sweetener and sugar substitute
sucrose,57-50-1,OC[C@]1([H])[C@](O)([H])[C@@](O)([H])[C@](O)([H])[C@](O[C@]2([C@](O)([H])[C@@](O)([H])[C@@](O2)([H])CO)CO)([H])O1,Metabolism,Endogenous Metabolite,
Sulbactam,68373-14-8,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)C,Microbiology & Virology,Anti-infection,irreversible β-lactamase inhibitor
Sulbactam sodium,69388-84-7,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)[O-])C.[Na+],Microbiology & Virology,Anti-infection,irreversible β-lactamase inhibitor
Sulconazole Nitrate,61318-91-0,C1=CC(=CC=C1CSC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-],Microbiology & Virology,Anti-infection,imidazole derivative with broad-spectrum antifungal activity
Sulfacetamide Sodium,127-56-0,CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+],Ubiquitination/Proteasome,Autophagy,Sulfonamide antibiotic
Sulfadiazine,68-35-9,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,Microbiology & Virology,Antibiotic,Sulfonamide antibiotic
Sulfadimethoxine,122-11-2,COC1=NC(=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N)OC,Microbiology & Virology,Anti-infection,Antimicrobial agent
Sulfadoxin,2447-57-6,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,Microbiology & Virology,Anti-infection,synthetic analog of para-aminobenzoic acid (PABA)
Sulfaguanidine,57-67-0,C1=CC(=CC=C1N)S(=O)(=O)N=C(N)N,Microbiology & Virology,Anti-infection,sulfonamide antibiotic
Sulfamerazine,127-79-7,CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N,Microbiology & Virology,Anti-infection,sulfonamide antibacterial
Sulfameter,651-06-9,COC1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,Microbiology & Virology,Antibiotic,long-acting sulfonamide antibacterial
Sulfamethazine,57-68-1,CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C,Microbiology & Virology,Anti-infection,sulfonamide antibacterial
Sulfamethizole,144-82-1,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,Microbiology & Virology,Anti-infection,sulfathiazole antibacterial agent
Sulfamethoxazole,723-46-6,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,Microbiology & Virology,Anti-infection,sulfonamide bacteriostatic antibiotic
Sulfanilamide,63-74-1,C1=CC(=CC=C1N)S(=O)(=O)N,Microbiology & Virology,Antibiotic,competitive inhibitor for bacterial enzyme dihydropteroate synthetase
Sulfaphenazole,526-08-9,NC1=CC=C(S(NC2=CC=NN2C3=CC=CC=C3)(=O)=O)C=C1,Metabolism,P450,CYP2C9 inhibitor
Sulfapyridine,144-83-2,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,Microbiology & Virology,Antibiotic,short-acting sulfonamide antibiotic
Sulfasalazine,599-79-1,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O,Others,Others,NF-κB activation inhibitor
Sulfathiazole,72-14-0,C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2,Microbiology & Virology,Anti-infection,short-acting sulfa drug
Sulfisoxazole,127-69-5,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,Microbiology & Virology,Anti-infection,selective ETA endothelin receptor antagonist
Sulfisoxazole Acetyl,80-74-0,O=S(C1=CC=C(N([H])[H])C=C1)(N(C(C)=O)C2=C(C)C(C)=NO2)=O,Microbiology & Virology,Bacterial; Endothelin Receptor,sulfonamide antibacterial
Sulindac,38194-50-2,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,Neuroscience,COX,Anti-inflammatory agent;COX inhibitor
Sumatriptan,103628-46-2,CNS(CC1=CC(C(CCN(C)C)=CN2)=C2C=C1)(=O)=O,Neuroscience,5-HT Receptor,5-HT1 receptor agonist
Sumatriptan Succinate,103628-48-4,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O,Neuroscience,5-HT Receptor,5-HT1 receptor agonist
Sunitinib,557795-19-4,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,Tyrosine Kinase,PDGFR,RTK inhibitor
Sunitinib malate,341031-54-7,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C.C(C(C(=O)O)O)C(=O)O,Tyrosine Kinase,VEGFR,VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor
Suprofen,40828-46-4,CC(C1=CC=C(C=C1)C(=O)C2=CC=CS2)C(=O)O,Immunology/Inflammation,TLR,dual COX-1/COX-2 inhibitor
Suramin hexasodium salt,129-46-4,C51H34N6Na6O23S6,Membrane Transporter/Ion Channel,P2X purinergic receptor,
Synephrine,94-07-5,,Natural Products,Adrenergic Receptor,
T 705,259793-96-9,C1=C(N=C(C(=O)N1)C(=O)N)F,Microbiology & Virology,HCV,Potent and selective RNA-dependent RNA polymerase inhibitor
Tacrine hydrochloride,1684-40-8,NC1=C2CCCCC2=NC3=CC=CC=C13.Cl,Neuroscience,AChE,cholinesterase inhibitor
Tacrolimus (FK506),104987-11-3,CO[C@@H]1C[C@H](/C=C(C)/[C@@H](OC([C@]2([H])CCCCN2C(C([C@]3(O)O[C@H]([C@@H](OC)C[C@H](C/C(C)=C/4)C)[C@@H](OC)C[C@H]3C)=O)=O)=O)[C@H](C)[C@H](CC([C@@H]4CC=C)=O)O)CC[C@H]1O,Microbiology & Virology,Antibiotic,"Macrolide calcineurin inhibitor,immunosuppressant"
Tadalafil,171596-29-5,O=C1N(C)CC(N([C@@H]2C(C=C3)=CC4=C3OCO4)[C@]1([H])CC5=C2NC6=CC=CC=C56)=O,Metabolism,PDE,PDE5 inhibitor
TAK-438,1260141-27-2,CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3.C(=CC(=O)O)C(=O)O,Membrane Transporter/Ion Channel,ATPase,Blocker of potassium-competitive acid
TAK-700 (Orteronel),426219-18-3,CNC(=O)C1=CC2=C(C=C1)C=C(C=C2)C3(CCN4C3=CN=C4)O,Endocrinology and Hormones,Androgen Receptor,"Human 17,20-lyase inhibitor"
Tamibarotene,94497-51-5,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,Others,RARs,RARα agonist
Tamoxifen,10540-29-1,CC/C(C1=CC=CC=C1)=C(C2=CC=C(OCCN(C)C)C=C2)\C3=CC=CC=C3,TGF-β / Smad Signaling,Autophagy; Estrogen Receptor/ERR; HSP,TGF-β modulatory and PKC inhibitory effects
Tamoxifen Citrate,54965-24-1,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Endocrinology and Hormones,Estrogen/progestogen Receptor,Antiestrogen drug
Tandospirone,87760-53-0,C21H29N5O2,Neuroscience,5-HT Receptor,
Tanshinone I,568-73-0,,Natural Products,Phospholipase (e.g. PLA),
Tanshinone IIA,568-72-9,,Immunology/Inflammation,IκB/IKK,
Tanshinone IIA---sulfonic sodium,69659-80-9,C19H17O6S.Na,Natural Products,CaMK,
Tasisulam,519055-62-0,C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br,Apoptosis,Caspase,antitumor agent
Taurine,107-35-7,C(CS(=O)(=O)O)N,Others,Others,Glycine receptor agonist
Tauroursodeoxycholic Acid,14605-22-2,C[C@H](CCC(NCCS(O)(=O)=O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@@]21C,Others,Others,
Taxifolin,480-18-2,,Natural Products,VEGFR,
Tazarotene,118292-40-3,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,Others,RARs,Topical retinoid;antiproliferative;inducer of TIG3 tumor suppressor
Tebipenempivoxil,161715-24-8,CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)OCOC(=O)C(C)(C)C)C(C)O,Microbiology & Virology,Anti-infection,Carbapenem antibiotic
Tedizolid,856866-72-3,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)CO)F,Microbiology & Virology,Antibiotic,Oxazolidinone for gram-positive infections
Telaprevir (VX-950),402957-28-2,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,Proteases,HCV Protease,HCV NS3-4A protease inhibitor
Telbivudine,3424-98-4,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,Microbiology & Virology,HBV,Reverse Transcriptase inhibitor
Telmisattan,144701-48-4,CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C,Endocrinology and Hormones,RAAS,Angiotensin II receptor antagonist
Temocapril HCl,110221-44-8,CCOC(=O)C(CCC1=CC=CC=C1)NC2CSC(CN(C2=O)CC(=O)O)C3=CC=CS3.Cl,Endocrinology and Hormones,RAAS,angiotensin-converting enzyme (ACE) inhibitor
Temozolomide,85622-93-1,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,DNA Damage/DNA Repair,DNA Alkylating,"DNA methylating, chemotherapeutic agent"
Temsirolimus,162635-04-3,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H](OC([C@]2([H])CCCCN2C(C([C@]3(O)O[C@@](C[C@H](OC)/C(C)=C/C=C/C=C/[C@H](C[C@@H](C)C4=O)C)([H])CC[C@H]3C)=O)=O)=O)CC([C@H](C)/C=C(C)/[C@@H](O)[C@H]4OC)=O)CC[C@H]1OC(C(CO)(C)CO)=O,PI3K/Akt/mTOR Signaling,mTOR,MTOR inhibitor
Teneligliptin hydrobromide,906093-29-6,CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5.CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5.Br.Br.Br.Br.Br,Proteases,DPP-4,Dipeptidyl peptidase-4 inhibitor
Teniposide,29767-20-2,COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase inhibitor
Tenofovir,147127-20-6,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,Microbiology & Virology,Reverse Transcriptase,HIV reverse transcriptase inhibitor
Tenofovir Disoproxil Fumarate,202138-50-9,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C1N=CN=C2N)OCOC(=O)OC(C)C.C(=CC(=O)O)C(=O)O,Microbiology & Virology,Reverse Transcriptase,Antiretroviral agent( HIV-1 RT inhibitor)
Tenoxicam,59804-37-4,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3,Immunology/Inflammation,,antiinflammatory agent
Terazosin HCl,70024-40-7,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.O.O.Cl,GPCR/G protein,Adrenergic Receptor,Selective α1-adrenoceptor antagonist
Terbinafine,91161-71-6,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,Microbiology & Virology,Antibiotic,Allylamine antifungal agent
Terbinafine HCl,78628-80-5,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21.Cl,Others,Squalene epoxidase,Potent non-competitive inhibitor of squalene epoxidase
Terbutaline Sulfate,23031-32-5,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.OS(=O)(=O)O,GPCR/G protein,Adrenergic Receptor,Selective β2-adrenergic receptor agonist
Terconazole,67915-31-5,C26H31Cl2N5O3,Microbiology & Virology,Anti-infection,Orally bioavailable broad-spectrum triazole antifungal agent
Terephthalic acid,100-21-0,,Others,Others,
Terfenadine,50679-08-8,CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O,Others,Others,Histamine H1-receptor antagonist
Teriflunomide,108605-62-5,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,Others,DHODH,Inhibitor of dihydroorotate dehydrogenase
Tetrabenazine,58-46-8,CC(CC1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1=O)C,Neuroscience,Dopamine Receptor,VMAT-inhibitor
Tetracaine HCl,136-47-0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C.Cl,Membrane Transporter/Ion Channel,Calcium Channel,Anaesthetic and allosteric inhibitor
Tetracycline Hydrochloride,64-75-5,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl,Microbiology & Virology,Antibiotic,Bacteriostatic antibiotics
tetrahydro-L-Biopterin (hydrochloride),69056-38-8,C[C@@H]([C@@H]([C@@]([H])(CN(C(N(C(N)=N1)[H])=C2C1=O)[H])N2[H])O)O.Cl.Cl,Metabolism,Hydroxylase,
Tetrahydrozoline HCl,522-48-5,C1CC(C2=CC=CC=C2C1)C3=NCCN3.Cl,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist
Tetrandrine,518-34-3,,Natural Products,Calcium Channel,
TG101348 (SAR302503),936091-26-8,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,Chromatin/Epigenetics,JAK,"JAK-2 inhibitor,potent and selective"
TH-302,918633-87-1,CN1C(=CN=C1[N+](=O)[O-])COP(=O)(NCCBr)NCCBr,DNA Damage/DNA Repair,Topoisomerase,"Hypoxia-activated prodrug,inhibits H460/HT29 cell growth"
Thalidomide,50-35-1,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,Apoptosis,TNF-α,"Immunomodulatory agent,sedative drug,angiogenesis inhibitor"
Theophylline,58-55-9,CN1C2=C(C(=O)N(C1=O)C)NC=N2,Natural Products,Adenosine Receptor; Autophagy; Endogenous Metabolite; Phosphodiesterase (PDE),
Thiabendazole,148-79-8,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,Others,Others,Fungicide
thiamine,59-43-8,CC([N+](CC(C1=N)=CN=C(N1)C)=CS2)=C2CCO.[Cl-],Others,Others,
Thiamine HCl (Vitamin B1),67-03-8,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-],Metabolism,Vitamin,hydrochloride salt form of thiamine
Thiamphenicol,15318-45-3,CS(=O)(=O)C1=CC=C(C=C1)C(C(CO)NC(=O)C(Cl)Cl)O,Microbiology & Virology,Anti-infection,antimicrobial antibiotic
Thio-TEPA,52-24-4,S=P(N1CC1)(N2CC2)N3CC3,DNA Damage/DNA Repair,DNA Alkylating,alkylating agent used to treat cancer
Thioguanine,154-42-7,C1=NC2=C(N1)C(=S)N=C(N2)N,DNA Damage/DNA Repair,DNA Methyltransferase,Purine antimetabolite
Thioridazine HCl,130-61-0,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC.Cl,Others,Others,Calcium channel protein inhibitor
Thiostrepton,1393-48-2,C72H85N19O18S5,DNA Damage/DNA Repair,DNA Synthesis,
Thonzonium Bromide,553-08-2,C[N+](CCN(C1=NC=CC=N1)CC(C=C2)=CC=C2OC)(C)CCCCCCCCCCCCCCCC.[Br-],Microbiology & Virology,Bacterial,surface active agent and inhibitor of V-ATPase proton transport
Thymidine,50-89-5,,DNA,DNA Synthesis,
Thymol,89-83-8,,Immunology/Inflammation,,
Tiagabine,115103-54-3,CC(C=CS1)=C1/C(C2=C(C=CS2)C)=C/CCN3CCC[C@](C(O)=O)([H])C3,Neuroscience,GABA Receptor,selective gamma-aminobutyric acid (GABA) reuptake inhibitor
Tiagabine hydrochloride,145821-59-6,CC(C=CS1)=C1/C(C2=C(C=CS2)C)=C/CCN3CCC[C@](C(O)=O)([H])C3.Cl,Neuroscience,GABA Receptor,GABA uptake inhibitor
Tianeptine sodium,30123-17-2,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)[O-].[Na+],Neuroscience,5-HT Receptor,"5-HT uptake facilitator,selective,antidepressant"
Ticagrelor,274693-27-5,CCCSC1=NC2=C(C(=N1)NC3CC3C4=CC(=C(C=C4)F)F)N=NN2C5CC(C(C5O)O)OCCO,GPCR/G protein,P2Y Receptor,P2Y12 receptor antagonist
Ticarcillin sodium,29457-07-6,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CSC=C3)C(=O)[O-])C(=O)[O-])C.[Na+].[Na+],Microbiology & Virology,Anti-infection,semisynthetic antibiotic
Ticlopidine HCl,53885-35-1,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl,GPCR/G protein,Adenosine Receptor,Purinergic (P2Y) receptor antagonist
Tideglusib,865854-05-3,C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43,PI3K/Akt/mTOR Signaling,GSK-3,non-ATP-competitive GSK-3β inhibitor
Tigecycline,220620-09-7,CC(C)(C)NCC(=O)NC1=C(C2=C(CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C2O)O)O)C(=O)N)N(C)C)C(=C1)N(C)C)O,Microbiology & Virology,Antibiotic,Glycylcycline antibiotic
Tilmicosin,108050-54-0,CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)O)N(C)C)O)CCN3CC(CC(C3)C)C)C)C)COC4C(C(C(C(O4)C)O)OC)OC,Microbiology & Virology,Anti-infection,macrolide antibiotic
Timolol Maleate,26921-17-5,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O,GPCR/G protein,Adrenergic Receptor,"Non-selective, beta-adrenergic receptor antagonist"
Tinidazole,19387-91-8,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,Microbiology & Virology,Antibiotic,anti-parasitic drug
Tioconazole,65899-73-2,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl,Microbiology & Virology,Anti-infection,antifungal medication
Tiopronin (Thiola),1953-02-2,CC(C(=O)NCC(=O)O)S,Others,Others,Drug for cystinuria treatment
Tiotropium Bromide,136310-93-5,O=C(C(C1=C([H])C([H])=C([H])S1)(C2=C([H])C([H])=C([H])S2)O[H])O[C@@]3([H])C([H])([H])[C@]4([H])[N+](C([H])([H])[H])(C([H])([H])[H])[C@@](C3([H])[H])([H])[C@@]5([H])O[C@@]45[H].[Br-],Neuroscience,AChR,MAChR M antagonist
Tioxolone,4991-65-5,OC1=CC(OC(S2)=O)=C2C=C1,Metabolism,Carbonic Anhydrase,CAI inhibitor
Tipifarnib (Zarnestra),192185-72-1,C27H22Cl2N4O,Metabolism,Transferase,
Tipiracil hydrochloride,183204-72-0,C1CC(=N)N(C1)CC2=C(C(=O)NC(=O)N2)Cl.Cl,Others,Thymidine phosphorylase,Thymidine phosphorylase inhibitor
Tiratricol,51-24-1,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(=O)O)I)I)O,Others,Others,thyroid hormone analogue
Tirofiban hydrochloride monohydrate,150915-40-5,O=C(O)[C@@H](NS(=O)(CCCC)=O)CC1=CC=C(OCCCCC2CCNCC2)C=C1.Cl.O,Others,Glycoprotein,Glycoprotein IIb/IIIa inhibitor
Tivantinib (ARQ 197),905854-02-6,O=C([C@H](C(C1=CC=C2)=CN3C1=C2CCC3)[C@@H]4C5=CNC6=CC=CC=C56)NC4=O,Tyrosine Kinase,c-MET,"C-Met inhibitor,non-ATP-competitive"
Tivozanib (AV-951),475108-18-0,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,Tyrosine Kinase,VEGFR,"VEGFR inhibitor,potent and selective"
Tizanidine,51322-75-9,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,GPCR/G protein,Adrenergic Receptor,α2 adrenergic agonist
Tizanidine HCl,64461-82-1,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl.Cl,GPCR/G protein,Adrenergic Receptor,α2-adrenergic receptor agonist
Tobramycin,32986-56-4,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,Microbiology & Virology,Anti-infection,Aminoglycoside antibiotic
"Tofacitinib (CP-690550,Tasocitinib)",477600-75-2,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,Chromatin/Epigenetics,JAK,Janus kinase inhibitor
Tofacitinib (CP-690550) Citrate,540737-29-9,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Chromatin/Epigenetics,JAK,Potent JAK inhibitor
TOK-001,851983-85-2,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4N5C=NC6=CC=CC=C65)C)O,Endocrinology and Hormones,Androgen Receptor,CYP17 inhibitor and androgen receptor (AR) antagonist
Tolazamide,1156-19-0,C14H21N3O3S,Others,Others,Sulfonylurea receptor 1 (SUR1) inhibitor
Tolazoline HCl,59-97-2,C1CN=C(N1)CC2=CC=CC=C2.Cl,GPCR/G protein,Adrenergic Receptor,non-selective competitive α-adrenergic receptor antagonist
Tolbutamide,64-77-7,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,Membrane Transporter/Ion Channel,Potassium Channel,first generation potassium channel blocker
Tolcapone,134308-13-7,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],Metabolism,Transferase,COMT inhibitor
Tolfenamic Acid,13710-19-5,CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O,Neuroscience,COX,Non-steroidal anti-inflammatory drug
Tolnaftate,2398-96-1,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,Microbiology & Virology,Anti-infection,anti-fungal agent
Tolperisone HCl,3644-61-9,CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2.Cl,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor
Tolterodine tartrate,124937-52-6,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(C(C(=O)O)O)(C(=O)O)O,Neuroscience,Muscarinic Receptor,Competitive muscarinic receptor antagonist
Toltrazuril,69004-03-1,CC1=C(C=CC(=C1)N2C(=O)NC(=O)N(C2=O)C)OC3=CC=C(C=C3)SC(F)(F)F,Microbiology & Virology,Antibiotic,antiprotozoal agent
Tolvaptan,150683-30-0,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,GPCR/G protein,Vasopressin Receptor,AVP V2-receptor antagonist
Topiramate,97240-79-4,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,Metabolism,Carbonic Anhydrase,"GluR5 receptor antagonist,anticonvulsant"
Topiroxostat,577778-58-6,C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N,Others,XAO,Xanthine oxidoreductase (XOR) inhibitor
Topotecan,123948-87-8,CC[C@]1(O)C(C=C2C3=NC4=CC=C(O)C(CN(C)C)=C4C=C3CN2C5=O)=C5COC1=O,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase 1 inhibitor
Topotecan HCl,119413-54-6,Cl[H].O=C1N(C([H])([H])C2=C([H])C(C(C([H])([H])N(C([H])([H])[H])C([H])([H])[H])=C3O[H])=C(C([H])=C3[H])N=C42)C4=C([H])C([C@@](C([H])([H])C([H])([H])[H])5O[H])=C1C([H])([H])OC5=O,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase 1 inhibitor
Torcetrapib,262352-17-0,CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)OC,Metabolism,CETP,CETP inhibitor
Toremifene Citrate,89778-27-8,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Endocrinology and Hormones,Estrogen/progestogen Receptor,Oral selective estrogen receptor modulator (SERM)
Torsemide,56211-40-6,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,Others,Others,pyridine-sulfonyl urea type loop diuretic
Trametinib (GSK1120212),871700-17-3,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5,MAPK Signaling,MEK1/2,"MEK1 and MEK2 inhibitor, potent and selective"
Trametinib DMSO solvate,1187431-43-1,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5.CS(=O)C,MAPK Signaling,MEK1/2,Allosteric MEK1/MEK2 kinase inhibitor
Tramiprosate,3687-18-1,,Neuroscience,Amyloid β,
Trandolapril,87679-37-6,O=C([C@@H](N[C@H](C(OCC)=O)CCC1=CC=CC=C1)C)N2[C@H](C(O)=O)C[C@@]3([H])CCCC[C@@]32[H],Proteases,ACE,angiotensin-converting enzyme (ACE) inhibitor
Tranexamic Acid,1197-18-8,C1CC(CCC1CN)C(=O)O,Others,Others,competitive inhibitor of plasminogen activation
Tranilast,53902-12-8,COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC,GPCR/G protein,Angiotensin Receptor,Angiogenesis inhibitor
Tranylcypromine hydrochloride,1986-47-6,N[C@H]1[C@H](C2=CC=CC=C2)C1.Cl,Chromatin/Epigenetics,Histone Demethylases,LSD1/BHC110 and monoamine oxidase (MAO) inhibitor
Trazodone HCl,25332-39-2,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl.Cl,Neuroscience,5-HT Receptor,5-HT receptor antagonist
Trelagliptin,865759-25-7,CN1C(=O)C=C(N(C1=O)CC2=C(C=CC(=C2)F)C#N)N3CCCC(C3)N,Proteases,DPP-4,"DPP-4 inhibitor,long-acting and selective"
Tretinoin (Aberela),302-79-4,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,Others,RARs,"retinoic acid, treats acne vulgaris and keratosis pilaris"
Triamcinolone,124-94-7,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,GPCR/G protein,Glucocorticoid Receptor,synthetic glucocorticoid agonist
Triamcinolone Acetonide,76-25-5,F[C@@]1([C@@](C([H])([H])[H])(C([H])=C2[H])C3=C([H])C2=O)[C@](C([H])([H])C3([H])[H])([H])[C@@]4([H])[C@@](C([H])([H])[C@]1([H])O[H])(C([H])([H])[H])[C@]5(C(C([H])([H])O[H])=O)OC(C([H])([H])[H])(C([H])([H])[H])O[C@]5([H])C4([H])[H],Others,Others,Antiinflammatory steroid
Triamterene,396-01-0,C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor
Trichlormethiazide,133-67-5,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl,Others,Others,thiazide diuretic
Triciribine,35943-35-2,[H][C@](N1C(N=C([H])N=C2N(C([H])([H])[H])N=C3N([H])[H])=C2C3=C1[H])([C@]4([H])O[H])O[C@@](C([H])([H])O[H])([H])[C@@]4([H])O[H],PI3K/Akt/mTOR Signaling,Akt,"Akt inhibitor,highly selective"
Triclabendazole,68786-66-3,CSC1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl,Cell Cycle/Checkpoint,Microtubule Associated,Microtubule associated inhibitor
Triclosan,3380-34-5,ClC1=C(OC2=CC=C(Cl)C=C2O)C=CC(Cl)=C1,Microbiology & Virology,Antibiotic,broad-spectrum antibacterial agent
Trifluoperazine 2HCl,440-17-5,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.Cl.Cl,Ubiquitination/Proteasome,Autophagy,Dopamine D2 receptor inhibitor
Triflurdine (Viroptic),70-00-8,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,Apoptosis,Thymidylate Synthase,Anti-herpesvirus antiviral drug
Triflusal,322-79-2,CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(=O)O,Neuroscience,COX,COX inhibitor
Trigonelline Hydrochloride,6138-41-6,,Natural Products,Others,
Trilostane,13647-35-3,N#CC1=C([C@@]2([H])O[C@@]2(C([H])([H])C3([H])[H])[C@@](C1([H])[H])(C([H])([H])[H])[C@]4([H])[C@]3([H])[C@@](C([H])([H])C([H])([H])[C@]5([H])O[H])([H])[C@]5(C([H])([H])[H])C([H])([H])C4([H])[H])O[H],Metabolism,Dehydrogenase,3β-HSD inhibitor
Trimebutine,39133-31-8,CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C,Endocrinology and Hormones,Opioid Receptor,Antimuscarinic
Trimethoprim,738-70-5,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,Microbiology & Virology,Anti-infection,bacteriostatic antibiotic
Trimipramine (maleate),521-78-8,CN(C)CC(C)CN1C2=C(C=CC=C2)CCC3=C1C=CC=C3.OC(/C=C\C(O)=O)=O,Neuroscience,Histamine Receptor,potent antagonist of histamine H1 receptor
Tripelennamine HCl,154-69-8,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2.Cl,Neuroscience,Histamine Receptor,H1-receptor antagonist
Triptolide,38748-32-2,,Immunology/Inflammation,NF-κB,
Triptonide,38647-11-9,,Others,dCTP Pyrophosphatase,
Troglitazone,97322-87-7,CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O,Metabolism,PPAR,Selective PPARγ agonist
Trometamol,77-86-1,C(C(CO)(CO)N)O,Neuroscience,COX,proton acceptor used to treat acidemia
Tropicamide,1508-75-4,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2,Neuroscience,AChR,Antimuscarinic drug
Tropisetron,105826-92-4,,Neuroscience,5-HT Receptor,
Trospium chloride,10405-02-4,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],Neuroscience,AChR,Antimuscarinic agent
Troxerutin,7085-55-4,C[C@@](O1)([H])[C@@](O)([H])[C@](O)([H])[C@](O)([H])[C@]1([H])OC[C@]2([H])[C@](O)([H])[C@@](O)([H])[C@](O)([H])[C@@](OC(C(C3=C(O)C=C(OCCO)C=C3O4)=O)=C4C5=CC(OCCO)=C(OCCO)C=C5)([H])O2,Others,Antioxidants,flavonoid
Troxipide,30751-05-4,COC1=CC(=CC(=C1OC)OC)C(=O)NC2CCCNC2,Others,Others,Gastric cytoprotective agent
"TSU-68 (SU6668,Orantinib)",252916-29-3,CC1=C(NC(=C1CCC(=O)O)C)C=C2C3=CC=CC=C3NC2=O,Tyrosine Kinase,VEGFR,"PDGFR/Flk-1/FGFR1 inhibitor,potent and competitive"
Tylosin tartrate,74610-55-2,CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)C)COC4C(C(C(C(O4)C)O)OC)OC.C(C(C(=O)O)O)(C(=O)O)O,Microbiology & Virology,Anti-infection,macrolide antibiotic
Tyramine,51-67-2,OC1=CC=C(CCN)C=C1,GPCR/G Protein,TAAR,
Tyrosol,501-94-0,C1=CC(=CC=C1CCO)O,Natural Products,Others,
"UK 14,304",59803-98-4,BrC1=C(NC2=NCCN2)C=CC3=C1N=CC=N3,GPCR/G protein,Adenosine Receptor,full α2-adrenergic receptor (α2-AR) agonist
Ulipristal,159811-51-5,CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C,Endocrinology and Hormones,Estrogen/progestogen Receptor,progestogen receptor modulator
Ulipristal acetate,126784-99-4,CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C,Endocrinology and Hormones,Estrogen/progestogen Receptor,Novel selective progesterone receptor modulator (SPRM)
Umbelliferone,93-35-6,,Natural Products,Others,
Undecanoic Acid,112-37-8,OC(CCCCCCCCCC)=O,Others,Others,
Uracil,66-22-8,C1=CNC(=O)NC1=O,Others,Others,antineoplastic agent
Urapidil HCl,64887-14-5,CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC.Cl,Neuroscience,5-HT Receptor,α1-adrenoceptor antagonist and 5-HT1A receptor agonist
Urea,57-13-6,O=C(N)N,Others,Reagents,organic compound
Uridine,58-96-8,C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O,DNA Damage/DNA Repair,DNA Synthesis,DNA/RNA synthesis chemical
Ursodiol,128-13-2,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,Others,Others,Bile acids for PBC treatment
Ursolic acid,77-52-1,,Natural Products,Others,
Valaciclovir HCl,124832-27-5,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N.Cl,Microbiology & Virology,Anti-infection,antiviral drug for herpes viruses
Valdecoxib,181695-72-7,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,Neuroscience,COX,COX-2 inhibitor
Valganciclovir HCl,175865-59-5,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N.Cl,Microbiology & Virology,CMV,prodrug for ganciclovir
Valnemulin HCl,133868-46-9,O[C@H]([C@](C)(C=C)C1)[C@H](C)[C@]2(CCC3=O)[C@@H]3[C@@]([C@@H]1OC(CSC(C)(C)CNC([C@@H](C(C)C)N)=O)=O)(C)[C@H](C)CC2.Cl,Microbiology & Virology,Anti-infection,pleuromutilin antibiotic
Valproic acid,99-66-1,CCCC(CCC)C(=O)O,DNA Damage/DNA Repair,HDAC,HDAC1 inhibitor
Valproic acid sodium salt (Sodium valproate),1069-66-5,CCCC(CCC)C(=O)[O-].[Na+],DNA Damage/DNA Repair,HDAC,HDAC inhibitor
Valsartan,137862-53-4,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,GPCR/G protein,Adenosine Receptor,Angiotensin II AT1 receptor antagonist
Vancomycin hydrochloride,1404-93-9,,Microbiology & Virology,Antibiotic,Narrow-spectrum glycopeptide antibacterial agent
Vandetanib (ZD6474),443913-73-3,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,Tyrosine Kinase,VEGFR,VEGFR2/EGFR antagonist
Vanillic acid,121-34-6,COC1=C(O)C=CC(C(O)=O)=C1,Others,Others,Used as a precursor in the synthesis of a wide range of bio-based epoxy resins and polyesters
Vanillin,121-33-5,OC1=C(C=C(C=O)C=C1)OC,Others,Others,flavorant
Vardenafil,224785-90-4,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,Metabolism,PDE,PDE5 inhibitor
Vardenafil HCl Trihydrate,330808-88-3,C23H32N6O4S.HCl.3H2O,Metabolism,PDE,
Varenicline Tartrate,375815-87-5,O=C([C@]([C@@](C(O[H])=O)([H])O[H])([H])O[H])O[H].[H][C@@]12C([H])([H])C(C([H])([H])N([H])C2([H])[H])([H])C3=C([H])C4=NC([H])=C([H])N=C4C([H])=C13,Neuroscience,AChR,"Subtype-selective agonist of α4β2 nicotinic receptors,orally active"
Vatalanib (PTK787) 2HCl,212141-51-0,C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4.Cl.Cl,Tyrosine Kinase,VEGFR,Tyrosine kinase receptor inhibitor
Vecuronium Bromide,50700-72-6,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-],Neuroscience,AChR,Nonpolarizing neuromuscular relaxant
"Vemurafenib (PLX4032, RG7204)",918504-65-1,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,MAPK Signaling,MEK1/2,BRAF kinase inhibitor
Venlafaxine,99300-78-4,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O.Cl,Neuroscience,5-HT Receptor,Dual serotonin/noradrenalin re-uptake inhibitor
Verapamil HCl,152-11-4,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl,Membrane Transporter/Ion Channel,Calcium Channel,L-type calcium channel blocker
Verteporfin,129497-78-5,O=C([C@H]1[C@](/C(N=C2/C=C(C(C)=C/3C=C)\NC3=C/C4=N/C(C(CCC(O)=O)=C4C)=C\5)=C/C6=C(C)C(CCC(OC)=O)=C5N6)(C)C2=CC=C1C(OC)=O)OC,Others,Others,Photosensitizer used in photodynamic therapy
Vidarabine,5536-17-4,C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O,Microbiology & Virology,HSV,antiviral drug for herpes viruses
Vidofludimus,717824-30-1,FC1=CC(C2=CC=CC(OC)=C2)=CC=C1NC(C3=C(C(O)=O)CCC3)=O,Metabolism,Dehydrogenase,DHODH inhibitor
Vilanterol trifenatate,503070-58-4,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl,GPCR/G protein,Adrenergic Receptor,β2-AR agonist
Vilazodone,163521-12-8,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N,Neuroscience,5-HT Receptor,Combined SSRI and 5-HT1A receptor partial agonist
Vilazodone Hydrochloride,163521-08-2,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N.Cl,Neuroscience,5-HT Receptor,Combined SSRI and 5-HT1A receptor partial agonist
Vildagliptin (LAF-237),274901-16-5,C1CC(N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N,Proteases,DPP-4,DPP-4 inhibitor
vinblastine,865-21-4,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,Natural Products,"Microtubule Associated,AChR",
Vinblastine sulfate,143-67-9,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O,Ubiquitination/Proteasome,Autophagy,Anti-mitotic agent
Vincristine,2068-78-2,O[C@]1(CC)CN(CC2)C[C@@](C1)([H])C[C@](C(OC)=O)(C3=C(OC)C=C(N(C=O)[C@]4([H])[C@@]56C7[C@](C=CCN7CC6)(CC)C(OC(C)=O)[C@@]4(C(OC)=O)O)C5=C3)C8=C2C9=CC=CC=C9N8.OS(O)(=O)=O,Cell Cycle/Checkpoint,Microtubule/Tubulin,"Microtubule disrupter,antitumor agent"
Vindoline,2182-14-1,,Natural Products,Microtubule Associated,
Vinorelbine,71486-22-1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,Natural Products,Microtubule Associated,
Vinorelbine ditartrate,125317-39-7,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC.C(C(C(=O)O)O)(C(=O)O)O.C(C(C(=O)O)O)(C(=O)O)O,Others,Others,Anti-mitotic chemotherapy drug
Vinpocetine,42971-09-5,O=C(C(N1C2=C(C3=C([H])C([H])=C([H])C([H])=C13)C([H])([H])C4([H])[H])=C([H])[C@@]5(C([H])([H])C([H])([H])[H])[C@]2([H])N4C([H])([H])C([H])([H])C5([H])[H])OC([H])([H])C([H])([H])[H],Metabolism,PDE,PDE inhibitor
Vitamin A,68-26-8,,Others,Others,Precursor of active retinoids
Vitamin A Acetate,127-47-9,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCOC(=O)C)C)C,Metabolism,Vitamin,Unsaturated nutritional hydrocarbons
Vitamin B12,68-19-9,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],Metabolism,Vitamin,water soluble vitamin
Vitamin C,50-81-7,O=C1OC(C(O[H])=C1O[H])([H])C(C([H])([H])O[H])([H])O[H],Others,Others,water soluble vitamin
Vitamin D2 (Ergocalciferol),50-14-6,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,Others,Others,DNA Polymerase inhibitor
Vitamin D3,67-97-0,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,Vitamin D Related,VD/VDR,Fat-soluble secosteroids
Vitamin K1,84-80-0,,Metabolism system,Osteocalcin,"Essential vitamin for the synthesis of coagulation factors II, VII, IX, and X in the liver"
Vitexicarpin,479-91-4,,Natural Products,NF-κB,
Voglibose,83480-29-9,C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO,Others,Others,α-glucosidases inhibitor
Vorapaxar,618385-01-6,CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C,Others,Others,"PAR-1 antagonist,potent and orally active"
Voriconazole,137234-62-9,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,Metabolism,CYP3A/CYP450,CYP51 inhibitor
"Vorinostat (SAHA, MK0683)",149647-78-9,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,DNA Damage/DNA Repair,HDAC,HDAC inhibitor
Vortioxetine,508233-74-7,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,Neuroscience,5-HT Receptor,5-HT receptors antagonist
Vortioxetine (Lu AA21004) HBr,960203-27-4,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Br,Neuroscience,5-HT Receptor,"5-HT receptor modulator, antidepressant and anxiolytic"
VRT752271,869886-67-9,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,MAPK Signaling,ERK,ERK1/ERK2 inhibitor
"VX-222 (VCH-222, Lomibuvir)",1026785-59-0,CC1CCC(CC1)C(=O)N(C2CCC(CC2)O)C3=C(SC(=C3)C#CC(C)(C)C)C(=O)O,Proteases,HCV Protease,NNI of HCV RNA polymerase
VX-661,1152311-62-0,C26H27F3N2O6,Membrane Transporter/Ion Channel,CFTR,
"VX-680 (MK-0457,Tozasertib)",639089-54-6,CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5,Chromatin/Epigenetics,Aurora Kinase,Aurora kinase inhibitor
VX-745,209410-46-8,C19H9Cl2F2N3OS,MAPK Signaling,p38,
VX-809,936727-05-8,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,Membrane Transporter/Ion Channel,CFTR,CFTR corrector
Warfarin,81-81-2,CC(CC(C1=C(O)C2=CC=CC=C2OC1=O)C3=CC=CC=C3)=O,Others,Others,anticoagulant drug
Wedelolactone,524-12-9,COC1=CC(=C2C(=C1)OC(=O)C3=C2OC4=CC(=C(C=C43)O)O)O,Immunology/Inflammation,IκB/IKK,
Xylazine,7361-61-7,,GPCR/G protein,Adrenergic Receptor,
Xylazine HCl,23076-35-9,CC1=C(C(=CC=C1)C)NC2=NCCCS2.Cl,GPCR/G protein,Adrenergic Receptor,α2 Adrenoceptor agonist
Xylitol,87-99-0,C(C(C(C(CO)O)O)O)O,Natural Products,Others,
Xylometazoline HCl,1218-35-5,CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C.Cl,GPCR/G protein,Adrenergic Receptor,α1 and α2 adrenergic receptor agonist
Xylose,25990-60-7,C(C(C(C(C=O)O)O)O)O,Others,Others,monosaccharide of the aldopentose type
YM155,781661-94-7,CC1=[N+](C2=C(N1CCOC)C(=O)C3=CC=CC=C3C2=O)CC4=NC=CN=C4.[Br-],Apoptosis,IAP,"Survivin suppressant,apoptosis inhibitor"
Yohimbine Hydrochloride,65-19-0,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O.Cl,Natural Products,Adrenergic Receptor,
Z-Ligustilide,4431-01-0,,Natural Products,Others,
Zafirlukast,107753-78-6,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,GPCR/G protein,Leukotriene Receptor,oral leukotriene receptor antagonist
Zalcitabine,7481-89-2,C1CC(OC1CO)N2C=CC(=NC2=O)N,Microbiology & Virology,Reverse Transcriptase,Reverse transcriptase inhibitor
Zaltoprofen,74711-43-6,CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O,Neuroscience,COX,Cyclooxygenase (COX) inhibitor
Zanamivir,139110-80-8,CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N,Microbiology & Virology,NA,Influenza A/B virus neuraminidases inhibitor
Zibotentan (ZD4054),186497-07-4,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,GPCR/G protein,Endothelin Receptor,"ETA receptor antagonist,potent and specific"
Zidovudine,30516-87-1,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,Reverse transcriptase inhibitor
Zileuton,111406-87-2,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,Immunology/Inflammation,5-Lipoxygenase,"5-lipoxygenase (5-LOX) inhibitor, orally active"
Zinc Pyrithione,13463-41-7,C1=CC(=S)N(C=C1)[O-].C1=CC(=S)N(C=C1)[O-].[Zn+2],Membrane Transporter/Ion Channel,Proton Pump,Proton pump inhibitor
Ziprasidone,146939-27-7,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,Neuroscience,5-HT Receptor,5-HT (serotonin)/dopamine receptor antagonist
Ziprasidone HCl,122883-93-6,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.Cl,Neuroscience,5-HT Receptor,Serotonin and dopamine receptor antagonist
Ziprasidone hydrochloride monohydrate,138982-67-9,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.O.Cl,Neuroscience,5-HT Receptor,5-HT (serotonin)/dopamine receptor antagonist
Zoledronic Acid,118072-93-8,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,Cell Cycle/Checkpoint,Rho,Potent nitrogen-containing bisphosphonates
Zolmitriptan,139264-17-8,CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3,Neuroscience,5-HT Receptor,Potent 5-HT1B/1D/1F agonist
Zonisamide,68291-97-4,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,Membrane Transporter/Ion Channel,Calcium Channel,Antiepileptic with anticonvulsant and mechanistic effect
Zotarolimus(ABT-578),221877-54-9,C52H79N5O12,PI3K/Akt/mTOR Signaling,mTOR,anti-proliferative drug used exclusively in coronary drug eluting stent
Zoxazolamine,61-80-3,C1=CC2=C(C=C1Cl)N=C(O2)N,Others,Others,uricosuric and muscle relaxant
α-L-Rhamnose monohydrate,6155-35-7,C[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)O1.O,Others,Others,"Part of plant cell wall polysaccharides, rhamnogalacturonan I and rhamnogalacturonan"